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Implantation and menstruation share many features consistent with an inflammatory
response. An accumulation of leukocytes in the endometrial stroma, accompanied
by increased vascular permeability, is apparent in the mid-late secretory phase.
Stromal leukocytes comprise macrophages and the uterine specific natural killer
(NK)-like large granular lymphocytes (LGLs), which are believed to be essential for
successful implantation. In the absence of pregnancy, an influx of neutrophils is
observed in the immediate premenstrual phase. It is not known whether migration
from the peripheral circulation contributes to the increase in numbers. A typical C-
X-C chemokine, interleukin-8 (IL-8), selectively attracts and activates neutrophils.
In contrast, a C-C chemokine, monocyte chemoattractant protein-1 (MCP-1)
stimulates the chemotaxis and activation of monocytes, NK cells and T
lymphocytes. Elevated concentrations of prostaglandins E2 and F2« (PGE2 and
PGF2a)> potent modulators of vascular permeability, are detectable in the
perimenstrual phase. Prostaglandins (PGs) are synthesised by cyclooxygenase
(COX), of which two isoforms exist, the constitutively expressed COX-1 and
inducible COX-2.
The present study has investigated the expression of the chemokines IL-8 and MCP-
1, and COX-2 in the human non-pregnant and pregnant endometrium. Both IL-8
and MCP-1 were localised by immunohistochemistry to the perivascular cells of all
blood vessel types in the endometrium. Similarly COX-2 immunostaining was
present in the vasculature and glandular epithelium. Reduced immunoreactivity was
detectable in the periovulatory, early and mid secretory phases. Maximal levels
were identified in the premenstrual or late secretory phase, coinciding with
progesterone withdrawal and in addition, with the accumulation of leukocytes in
uterine stroma. In first trimester decidua, low levels of expression were observed for
IL-8 and COX-2, with slightly higher levels for MCP-1. This pattern was confirmed
by measurement of mRNA levels by non-competitive semi-quantitative RT-PCR.
Equal loading of RNA samples was ensured by measurement of GAP-DH
expression levels. RT-PCR product yield for GAP-DH, IL-8, MCP-1 and COX-2
was determined by ELISA. Maximal expression was observed in menstrual phase
samples. Decidual mRNA expression patterns were consistent with
immunohistochemical data.
The role of progesterone in regulation of local mediator expression was examined
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by immunohistochemical analysis of endometrium and decidua obtained from
women with clinically perturbed progesterone concentrations. Additionally, RNA
extracted from tissue from timed endometrial biopsies was subjected to RT-PCR for
GAP-DH, IL-8, MCP-1 and COX-2. 48 hours after exogenous progesterone
withdrawal a significant elevation in IL-8 and COX-2 mRNA expression was
detected. Further supportive evidence for an inhibitory role for progesterone was the
low expression of IL-8 and COX-2 mRNA in women administered hCG to extend
the lifespan of the corpus luteum. Elevated endometrial immunoexpression of IL-8
and COX-2 was detected in the first few months after exposure to intra-uterine
levonorgestrel, declining with long term exposure. An in vitro culture system was
employed to investigate further chemokine and COX-2 expression. Endometrial
explants were cultured for 2 hours with serum, phorbol myristate acetate (PMA1) and
progesterone. RNA extracted was subjected to amplification by RT-PCR for GAP-
DH, IL-8, MCP-1 and COX-2. A dramatic elevation in the number of mRNA
transcripts for IL-8, MCP-1 and COX-2 was detected following culture with serum,
which was augmented by the addition of PMA. No significant decrease in
expression was observed in the presence of progesterone.
A further aspect of this study was to examine a putative immunomodulatory role of
endometrial prolactin (PRL). PRL is produced by decidualised stromal cells and is
believed to function as an autocrine / paracrine factor in the uterus. The localisation
and temporal expression of PRL-R in the endometrium was investigated. Strong
immunoreactivity was displayed by a subset of stromal cells and glandular
epithelium, from the mid-late secretory phase and continuing into early pregnancy.
This is indicative of a role in decidualisation and paracrine regulation of glandular
activity. The temporal and spatial expression of the chemokines is in agreement
with a role in facilitating leukocyte recruitment to the endometrium. This further
supports both the involvement of IL-8, MCP-1 and PGs in the initiation of
menstruation, and a downregulation by progesterone. PRL-R are present in the
endometrium at a time when leukocyte proliferation / differentiation occurs,
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CHAPTER 1
GENERAL INTRODUCTION & LITERATURE REVIEW
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1.1 The Human Endometrium and Menstrual Cycle
The human endometrium undergoes cyclical activity, with well defined phases of
proliferation, differentiation and degradation (Carson, 1992). This provides a unique
and specialised environment for the implantation of a blastocyst and modulates
subsequent invasion of trophoblast and placentation. In the absence of pregnancy,
the functional layer of the endometrium is shed during menses and rapidly replaced
during the following proliferative phase. These changes are governed by the
endocrine sex steroid hormones oestradiol and progesterone (Johannisson et ah,
1982), released from the ovarian follicle and corpus luteum respectively under the
control of the pituitary gonadotrophin hormones follicle stimulating hormone (FSH)
and luteinising hormone (LH). The histological and morphological features of the
endometrium throughout the menstrual cycle have been described in detail (Noyes et
al., 1950; Buckley et al., 1989; Strauss III et al., 1991; Yen, 1991).
1.11 Proliferative Phase
In the proliferative or follicular phase of the cycle, the upper layer of the
endometrium (functionalis) undergoes rapid regeneration from the basalis
endometrium which is retained after menstruation (Haines et al., 1987).
Progressively increasing circulatory levels of oestradiol from the maturing follicle
direct extensive proliferation of stromal, glandular epithelial cells and vascular
elements. Regeneration is completed by day 5 from the last menstrual period (LMP),
producing a tightly packed stroma of fibroblast-like cells and straight, narrow,
tubular glands comprised of columnar epithelial cells with a low nucleus,
interspersed with small vessels and capillary networks. Mitotic activity is apparent
throughout the proliferative phase, extending three days post ovulation. The
proliferative phase is variable in length and may be subdivided into the early (day 5 -
7) , mid (day 8 - 10) and late (day 11-14) proliferative stages, each displaying
subtle differences in histological appearance. The late proliferative stage, is
especially characterised by extensive glandular growth and pseudo-stratification of
the epithelial cells.
1.12 Ovulation and Secretory Phase
Ovulation is triggered by the LH surge (around day 14) which in turn is stimulated
by a peak in oestradiol levels. Luteinisation of the corpus luteum results in
production of progesterone and oestradiol from the steroidogenic luteal cells.
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Progesterone is essential for the initiation and maintenance of pregnancy, which is
reflected by its continuous production throughout the gestational period, initially
from the corpus luteum until the placenta takes over steroid production (Csapo et ah,
1973). Many endometrial histological changes are associated with the progesterone
dominated secretory or luteal phase. The luteal phase is generally of constant length
(14 days) and obvious histological differences are identifiable between early (days
15 - 18), mid (days 19 - 24) and late (days 25 - menses) secretory phases. One of the
first indications that ovulation has taken place is the appearance of subnuclear
intracytoplasmic glycogen rich vacuoles in the glandular epithelial cells. This causes
displacement of the nuclei and the glands become tortuous and increase in diameter.
By the mid secretory phase (days 18 - 24), acidophilic secretions are evident in the
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glandular lumen, comprising glycoproteins, uteroglobulin-like protein, pregnancy-
associated endometrial protein (PEP) and pregnancy-associated endometrial a2
globulin (a2PEG) (synonyms: placental protein 14 (PPM), endometrial protein 15,
progestogen-dependent endometrial protein). Although the precise physiological
functions of these secretions are unclear, the temporal production indicates a role in
the preparation of the uterus for implantation, with visible secretory activity peaking
at day 20 - 21. Stromal changes are also evident, with increased vascularisation
accompanied by fluid filled oedema. The first predecidual transformations are
detectable from day 23, with the development of spiral arterioles. Under
progesterone control, closely associated stromal cells are seen to enlarge and become
rounded, with the acquisition of eosinophilic cytoplasm and become surrounded by a
thick pericellular matrix. In the late secretory or premenstrual phase cessation of
glandular secretory activity ensues and glands become dilated and increasingly
tortuous ("sawtoothed appearance"). An accumulation of bone marrow derived cells
is apparent in the stroma. These morphological changes characterising
decidualisation (Finn et ah, 1984) "spread" throughout the functional endometrium
and proceed into deeper layers if pregnancy occurs (Bell, 1991). First trimester
































In the absence of implantation and pregnancy, the terminally differentiated
decidualised endometrium must be shed to allow regrowth of the endometrium.
Failure of a human chorionic gonadotrophin (hCG) signal production from an
implanted blastocyst within 7 days of ovulation results in luteolysis and regression of
the corpus luteum (Yen, 1991). Thus, production of progesterone and oestradiol
ceases, resulting in the breakdown of the endometrium functionalis. Withdrawal of
the steroids affects the integrity of the spiral arterioles and eventually leads to
bleeding. This process facilitates the shedding of the endometrium and menses.
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The shedding of the endometrium at the end of each cycle is a phenomenon almost
unique to humans, the exceptions being old world primates, elephant shrews
(Elephantulus myuras jamesoni) and certain species of bats (Glossophaga soricina
and Carollia). Although the evolution of this wasteful process is not understood, it is
believed to be a reaction to the extensive invasion that characterises the implantation
of the human trophoblast (Finn, 1986; Finn, 1994). To regulate such a potentially
dangerous event, maternal endometrium responds by becoming terminally
differentiated. During the luteal phase, stromal cells undergo decidualisation, an
accumulation of leukocytes in the stroma is apparent and extensive vascularisation
occurs, most notably with the formation of the specialised spiral aterioles. These
changes in stroma and the presence of bone marrow derived cells enables the
production of a variety of local factors capable of modulating invasion. Decidual cell
formation and maintenance and the integrity of the vasculature are entirely
dependent on the presence of progesterone (Finn, 1986). When the steroid hormones
are withdrawn in a non-conception cycle, the decidualised endometrium is sloughed
off to allow the regrowth of the endometrium functionalis. Other animals, such as
mice, also experience invasive implantation and the endometrium undergoes
profound cellular and vascular changes in line with the above outlined theory.
However, this decidualisation only occurs when stimulated by the presence of a
blastocyst in the uterine lumen, unlike in women where decidualisation occurs in
every menstrual cycle, and does not culminate in menses. Menstruation may be
simulated in ovariectomised mice by the induction of pseudodecidualisation by
placing a drop of oil in the steroid primed endometrium. Withdrawal of steroid
treatment results in the initiation of menses, with an accompanying leukocyte
infiltrate (Finn et ah, 1984).
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Little is known about the cellular interactions occurring during normal or
dysfunctional menstruation. Pioneering investigation into the morphological events
involved in menstruation were conducted in 1940 by Markee (Markee, 1940).
Vascular and cellular changes in endometrium transplanted in the anterior chamber
of the eye of the rhesus macaque were observed during the perimenstrual and
menstrual stages. The first sign of impending menses was the apparent slowing of
blood in the functionalis vasculature. This was accompanied by a dramatic reduction
in thickness of the endometrium, presumably due to the reabsorption of the stromal
oedema. Consequently, the highly coiled spiral arterioles were observed to become
compressed, attributed to the "shrinkage" of the tissue, and intense vasoconstriction
of spiral arterioles occurs. This induced a hypoxic state, leading to degradation of
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vessel walls and bleeding from focal points. Fragmented tissue was eliminated by
blood flow from damaged vessels during menses which lasts 3-5 days. With the
cessation of bleeding, regeneration of vasculature and endometrial stromal and
epithelium occurred directed by oestradiol.
The molecular events and biochemical signalling involved in these processes is still
unknown. Recent ultrastructural investigations (Ludwig et al., 1991; Roberts et al.,
1992) have revealed lesions at focal points in both epithelium and stroma and a
significant breakdown of the extracellular matrix (ECM), forming both the basal
lamina of endothelial and epithelial cells and the interstitial matrix. Considerable
interest has consequently been directed into the role of matrix metalloproteinases
(MMPs) in this degradation. This family of secreted zinc proteins comprises the
collagenases, gelatinases and stromelysins, each possessing preferential degradative
activity to particular substrates. MMP-1 (interstitial collagenase) degrades collagen
types I - III, VII and X; MMP-2 (gelatinase-A) degrades gelatins and collagen types
IV, V, VII, XI; MMP-3 (stromelysin) degrades proteoglycans, fibronectin and
laminin and MMP-9 (gelatinase-B) degrades gelatins and collagen types IV and V.
MMPs-1, -2, -3 and -9 have all been detected in the human endometrium
(Salamonsen, 1996a) and in combination would be capable of causing the
degradation of all components of endometrial ECM. Regulation of MMP activity
occurs at the translational level, with induction by a number of growth factors
(epidermal growth factor (EGF), transforming growth factors-a and -(3 (TGF-a,
TGF-[3)) (Matrisian et al., 1990), cytokines (interleukin-1 (IL-1), tumour necrosis
factor-a (TNF-a)) (Salamonsen et al., 1996b), steroid hormones and oncogenes, and
additionally post-translationally with the proteolytic activation of pro-enzymes. A
further element of control is exerted through specific production of tissue inhibitors
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of MMPs (TIMPS) (Nagase, 1991). mRNA transcripts for proMMP-1 and -3 are
detectable in the endometrium in the period immediately prior to and during menses
(Hampton et ah, 1994), with elevations in the expression or activation of MMP-7, -2
and -9 in the premenstrual period (Salamonsen, 1996a). Furthermore,
immunohistochemical localisation has defined a close spatial relationship between
MMPs and regions of endometrial degradation (Brenner et ah, 1996; Salamonsen et
ah, 1996b). The temporal expression is indicative of induction of transcription by
progesterone withdrawal, and this has been verified by in vitro research (Marbaix et
ah, 1992; Marbaix et al., 1995; Brenner et al, 1996; Salamonsen et ah, 1997).
Moreover, an indirect regulation by the steroid via a number of endometrial
lymphoid derived locally acting cytokines and proteases has been postulated for
regulating MMP expression (Salamonsen et al., 1996b). Production of MMPs by
specific endometrial leukocyte subtypes reinforces the role of migratory cells in the
regulation of endometrial function (Shi et al., 1995; Vincent et al., 1997). Further
investigations are being undertaken to verify the involvement and regulation of
MMPs in the initiation of menstruation and additionally in the remodelling that
occurs in the rapid regeneration of the proliferative endometrium. Recent
publications have highlighted an additional role for MMPs-2 and -9 in the tissue
remodelling associated with trophoblast invasion of the maternal decidua during
implantation and placentation (Sharkey et al., 1996; Bjorn et al., 1997).
Since one of the first signs of impending menses is the intense vasoconstriction of
the spiral arterioles, many investigations have attempted to isolate the vasoactive
substances mediating this effect. Prostaglandins, locally acting mediators which have
potent actions on vascular tone, have been implicated in the processes of
menstruation, particularly as high concentrations are detectable in menstrual blood
(Pickles et al., 1965). Prostaglandin F2« (PGF2«) stimulates constriction of blood
vessels and thus it was presumed that PGF2« was responsible for the
vasoconstriction identified preceding menses. Recently, however, more attention has
focused on a family of vasoconstrictor peptides called the endothelins, comprising
endothelin-1 (ET-1), ET-2 and ET-3. Endothelin-1 is the most potent known
vasoconstrictor, and has been detected in the human non-pregnant and pregnant
endometrium localised to the glandular epithelium, with documented peaks in
expression in the perimenstrual period (Cameron et al., 1992; O'Reilly et al., 1992;
Cameron et al., 1993; Maggi et al., 1994; Ohbuchi et al., 1995). Furthermore, the
enzyme responsible for the degradation of endothelin, neutral endopeptidase (NEP),
is produced by the mid secretory phase endometrium, with markedly reduced
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concentrations detectable premenstrually (Casey et al., 1991). An opposite situation,
that is reduced endothelin and elevated NEP, appears to be occurring in the
endometrium of women reporting menorrhagia (Marsh et al, 1997), or abnormal
bleeding which is a common side effect experienced by users of progestin-only
contraceptives (Marsh et al, 1995). Receptors for endothelin, (ETa and ETg) have
been identified on a number of endometrial elements, including the endothelial cells
of vessels, with alterations in subtype expression throughout the menstrual cycle
(O'Reilly et al., 1992). Most notably, ETb is selectively expressed by the
decidualised stromal cells, both during first trimester decidua and in endometrium
exposed to synthetic progestin via an intra-uterine device (Kohnen et al., 1997).
Different functions have been allocated to the two distinct receptors, with
vasoconstrictor activity designated to ETa (Fried et al., 1991). Endothelins have thus
been implicated in a number of uterine functions, firstly in mediating
vasoconstriction before and after menstruation, to regulate blood loss, but also in
facilitating decidualisation and implantation (Cameron et al., 1992; Marsh et al.,
1995; Marsh et al., 1996; Kohnen et al., 1997).
1.14 Implantation
Successful implantation is crucial for the establishment of pregnancy (Edwards,
1995). It involves a distinct series of events, between a perfectly synchronised
embryo and endometrium, beginning with fertilisation of the oocyte to the formation
of a fully functional placenta (Tabibzadeh et al., 1995a). The embryo prepares for
implantation during cleavage. Sufficient divisions must have occurred to create
adequate cell numbers to form the inner cell mass and trophectoderm. Embryonic
transcription is initiated at the 8 cell stage and after hatching from the zona pellucida
on day 7 (Edwards et al., 1978), partial differentiation of the cytotrophoblast cells to
syncytiotrophoblast takes place (Bevilacqua et al., 1988). Trophoblast cells are the
source of numerous growth factors, inducers, and cytokines, which are believed to
assist in the preparation of the uterus for implantation (Edwards, 1995) and adhesion
molecule expression has been detected (Sutherland et al., 1993).
As previously stated, synchronisation of embryo and endometrium is vital for
successful implantation and to this end a putative "implantation window" has been
identified during which the endometrium possesses maximal receptivity (Psychoyos,
1994). This interval of 4 days spans days 20 - 24 of the menstrual cycle and is
characterised by the expression of a number of crucial factors. Firm adhesion of the
blastocyst is believed to be mediated through the cell adhesion molecules integrins
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and their counter receptors on the trophectoderm (Klentzeris, 1997; Sueoka et ah,
1997). Integrins are heterodimeric transmembrane glycoproteins, comprised of an a
and [3 subunit (Klentzeris, 1997). They interact with components of the ECM and
cell surface molecules, facilitating cell-cell communication, cell attachment and
migration. Cycle dependent expression of 3 integrin dimers ocj(31 (collagen / laminin
receptor), OC4P1 (fibronectin receptor) and cxvP3 (vitronectin receptor) in endometrial
glandular and surface epithelium has been identified, the co-expression of which
frame the implantation window (Lessey et ah, 1994). These have proved to be
reliable markers of endometrial receptivity, for instance, in circumstances of luteal
phase defect (LPD), a disorder characterised by a delay in endometrial maturation
and related to infertility, anomalous integrin expression has been reported (Lessey et
t
al., 1996). Administration of steroid hormones in the form of the oral contraceptive
alters integrins associated with uterine receptivity (Somkuti et al., 1996). In addition,
CC4P1 (also named very late antigen-4 (VLA-4)), which is proposed to interact with
fibronectin expressed by trophoblast, is undetectable in women with unexplained
infertility (Klentzeris et al., 1993).
Another marker of endometrial receptivity which has emerged in recent years is
leukaemia inhibitory factor (LIF) (Stewart, 1994). This pleiotropic cytokine,
affecting proliferation and differentiation of variety of cell types, is strongly
expressed by the glandular epithelium in the mid secretory phase, temporally
coinciding with the onset of the implantation window (Charnock-Jones et al., 1994).
Furthermore, in transgenic mice homozygous for LIF deficiency (LIFVLIF"),
implantation failed to occur (Stewart et al., 1992). Preimplantation embryos were
unaffected as indicated by successful implantation when transferred to wild type
recipient mothers and by the "rescue" of implantation in LIF'/LIF" female mice by
exogenous LIF injection. The role LIF plays in human implantation is not yet
understood, but factors negatively influencing endometrial receptivity due to
retardation of endometrial development (Gemzell-Danielsson et al., 1997), such as
administration of 200mg or 400mg of the antigestogens mifepristone (RU486) and
onapristone (ZK98299) immediately postovulation (LH+2), result in diminished LIF
immunoreactivity in glandular epithelium on day LH+6 (Cameron et al., 1997).
Similarly, intermittent daily low dose administration of mifepristone reduces LIF
immunostaining in mid luteal phase glandular epithelium (Gemzell-Danielsson et al.,
1997a).
The process of implantation has been likened to an inflammatory response, with
common features including increased vasopermeability, leukocyte accumulation and
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expression of inflammatory mediators (Kelly et al., 1994). All these factors are
believed to have an integral role in the promotion and modulation of trophoblast
invasion. Of particular interest are the locally acting mediators, interleukin-1 (IL-1)
and prostaglandins (PGs). The IL-1 system has been implicated in the initiation of
implantation, following studies in mice whereby blockade of IL-1 activity, by
exposure to the naturally occurring receptor antagonist, prevents attachment and
implantation of the embryo (Simon et al., 1994). The IL-1 system is comprised of
the 2 ligands, EL-la and IL-1 [3 (which share 26% homology), EL-1 receptors (types 1
and 2) and the previously mentioned receptor antagonist (IL-lra). IL-1 type 1
receptor (IL-1R tl) is expressed by most cell types and appears to be the major route
of signal transduction (Polan et al., 1995). IL-1 (3 is produced and secreted by stromal
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macrophages and vascular endothelial cells of the luteal phase endometrium and
additionally by the peri-implantation embryo (Simon et al., 1993). The expression of
the receptor by glandular and surface epithelium during the implantation window
furthers the supposition that IL-1 is involved in embryo-endometrium interactions
(Simon et al., 1995a). IL-lra has also been detected in the human endometrium as a
product of epithelial cells and circulating monocytes (Simon et al., 1995b), as both
intracellular (Haskill et al., 1991) and secreted (Eisenberg et al., 1990) forms. Thus
complex interplay between all members of the IL-1 system is likely to be a key'
element in regulating implantation.
The involvement of prostaglandins in implantation remains uncertain, although their
temporal expression and specific actions on decidualisation and the vasculature
strongly reinforce an association (Psychoyos et al., 1995). Prostaglandins (PGs) are
produced primarily by the glandular epithelial cells (Smith et al., 1988) and high
concentrations of PGE2 and PGF2a have been detected in the peri-implantation
window and during menstruation (reviewed by (Van der Weiden et al., 1991)).
Progesterone regulated PGE binding sites have been recognised in stromal cells
(Kennedy et al., 1983a; Kennedy et al., 1983b), which are downregulated following
exposure to RU486 (Martel et al., 1989). PGs have been primarily implicated in the
extensive vascular changes occurring immediately prior to implantation (Kennedy et
al., 1981). The dramatic increase in vascular permeability is essential for both
implantation and decidualisation, and administration of PG inhibitor indomethacin
inhibits or delays these events (Lau et al., 1973; Rankin et al., 1979). Moreover, PGE
treatment of cultured stromal cells induces decidualisation (Kennedy, 1986). In the
mouse, the PGE2 receptor (EP2 subtype, through which the vasodilatory effects of
PGE2 are mediated) is selectively expressed by the luminal epithelium at exactly the
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time when implantation would take place (Lim et al., 1997a). It is therefore evident
that a complex network of locally acting factors exists, interacting to promote and
regulate implantation.
The first contact between embryo and endometrium takes place around 5-6 days
after fertilisation, during which the blastocyst has travelled down the fallopian tube
reaching the uterine cavity. The initial contact between embryo and endometrium is
almost certainly mediated or enhanced by the presence of pinopodes on the surface
epithelium of the endometrium (Nikas, 1995). These organelles have been
implicated in the pinocytotic reduction of uterine fluid volume which facilitates
close contact between the trophectoderm and epithelium (Edwards, 1995).
Pinopodes are clearly visible by ultrastructural observation of mid-luteal phase
endometrium (days 19-21) (Martel et al., 1981) corresponding to peak progesterone
levels (Martel et al., 1991). A suggestion that pinopodes may also express cell
adhesion molecules has raised further interest in their role in blastocyst attachment
(Kimber, 1994).
Apposition of embryo and epithelium produces the initial contact and leads to a
further stronger attachment, thought to be mediated through integrins and other cell
adhesion molecules (CAMs) (Klentzeris, 1997; Sueoka et al., 1997). Newly
differentiated syncytiotrophoblast penetrates the surface epithelium, and causes the
degradation of the underlying basement membrane. Further invasion of the
endometrium functionalis takes place, directed towards the specialised spiral
arterioles. The endometrium and basal lamina are systematically degraded as the
trophoblast makes firm contact with the maternal arteries. Once sufficiently bathed
in maternal blood, the cytotrophoblast cells migrate within the syncytiotrophoblast,
and rapid angiogenesis ensues providing the placenta proper with an extensive
vascular network. The highly invasive implantation occurring in humans requires
careful modulation, as over- or under-invasion can lead to a number of clinical
complications, such as placenta accreta, where excessive invasion of the
myometrium and peritoneum occurs resulting in maternal haemorrhage; and
disorders ranging from pre-eclampsia or intrauterine growth retardation to fetal death
with insufficient placentation (Pijnenborg, 1994). There appears to be a finely tuned
balance, probably mediated by the production of numerous local factors by both the
peri-implantation endometrium and the lymphoid cells closely associated with
invading trophoblast (Simon et al., 1996). These will be discussed in more detail in
later sections of the introduction (section 1.3).
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1.2 Sex Steroid Hormones
The ovarian sex steroid hormones, oestradiol and progesterone are responsible for
the broad cyclical changes in endometrial histological appearance, as well as in the
regulation of many paracrine factors. Signal transduction occurs through their
interaction with intranuclear receptors, transcription factors which bind to specific
palindromic hormone response elements (HRE) located in the promoter regions of
target genes, positively or negatively regulating gene expression. Oestrogen (ER)
and progesterone receptors (PgR) belong to a superfamily of nuclear steroid
receptors including glucocorticoid, mineralocorticoid and androgen receptors, and
share many functional similarities (Catt, 1996). In particular, in reproductive tissues,
progesterone binding to PgR is likely to effect transcriptional activity in a similar
fashion to Cortisol (Strahle et al., 1989). The expression of the receptors is tightly
regulated by the steroids themselves, with oestradiol inducing transcription and
translation of both ER and PgR, and progesterone causing their downregulation
(Clarke et ah, 1990). A definitive pattern of steroid receptor expression in the
endometrium has been reported (Lessey et al., 1988; Snijders et al., 1992) and
proves to be a useful tool in assessing endometrial maturation (Garcia et al., 1988;
Bouchard et al., 1991). ER are strongly expressed by glandular and stromal elements
during the proliferative phase, with peak expression prior to ovulation in the late
proliferative stage. Downregulation by progesterone occurs in the secretory phase in
all cell types, resulting in negligible ER presence. Similarly, PgR expression is
elevated in both glandular epithelial and stromal cells in the proliferative phase and
in the immediate postovulatory period. Glandular receptors diminish with exposure
to progesterone and are undetectable during the remainder of the menstrual cycle.
PgR do persist, albeit at a lower level, in the stromal compartment. It is interesting
that in the secretory phase, PgR are particularly apparent around the blood vessels
(see Figure 2), especially the spiral arterioles (Bouchard et al., 1991; Perrot-Applanat
et al., 1994). There is controversial evidence for the expression of PgR by the
endothelial cells, with positive immunostaining detected only during pregnancy
(Bouchard et al., 1991; Wang et al., 1992; Perrot-Applanat et al., 1994). This spatial
expression pattern is maintained throughout pregnancy, with a possible shift from
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Figure 2 Progesterone receptor distribution in the (A) proliferative and (B)
secretory phase endometrium. Immunostaining using a monoclonal antibody specific
for PgR-A and PgRe isoforms was conducted by Dr Hong Wang. Note the presence
of PgR in perivascular cells of blood vessels (V) in secretory phase endometrium.
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Recently a second isoform of both the ER and PgR has been discovered. A novel
ER, named ER-|3, was cloned in 1996 from rat prostate and ovary (Kuiper et al.,
1996) and possesses a high sequence homology cDNA with the existing ER, now
named ER-a (Gustafsson, 1997). Both isoforms of the ER exhibit similar affinities
and specificities for oestrogens, and can induce transcription of an oestrogen
responsive reporter gene construct in a identical fashion. A recent publication reveals
that ER-a and ER-(3 can form transcriptionally active heterodimers (Petterson et al.,
1997). It is believed that differences in the expression of the two isoforms determine
the regulation of target genes in different tissues. There appears to be a degree of
overlap in function, however, as the ER-a knock out mouse described in 1993
possessed no gross histological abnormalities, although multiple reproductive
abnormalities were detected (Lubahn et ah, 1993). The expression of ER-(3 has been
reported in various tissues, including the ovary and uterus (Byers et al., 1997; Deb et
al., 1997), although no detailed studies into endometrial expression have been
conducted to date.
The progesterone receptor exists in the A and B isoforms, following the discovery of
the B form with an 164 amino acid N-terminal extension (Tung et al, 1993). PgRA
(94kDa) and PgRe (120kDa) proteins arise from translation of separate mRNAs due
to different transcription initiation sites on the same gene (Kastner et al., 1990). Both
isoforms bind to progesterone and elicit a positive response (Shrader, 1993).
Differences in signal transduction and cellular response have been suggested
(Kastner et al., 1990), although this has not been confirmed and the implications for
endometrial physiology are equally uncertain. It has been reported that PgRA and
PgRe isoforms can form heterodimers and interact with progesterone response
elements, with potentially different transcriptional activation properties than AA and
BB homodimers (Meyer et al., 1990). An interesting finding is that in certain
situations antigestogen binding to PgRs elicits a positive response, i.e. acts as a
partial agonist (Meyer et al., 1990). Both isoforms of PgR are present in human
endometrium, with peak expression of both in the mid proliferative phase (Wang et
al., 1997b). The ratio of PgRA:PgRB was reported to be increased premenstrually
and immediately after menses (Mangal et al., 1995). PgRe appear to be
preferentially downregulated by progesterone in the secretory phase and in early
pregnancy, whilst PgRA are the dominant form in secretory and decidual stromal
cells (Wang et al., 1997b). The differential regulation of the two forms is further
supported by the findings that in progestin exposed endometrium (via a
levonorgestrel releasing intra-uterine device (Lng-IUS) or subdermal administration
25
(Norplant®)) PgR.A are the predominant isoform (Critchley et al., 1998a; Wang et
ah, 1997a).
Modulation of progesterone levels is a useful tool in reproductive medicine. Since
the discovery of antiprogestins, a greater understanding of progesterone function has
been attained, manifesting itself in the use of the receptor antagonists for a variety of
clinical and biological uses. A common use for mifepristone (RU486) is in the
medical termination of pregnancy (< 9 weeks gestation), in combination with a dose
of a prostaglandin Ei (PGEi) analogue (Cameron et ah, 1986a; Bahzad et ah, 1989).
Investigations into the contraceptive potential of mifepristone or closely related
onapristone are continuing, based on the theory that administration of antiprogestins
delay or disrupt uterine development, thus interfering with endometrial recep'tivity
(Cameron et ah, 1994; Gemzell-Danielsson et ah, 1994).
The precise molecular and cellular actions of the steroid hormones are not fully
realised. For instance, it is not clear whether the effects on endometrial morphology
are conveyed directly through binding to the nuclear receptors in target cells, or
indirectly through steroid responsive cytokine networks. The latter situation is
certainly supported by the obvious steroid mediated changes and events occurring in
cell types when receptor expression is minimal (e.g. induction of epithelial gland
activity in the secretory phase).
1.3 Endometrial Leukocytes
The presence of lymphoid cells in the endometrial stroma has been well
documented. Fluctuations in the number and subtype of endometrial leukocytes have
been reported throughout the menstrual cycle and in pregnancy (Bulmer et al.,
1991a; Starkey et al., 1991). In the proliferative phase, few leukocytes are detectable
in the endometrium. A significant increase in the leukocyte numbers is observed in
the mid to late secretory phase and these remain during early pregnancy (Figure 3).
The majority of endometrial leukocytes are the phenotypically unique large granular
lymphocytes (LGLs, eGLs), which are specific to the uterus and macrophages. In
addition, a small number of T lymphocytes are present scattered throughout the
stroma and surrounding epithelial glands, but no cyclical variations in number have
been observed. Mast cells have been identified scattered throughout the stroma, with
obvious peaks in activation in the mid-secretory and perimenstrual phase (Jeziorska
et al., 1995). In early pregnancy, macrophages and LGLs are the predominant
leukocyte subpopulations in the uterus (Loke et al., 1995a; Loke et al., 1997), but a
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rapid decline in LGL numbers occurs by the third trimester of pregnancy, resulting
in their virtual absence at term (Bulmer et al., 1991a; Haller et ah, 1993). In the
absence of pregnancy, a distinct influx of neutrophils and eosinophils is observed in
the immediate premenstrual phase (Poropatich et al., 1987; Jeziorska et al., 1995).
Macrophages form around 20% of the total endometrial leukocyte population in late
secretory endometrium and first trimester decidua (Loke et al., 1995a). Originally no
fluctuations in cell number throughout the cycle were identified (Bulmer et al.,
1988), but recently the availability of monoclonal antibodies with perhaps greater
specificity for macrophages (e.g. CD68, CD 14) has resulted in opposing findings. In
particular, an increase in macrophage numbers has been noticed from the mid-late
luteal phase and in first trimester decidua (Kamat et al., 1987; Klentzeris et al.,
1992).
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Figure 3 Changes in leukocyte subpopulations throughout the menstrual cycle
and in first trimester of pregnancy. The major subtype are the uterine specific LGLs
(uterine NK cells), the numbers of which increase sharply in the secretory phase and
in early pregnancy. Elevated numbers of macrophages are present in the secretory
phase and a further increase is observed in early pregnancy. No significant
fluctuations in the number of T or B cells is detectable. Reproduced, with
permission, from Loke, Y.W. and King, A., Mol Med Today 3, 153-159
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LGLs are believed to be of the natural killer (NK) cell lineage (Dietl et al., 1992) due
to their strong expression of cell surface antigen CD56 (embryonic neural-cell
adhesion molecule E-NCAM) (Lanier et ah, 1989), which is expressed to a lessor
extent by peripheral circulating NK cells (King et al., 1991). However, other
classical NK markers, including CD 16 and CD3 are absent. LGLs exhibit reduced
cytotoxic activity towards the K562 cell line, a traditional NK cell target (King et ah,
1989). The favoured hypothesis as to the mechanism of LGL appearance in the
endometrium is that a precursor cell type is selectively recruited to the endometrium
from the peripheral circulation, whereby it is activated to become the uterine specific
LGLs (Marzusch et ah, 1993). This is supported by the existence of a subset of
circulating NK cells, which have low surface expression of CD56 and no CD 16
t
expression. These comprise around 1% of peripheral NK cells (Lanier et ah, 1986),
and elevated numbers have been detected in women (King et ah, 1991). Adhesion
molecules capable of facilitating LGL / endothelial interactions have been identified
on decidual blood vessels and LGLs, particularly ICAM and CD1 la (CCLP2) and to a
lessor degree VCAM and counter receptor CDw49a (a4(3i) (Marzusch et ah, 1993),
in agreement with previous examinations of NK cell migration (Allavena et ah,
1992). It has been proposed that upon entry to the endometrium, a precursor cell type
could undergo proliferation and differentiation, with the acquisition of granulated
cytoplasm and increased CD56 cell surface expression (King et ah, 1991). Treatment
of the putative precursor cells with IL-2 upregulates cell surface CD56 expression
and produces a decidual LGL-like phenotype (Dietl et ah, 1992; Saito et ah, 1993a).
Other potential candidates which may be responsible for such an alteration have
been proposed, including C-C chemokines (Maghazachi et ah, 1996), transforming
growth factor-(32 (TGF-|32) (Saito et ah, 1993a), PGE (Linnemeyer et ah, 1993), IL-
12, IL-15, and prolactin (Handwerger et ah, 1992; King et ah, 1992; Loke et ah,
1995b), although no conclusive evidence has been offered.
The exact function of the endometrial population of leukocytes is unknown. Both the
LGLs and macrophages, however, are believed to be an important component of the
decidualised endometrium, vital for the regulation of implantation and placentation
(Bulmer et ah, 1991b; King et ah, 1991). Several studies have examined the
distribution of leukocytes in decidua collected from women suffering recurrent
miscarriage. Although a major cause of spontaneous abortion is fetal genetic
abnormality, between 40-60% of cases remain unexplained (Stray-Pederson et ah,
1984). A link between uterine leukocytes and unsuccessful pregnancy was forged
following the detection of elevated Thl-like (inflammatory) cytokine expression by
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decidual leukocytes derived from cases of recurrent abortion (Hill et al., 1995). This
is believed to create a hostile environment to the developing fetus, and successful
pregnancy has been related to a Th2 profile in the uterus (Lin et ah, 1993)(see
section 1.54). Alterations in endometrial leukocytes have been described in women
suffering from failed pregnancy, including increased ratios of CD4+:CD8+ T cells,
elevated numbers of B cells and classical NK cells (CD57+) and also an overall
reduction in total leukocyte numbers (Lachapelle et ah, 1996; Vassiliadou et ah,
1996).
LGLs cluster near glands and spiral arterioles, thus experiencing a close spatial
relationship with decidualised stromal cells and invading trophoblast (King et ah,
1990; Bulmer et ah, 1991b). A role in the modulation of trophoblast invasion and
protection of the genetically distinct fetus has been postulated. Rejection of foreign
transplanted grafts involves T cell recognition of highly polymorphic major
histocompatibility complex (MHC) antigens (human lymphocyte antigens (HLA)).
HLA Class 1 antigens are expressed by nearly all nucleated cells, and may be
subdivided into classical (HLA-A, -B and -C) and non classical (HLA-E, -F and -G)
families. Extravillous trophoblast expresses both HLA-C and -G (Ellis et ah, 1990;
Kovats et ah, 1990; King et ah, 1996a), both of which exhibit low polymorphism
and surface expression. The prime recognition target cell is believed not to be T
cells, but the uterine specific LGLs (Loke et ah, 1997), reinforcing the evidence for a
primitive immunological system in the uterus (Loke et ah, 1996). Peripheral NK
cells interact with HLA-C and -G via three distinct receptor families. The KIRs
(killer inhibitory receptors) and KARs (killer activator receptors) stimulate opposing
responses, through cytolysis and cytokine production (Gumperz et ah, 1995; Lanier
et ah, 1996). The third receptor designated CD94 (Philips et ah, 1996) is believed to
bind to both HLA-C and -G, and to have a similar role in the modulation of cell
killing and cytokine production. Initial investigations into the expression of KIRs /
KARs and CD94 by decidual LGLs support the hypothesis that LGLs interact with
the non-classical and classical HLA antigens (Loke et ah, 1997). NK cells
preferentially kill cells with little or no surface expression of class I HLA antigens
(the "missing self hypothesis") (Ljunggren et ah, 1990), thus their presence would be
protective to the trophoblast (Pasmany et ah, 1996). A balance is likely to exist
between LGL mediated cell killing and protection depending on the trophoblast
expression of HLA-C and -G and the repertoire of maternal NK receptors (Loke et
ah, 1997).
A further element of regulation of implantation and menstruation is through the
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ability of the LGLs, macrophages, and to some extent neutrophils, to produce a vast
array of immunoregulatory factors including cytokines and prostaglandins (Haller et
ah, 1993; Saito et ah, 1993b; Leslie et ah, 1994; Saito et ah, 1994). Additionally,
stromal macrophages, neutrophils, eosinophils and mast cells may also have a
function in tissue breakdown or remodelling in the perimenstrual and menstrual
period. All have the potential to produce MMPs and additionally, contain potent
activators of endometrial derived MMPs (mast cell tryptase, neutrophil elastase,
granzyme A, perforin etc.) (King et al., 1993; Salamonsen et ah, 1996b). It has also
been proposed that these enzymes could induce trophoblast cell death (Shiver et ah,
1992), possibly in cases of abnormality or over invasion, and additionally can affect
migration and proliferation by altering attachment to the ECM. A role can therefore
be visualised for endometrial leukocytes both in the promotion and regulation of
implantation and as contributors to the tissue breakdown and the inflammatory
response which occurs prior to and during menses.
The factors controlling the mode of appearance and fluctuation of leukocyte
subtypes throughout the menstrual cycle are similarly uncertain. The cyclical pattern
of leukocyte presence is suggestive of steroidal control, but the recent demonstration
that they do not possess either ER or PgR implies that this regulation is exerted
indirectly (King et al., 1996b). In a sheep model, an influx of leukocytes occurs on
withdrawal of progesterone (Staples et al., 1983). It is interesting that the
accumulation of endometrial leukocytes in the human corresponds to decreasing
steroid levels, leading to the hypothesis that progesterone presence allows
decidualisation and suppresses leukocyte infiltration (Clemens, 1977). Withdrawal
of progesterone stimulates an acute inflammatory response, including leukocyte
accumulation, and culminates in menstruation (Finn, 1986). Co-localisation studies
have revealed that in the secretory phase of the menstrual cycle stromal leukocytes
express the cell proliferation marker Ki67 (Pace et al., 1989; Tabibzadeh, 1990; King
et ah, 1991) indicating that the increase in numbers is accounted for, at least in part,
by in situ proliferation. However, the further increase in LGL numbers observed in
first trimester decidua can not be accounted for by proliferation. It is likely however,
that the migration of leukocytes from the peripheral circulation also contributes to
leukocyte accumulation (Lea et al., 1991; Marzusch et al., 1993).
1.4 Leukocyte Migration
Leukocyte migration from the peripheral circulation into tissue stroma occurs at sites
of inflammation. This is a complex multistep event, involving sequential leukocyte
31
adherence, simultaneous expression of leukocyte adhesion molecules and their
corresponding receptors on endothelial cells (Frenette et al., 1996), and directed
migration along a chemotactic gradient (Adams et ah, 1994; Schall et ah, 1994;
Springer, 1990; MacKay and Imhof, 1993). For description purposes, this can be
separated in to 3 main steps:
1. An initial loose contact between leukocyte and the endothelial cells lining the
vessel is mediated by the cell adhesion molecules, selectins. E-selectin / P-Selectin
expression on the luminal endothelium is up-regulated by pro-inflammatory
mediators, such as IL-1 (3 and TNF-a, stimulating endothelial activation. Leukocytes
may then bind via L-Selectin, which contains the carbohydrate sialyl Lewis X
ligand. This forms a transient and reversible bond, permitting "rolling" of the
leukocyte along the endothelial cell surface. This prolonged contact with the
endothelial cells is believed to enhance exposure of the leukocyte to
chemoattractants, and the leukocyte itself may produce mediators to further activate
the endothelium.
2. Rolling is arrested by a secondary activation of integrins on the surface of
leukocytes by an alteration of the extracellular binding domain. These are of the [32
and [31 integrin family which include lymphocyte function-associated antigen - 1
(LFA-1) and very late-activation antigen-4 (VLA-4). These allow the formation of a
firm attachment of the leukocyte via counter receptors such as intercellular adhesion
molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)
respectively. In addition, platelet endothelial cell adhesion molecule (PECAM) has
been identified in the endometrium. These cell adhesion molecules are also up
regulated by the release of proinflammatory mediators IL-1 [3, TNF-a, Interferon-y
(IFN-y) and chemokines. Leukocytes become tightly adhered to the vessel wall and
take on a flattened morphology.
3. Transendothelial migration may now occur, by the extravasation of leukocytes
through cell junctions into the extracellular matrix of underlying tissue. Migration of
the leukocyte into a particular tissue and to a specific location within the stroma is
directed by locally produced chemotactic agents. The transendothelial gradient is
generated by the immobilisation of chemoattractants by components of the ECM.
Glycosaminoglycans (GAGs) on the proteoglycan CD44, particularly chondroitin
sulphate, have been demonstrated to form a scaffolding for C-C chemokine
macrophage inflammatory protein-(3 (MIP-1[3) (Tanaka et al., 1993; Koopman et al.,
1997) and a similar mechanism has been proposed for sequestering interleukin-8 (IL-
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8) and related chemokines (Witt et al., 1994; Middleton et al., 1997). Chemokines
have the potential to facilitate or amplify leukocyte infiltration, by the upregulation
of adhesion molecules (Jonjic et al., 1992).
1.5 Inflammatory Mediators
1.51 Chemokines
A family of cytokines which possess specific chemoattractant activity for leukocyte
subtypes are the chemokines (for reviews (Matsushima et al., 1992; Baggiolini et al.,
1994; Mantovani et al., 1996; Baggiolini et al., 1997)). Chemotactic cytokines or
chemokines play a major role in the recruitment of inflammatory cells to sites of
i
infection, thus being potent mediators of inflammatory responses. Much interest has
been raised into the expression of chemokines, due to their involvement in many
pathological states, including asthma, rheumatoid arthritis, allergies and
atherosclerosis (Gura, 1996; Strieter et al., 1996). The chemokine family comprises a
number of structurally related low molecular weight heparin binding glycoproteins
(8-10 KDa) sharing 20 - 80% homology at the amino acid (aa) level. Members of
the chemokine family are identified by the presence of four highly conserved
cysteine residues. The positioning of the first two N-terminal cysteine residues
determines the classification into one of two subfamilies (Lindley et al., 1993). The
a or C-X-C chemokines are characterised by an intervening unconsented amino acid
residue between the cysteine pair. Conversely, the members of the (3 or C-C family
are recognised by the adjacent positioning of the cysteine residues. The recent
discovery of a novel chemokine, lymphotactin, which does not fit into either
previously designated family, has caused the alteration in the nomenclature to
include a third subfamily (Kelner et al., 1994). This comprises to date just the single
chemokine, with the distinctive structural motif of a single cysteine residue at the N-
terminal region (hence the nomenclature as the C or y chemokine subfamily).
Lymphotactin is chemotactic for T and B lymphocytes but not monocytes or
neutrophils. Earlier this year a further family of chemokines, the fractalkines,
possessing the C-X-X-X-C motif, were described (Bazan et al., 1997; Schall, 1997).
The number of members and the complexity of the chemokine superfamily continues
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Interleukin-8 (IL-8) or neutrophil attractant protein-1 (NAP-1) is a classical
chemokine, whose expression and activity has been extensively investigated. IL-8
belongs to the a or C-X-C family and further members include melanocyte growth
stimulatory activity / growth related oncogene-a (MGSA / GRO-a), GRO-J3, GRO-
y, neutrophil-activating protein derived from epithelial cells (ENA-78) and
interferon-inducible protein (IP-10). Generally, all possess chemotactic activity for
neutrophils, although certain members (IL-8 and IP-10) have been attributed with the
induction of T lymphocyte chemotaxis (Larsen et ah, 1989a; Taub et ah, 1993).
Further properties include activation of neutrophils, by inducing shape change and
exocytosis. Thus neutrophils may be recruited to a site of inflammation upon which
they are activated to release their repertoire of immunomodulatory cytokines and
proteases. This infiltration is enhanced by PGE which acts synergistically in the
migration of neutrophils into rabbit skin sites (Foster et ah, 1989; Rampart et al.,
1989; Colditz, 1990).
IL-8 was originally detected as a monocyte secreted product, but is now known to
also be produced by a variety of cell types, including epithelial, endothelial and
smooth muscle cells, fibroblasts and lymphocytes. The gene encoding IL-8 is
situated on chromosome 4, amongst a cluster of C-X-C chemokine genes in the ql2-
21 region, and is comprised of 4 exons and 3 intronic regions (Matsushima et al.,
1988; Mukaida et al, 1989). Upon induction by numerous pro-inflammatory
mediators, e.g. IL-1, TNF-a, LPS, phorbol esters and certain viruses, the 297bp
coding region is transcribed and translated producing a 99aa precursor protein. After
cleavage of the 20aa leader sequence, the mature form is secreted and subjected to
post translational processing of the N-terminal region. IL-8 exists as a homodimer in
solution, although the monomeric form is the recognised active form (Rajarathnam
et al., 1994).
Monocyte chemoattractant protein-1 (MCP-1) is a typical C-C chemokine. Unlike
the C-X-C family, the P or C-C chemokines do not stimulate neutrophil chemotaxis,
but instead possess chemotactic activity for mononuclear cells particularly
monocytes. MCP-1 additionally is a potent chemoattractant for T lymphocytes (Cai
et al., 1995; Roth et al., 1995), basophils, mast cells (Feliciani et al., 1995) and also
natural killer cells (Allavena et ah, 1994) and IL-2 activated NK cells (Maghazachi
et al., 1994). Other members of the C-C chemokine subfamily are monocyte
chemoattractant proteins-2, -3, -4 and -5 (MCP-2, MCP-3, MCP-4, MCP-5)
(Godiska et al., 1997; Sarafi et al., 1997), eotaxin, macrophage inflammatory
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protein-la and 1(3 (MlP-la and 1(3) and RANTES (Regulated on Activation,
Normal T Expressed and Secreted) (Uguccioni et al., 1995; Uguccioni et al., 1996;
Baggiolini et al., 1997). The genes encoding MCP-1 and other C-C chemokines are
located on human chromosome 17, closely positioned within the q 11-21 region
(Shyy et al., 1990).
MCP-1, the human homologue of the murine JE (Yoshimura et al., 1989), is a 76aa
basic heparin binding protein, displaying varying degrees of glycosylation (Jiang et
al., 1990). MCP-1 is positively regulated by pro-inflammatory stimuli, such as IL-1
and TNF-a, as is IL-8 (Baggiolini et al., 1994), but is additionally induced by
platelet derived growth factor (PDGF) (Zullo et al., 1985). This growth factor has no
i
effect on IL-8 production, indicating that regulatory differences in the gene
expression of these chemokines exists (Yoshimura et al., 1990). Originally detected
as an immediate early gene produced by fibroblasts (Rollins et al., 1988), MCP-1
production by epithelial, endothelial, smooth muscle cells and a variety of lymphoid
cells has since been reported (Larsen et al., 1989b; Yoshimura et al., 1989; Sica et
al., 1990; Wang et al., 1991).
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Table 1 Table of main chemokines:


























































































Chemokines elicit their response via interaction with G protein coupled receptors,
possessing the classical 7 transmembrane domains (Murphy, 1994; Premack et al.,
1996). G (guanine nucleotide) binding proteins are comprised of three subunits, the
a, (3 and y. Ligand binding stimulates guanosine triphosphate (GTP) binding and
hydrolysis. Two high affinity IL-8 receptors exist, the IL-8RA which binds soley to
IL-8, and IL-8RB with specific binding for IL-8 and other members of the C-X-C
family (Horuk, 1994; Chuntharapai et al., 1995). A promiscuous IL-8 receptor
present on erythrocytes (the Duffy antigen receptor for chemokines (DARC) or
erythrocyte chemokine receptor - ECKR) (Hadley et al., 1997), also transduces a
signal through interaction with C-C chemokines including MCP-1, and is believed to
act as a clearance mechanism for circulatory chemokines (Neote et al., 1993). This
antigen, initially identified as participating in Plasmodium vivax (malaria parasite)
cell invasion (Horuk, 1994), has since been detected on a number of non-erythroid
cell types, including endothelial cells of postcapillary venules (Hadley et al., 1994).
This corresponds to the site of leukocyte trafficking and is has been suggested that
chemokines are immobilised on the endothelium through binding to DARC, in a
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similar fashion as chemokine binding to proteoglycans, thus providing another
possible mechanism for chemokine presentation to circulating leukocytes (Hadley et
al., 1997; Middleton et al., 1997).
Multiple C-C chemokine receptors have been identified, each with differing ligand
specificity. CCR1 (formerly named CC CKR1 or MlP-la / RANTES receptor)
interacts with MlP-la, RANTES, MCP-2 and -3 (Gao et al., 1993; Ben-Baruch et
al., 1995). CCR2 is a high affinity receptor for MCP-1 (Neote et al., 1993), but may
also bind to MCP-2, -3, and -4 (Combadiere et al., 1995; Uguccioni et al., 1996).
Three additional receptors have been cloned CCR3 - 5, each recognising at least
three C-C chemokines (Baggiolini et al., 1997).
i
Chemokine binding to virally encoded receptors has also been reported, such as the
human herpes virus and cytomegalovirus encoded receptors. The physiological
significance of this is unknown. Additional interest in chemokine receptors has been
prompted by the finding that the C-C chemokine receptors act as a cell entry co-
factor for HIV-1 (Feng et al., 1996) and MlP-la, MIP-lp and RANTES are
suppressors of viral replication, functioning through blocking entry to the receptor
(Cocchi et al., 1995). Furthermore, humans homozygous for an inactivating mutation
of the CCD5 gene appear to be resistant to HIV-1 (Gao et al., 1997). This has
intensified the search for chemokine receptor antagonists which could have
significant functions in inflammatory situations, other than viral infection.
1.53 Reproductive Significance of Chemokines
The involvement of chemokines in pathological conditions has been well
investigated, however there is increasing evidence for their roles in physiological
situations. Chemokine expression in reproductive tissues has been examined with
regard to a role in normal physiological functioning. Interleukin-8 (IL-8) has been
detected in the human cervix (Barclay et al., 1993), endometrium (Arid et al., 1993;
Critchley et al., 1994), chorio-decidua (Dudley et al., 1993) and the placenta (Saito
et al., 1994). Elevated levels of IL-8 are detectable in amniotic fluid in cases of
infection-associated preterm labour and chorioamnioitis, leading to the speculation
that the chemokine is involved in the pathogenesis of these conditions. A role for IL-
8 in normal parturition has also been proposed (Kelly et al., 1992; Kelly, 1996).
Cervical ripening precedes parturition and is associated with a neutrophil infiltrate. It
has been postulated that these are the major source of collagenases and other MMPs
which are responsible for the softening and increased elasticity of the cervix.
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Increased production of IL-8 in the cervix coincides with neutrophil influx prior to
ripening at term (Osmers et ah, 1995) and cervical ripening can be reproduced in
rabbits and guinea pigs following treatment with IL-8 (Chwalisz et ah, 1994; El
Maradny et al., 1996). Furthermore, IL-8 has been implicated in the premenstrual
infiltrate of neutrophils to the endometrium, where it has been postulated they have a
vital role in the initiation of menstruation (Kelly et al., 1994). Supporting evidence
for the latter hypothesis came from immunohistochemical studies, where IL-8 was
localised to the perivascular cells of blood vessels in non-pregnant and pregnant
endometrium (Critchley et al., 1994). In this position a role in facilitating
recruitment of neutrophils can be conceived.
Induction of IL-8 mRNA and protein by IL-la and TNF-a in cultured endometrial
and decidual stromal and epithelial cells has been observed (Arici et al., 1993).
These findings lend further support to a cytokine network in the uterus. A
suppression of IL-8 production by chorio-decidual cells (Kelly et al., 1994) and
cervix (Ito et al., 1994) by progesterone in vitro has been demonstrated, acting
through progesterone receptors present within the cell, binding to progesterone /
glucocorticoid response elements in the promoter region of the gene. If a similar
downregulation by progesterone occurs in vivo, the withdrawal of progesterone
premenstrually would remove the inhibitory effect, resulting in an increased
production of IL-8 and accompanying neutrophil influx. Little is known about the
downregulation of MCP-1, with the exception of an inhibition by glucocorticoids in
certain cell lines (Brach et al., 1992; Shyy et al., 1995). This could indicate a
negative regulation by progesterone in reproductive tissues.
MCP-1 has not been directly linked with normal uterine function, but a role in the
pathogenesis of endometriosis has been postulated. Peritoneal fluid collected from
laparoscopically diagnosed endometriosis contains elevated levels of MCP-1 and
MCP-1 production by endometriotic cells has recently been described (Akoum et al.,
1996). These findings correlate well with the increased numbers of activated
macrophages present in the lesions (Halme et al., 1983; Halme et al., 1987).
Furthermore, another C-C chemokine, RANTES, which shares many functional
similarities with MCP-1, has been implicated in the aetiology of this disease
(Hornung et al., 1997). A role for MCP-1 in leukocyte recruitment to the normal
endometrium has not been investigated. MCP-1 mRNA and immunoreactive protein
has been detected in ovarian tumours, associated with infiltrating macrophages,
which are thought to contribute to the aetiology of the disorder (Negus et al., 1995).
A recent publication describes MCP-1 in follicular fluid and as a product of ovarian
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stromal cells (Arici et al., 1997). Ovulation is an inflammatory-like response, and a
considerable population of macrophages is present in the follicle prior to rupture. A
role in the process of ovulation through macrophage recruitment was substantiated
by an elevation in MCP-1 levels both after hCG / LH administration and in in vitro
culture systems.
Chemokines also possess properties not associated with leukocyte chemotaxis. IL-8
and MCP-1 are potent activators of neutrophils and monocytes, NK cells and
lymphocytes respectively. Activated leukocytes undergo shape changes, produce an
array of active cytokines, including chemokines, and prostaglandins, and may
release degradative enzymes (Loetscher et al., 1996). A system whereby the local
inflammatory response is amplified can thus be visualised, and further leukocyte
homing is enhanced by upregulation of cell adhesion molecules. C-C chemokines
have also been described to induce T cell proliferation and cytokine production
(Alam, 1997). Of potential relevance in the endometrium, C-C chemokines,
including MCP-1, can induce killer cells from CD56+ NK cells, in a manner similar
to IL-2 generation of LAK cells (Maghazachi et al., 1996). An independent research
group have provided complementary results, of NK cell activation, enzyme release
and Ca2+ mobilisation by C-C chemokines (Loetscher et al., 1996).
A further example is that IL-8 and other C-X-C chemokines containing the E-L-R
(glutamic acid-leucine-arginine) motif in their amino acid sequence, are potent
stimulators of angiogenesis (Strieter et al., 1995a). Conversely, members of the C-X-
C chemokine family that do not contain the E-L-R motif are potent inhibitors of
angiogenesis, e.g. platelet factor 4 (PF4). IL-8 stimulates both endothelial and
smooth muscle cell chemotaxis and proliferation (Koch et al., 1992; Yue et al.,
1994). A role for chemokine induced angiogenesis has been determined in tumour
associated vascularisation (Strieter et al., 1992; Strieter et al., 1995; Arenberg et al.,
1997), and in neovascularisation of ectopic endometrium associated with
endometriosis (Ryan et al., 1995) and a similar involvement in endometrial blood
vessel development could be envisaged. The endometrium is one of the few adult
non-malignant tissues in which angiogenesis regularly takes place (Goodger et al.,
1994). Three peaks in endometrial angiogenesis have been identified (Rogers et al.,
1992), for the regeneration of the functionalis vasculature following menses, in the
mid proliferative phase under oestrogenic control and in the secretory phase whilst
spiral arteriole differentiation occurs in the decidualised endometrium (Kaiserman-
Abramof et al., 1989). There has been considerable evidence for the involvement of
locally active factors in endometrial vessel growth, especially vascular endothelial
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growth factor (VEGF) (Smith, 1996). Evidence of elevated peritoneal concentrations
of IL-8 corresponding to neovascularisation in endometriotic lesions (Ryan et ah,
1995) supports the hypothesis that this chemokine participates in angiogenesis in the
endometrium.
1.54 Cytokines
A role for chemokines in the endometrium can thus be proposed, based on previous
evidence of chemokine and endometrial functions. It must be remembered, however,
that these are just a few components of a widespread and complex network of locally
acting factors which together regulate cellular communications. First identified as
products and modulators of immune cells, it is now clear that cytokines play a piajor
role in the regulation of many physiological and pathological processes in virtually
every cell type. Cytokines are capable of stimulating responses via intercrine,
autocrine, paracrine and endocrine communications. Moreover, they have been
widely recognised as vital mediators in important uterine processes, such as
proliferation, decidualisation, implantation and menstruation, and further provide a
means of communication between embryo and endometrium (Tabibzadeh, 1991;
Tabibzadeh et ah, 1995a). Cytokines rarely function in isolation, and thus a complex
interplay of local factors is likely to contribute to cell signalling in most biological
situations. This creates a great deal of overlap in functions, and introduces
redundancy into the system. The cytokine family encompasses many divisions, the
interleukins (1 - 15), interferons (a, [3 and y), colony stimulating factors (M-CSF, C-
CSF, GM-CSF), tumour necrosis factors (TNF) a and (3, growth factors (epidermal
growth factor (EGF), transforming growth factors (TGF), platelet derived growth
factor (PDGF)). The list is too extensive to examine in full detail in this thesis, but
cytokines with known importance in the hypothalamic-pituitary-ovarian-endometrial
axis, with particular reference to the modulation of inflammatory type situations,
will be discussed. Of particular interest are three pro-inflammatory mediators, IL-1,
TNF-a and IL-6, all of which have been implicated in both normal and
pathologically abnormal uterine functioning (Hill, 1992; Tabibzadeh, 1994a;
Tabibzadeh, 1994b). Diverse functions including modulation of proliferation,
leukocyte chemotaxis and activation, prostaglandin induction and initiation of
menstruation have been attributed to these endometrial cytokines. The tight
regulation of these factors is believed to be a key factor in successful reproduction
(Austgulen et al., 1994).
Interleukin-1 (IL-1), as previously described (section 1.14), is a pro-inflammatory
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mediator which has been implicated in numerous aspects of uterine function. Peaks
of expression of IL-1 a and (3 are observed in the peri-implantation period and prior
to menses. IL-1 functions primarily by inducing the transcription or increased
translation of inflammatory factors, including IL-6, TNF-a, IL-8, MCP-1 and by
induction of PGE synthesis (Romero et al., 1989). The detection of TNF-a and its
two distinct receptors in the utero-placental unit has been well documented. This
cytokine is produced by the secretory (Philippeaux et al., 1993) and menstrual phase
endometrium (Tabibzadeh et al., 1994c) and villous trophoblast (Lea et al., 1997)
and receptors are present in uterine cells. Previously conferred with chemotactic
activity (Ming et al., 1987), this is likely to be an indirect effect via chemokine
production (Matsushima et al., 1988). The expression of TNF-a by the endothelium
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of the endometrium (Philippeaux et al., 1993) reinforces roles in vascular
permeability and induction of apoptosis (Robaye et al., 1991). Inappropriate
expression of TNF-a appears to be detrimental to pregnancy, as demonstrated in a
mouse model, where injection of the proinflammatory cytokine induced abortion
(Chaouat et al., 1990). Additionally, elevated concentrations of both IL-1 and TNF-a
have been identified in the peritoneal fluid of women with endometriosis (Fakih et
al., 1987; Halme, 1989), in agreement with the inflammatory nature of this
pathological disease, and further accounts for the increased levels of peritoneal
chemokines.
IL-1 and TNF-a induce amongst other factors the pleiotropic cytokine interleukin-6
(IL-6). IL-6 in turn downregulates the expression of IL-1 and TNF-a (Chrousos,
1995), thus having an important role in the regulation of the inflammatory response.
IL-6 is ubiquitously produced by a number of lymphoid and non-lymphoid cells,
including the endometrial stroma, glandular epithelium and endothelium
(Tabibzadeh et al., 1989a; Tabibzadeh et al., 1992; Laird et al., 1993), with a
progressive rise in glandular and surface epithelium expression detected in the
secretory phase (Tabibzadeh et al., 1995b). In a cell culture system, IL-6 production
from stromal cells was shown to be inhibited by oestrogen at physiological
concentrations (Tabibzadeh et al., 1989b), which correlates with its inhibitory effect
on stromal cell proliferation (Zarmakoupis et al., 1995). IL-6 is a potent mediator of
immune cell development, particularly T and B cell differentiation, and induces the
synthesis of acute phase proteins (Gauldie et al., 1987). An involvement in
folliculogenesis and regulation of ovarian steroidogenesis has been reported, and it
has been postulated that IL-6 has a main role in the maintenance of endometrial
homeostasis. Soluble and membrane bound forms of the receptor exist, which
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dimerise with signal transducing glycoprotein gp-130. Increased serum
concentrations of soluble receptor are observed during pregnancy (Austgulen et al.,
1994). This has been correlated with a role in early placentation, placental hormone
production (Nishino et ah, 1990) and fetal immune system development (Biesecker
et al., 1993). Recent evidence using knockout mice suggests that IL-6 also stimulates
the expression of chemokines IL-8 and MCP-1, thus augmenting leukocyte
infiltration into tissue sites (Romano et al., 1997).
Pioneering work by Wegmann provided the hypothesis of the Thl / Th2 paradigm
in the maternal-fetal interface (Wegmann et al., 1993). T helper cells (CD4+) may be
classified into two groups, according to cytokine production and thus the type of
immune response stimulated (Kurt-Jones et al., 1987; Mosman et ah, 1989)? It is
now believed that T cells are not the sole sources of these cytokines, and a more
general concept of Thl and Th2 type cytokine production by most cell types is
widely accepted (Mosmann et al., 1996). Thl type cytokines (IL-2, IL-12 and IFN-"i)
are inflammatory cytokines and generally stimulate a cell mediated cytotoxic or
inflammatory response. Th2 type cytokines comprise IL-10, IL-4, IL-5, IL-6 and
cause a switch to humoral (antibody) mediated responses. A Th2 profile has been
postulated to confer local suppression of an inflammatory response and it has been
proposed that a Th2 cytokine environment is favourable for successful allopregnancy
(Wegmann et al., 1993). Indeed upregulation of IL-10 and other Th2 cytokines, is
observed during pregnancy (Lin et al., 1993) and evidence for an upregulation of
Thl cytokines has been detected in failed pregnancy (Hill, 1995; Chaouat et al,
1990; Haynes and Smith, 1997). Thl cytokines are believed to be detrimental to
pregnancy, as TNF-a, IFN-y and IL-2 have all been demonstrated to have adverse
effects on fetal development and trophoblast proliferation (Raghupathy, 1997).
Furthermore, there is evidence for a alleviation of symptoms associated with Thl
type conditions during pregnancy (Da Silver et al., 1992; Krishnan et al., 1996).
Whilst T helper cells make up a minority of endometrial leukocytes, production of
Th2-like cytokines by other lymphoid cells, in particular macrophages, and non-
lymphoid endometrial cells and trophoblast could create this environment (Kelly and
Critchley, 1997a). Prostaglandins are known to be important regulators of
lymphocyte responses, and recently this has been reinforced by the suggestion that
PGE2 regulates the balance between humoral and inflammatory responses, through
the favouring of a Th2 tilt (upregulation of IL-10 and downregulation of IL-12, IFN-
y, IL-2) (Snijdewint et ah, 1993; Strassmann et al., 1994; Hilkens et al., 1995; Kraan
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et al., 1995). Furthermore, IL-10 selectively downregulates Thl cytokines, especially
IFN-yand IL-12 (Fiorentino et al., 1989; Mosmann et ah, 1991). Both IFN-yand EL-
12 are potent mediators of NK cell function, and thus may activate NK cells that
may damage the trophoblast (Drake et al., 1989; Kelly et al., 1997a). The
downregulation of Thl-type cytokines at the maternal-fetal interface during
pregnancy may therefore decrease NK cell cytotoxicity and serve as a protective
mechanism for trophoblast (Kelly, 1996). The hypothesis of the Thl to Th2 switch
during pregnancy remains controversial, however it is widely believed that there is a
bias away from potentially harmful Th 1 type cytokines and towards Th2 cytokine
production in the pregnant uterus (Guilbert, 1996; Vince et al., 1996; Lim et al.,
1998).
1.55 Nitric Oxide
With increasing interest into paracrine interactions within the endometrium, attention
has been focused on local mediators which may contribute to the processes of
implantation, decidualisation and menstruation. Nitric oxide (NO) is a potent
mediator of vascular permeability, immune cell function, and additionally has
inhibitory actions on platelet aggregation and smooth muscle proliferation (Rosselli,
1997). NO is synthesised from L-arginine by nitric oxide synthase (NOS) in many
distinct cell types. Three isoforms of NOS have been identified, two of which are
constitutively expressed and are calcium dependent, endothelial NOS (eNOS) and
neuronal NOS (nNOS), whilst the third, inducible NOS (iNOS), is rapidly induced in
response to inflammatory type stimuli, independent of calcium.
In apparently divergent roles, NO has been identified to act as both an inflammatory
and anti-inflammatory agent. Within the uterus, NOS has been detected in the
glandular, stromal and vascular components of non-pregnant and pregnant
endometrium, as well as in the myometrium (Telfer et al., 1995; Telfer et al., 1997).
During pregnancy, additional NOS mRNA expression has been described in fetal
membranes and placenta (Dennes et al., 1997). Here, NO has been attributed with
roles in maintaining placental perfusion and myometrial quiescence during
pregnancy through its actions as a vasodilator and smooth muscle relaxant (Dennes
et al., 1997). Consistent with this, NO is produced by the decidua and myometrium
throughout pregnancy, but with reduced NOS activity and myometrial responsivess
at term (Natuzzi et ah, 1993; Sladek et al., 1993). Furthermore, inhibition of NO
synthesis by administration of N^-nitro-L-arginine methyl ester (L-NAME) results
in pre-eclamptic like symptoms and maternal hypertension in pregnant rats
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(Buhimschi et al., 1996).
An apparently opposing function has also been proposed for NO in the tissue
remodelling associated with cervical ripening (Chwalisz et al., 1997). Whilst
decidual NO synthesis is downregulated at term, cervical NOS activity increases
(Buhimschi et al., 1996) and local application of NO to the cervix in guinea pigs
stimulates cervical ripening. A similar role may be envisaged in the inflammatory
type response during menstruation, and additionally NO may influence menstrual
blood loss through its vasodilatory action and inhibit platelet aggregation. It is also
noteworthy that leukocytes within the mouse endometrium, including NK cells, mast
cells and macrophages, have been identified as a source of NO, which may have
important implications for leukocyte functioning at the materno-fetal interface'(Hunt
et al., 1997).
These actions are frequently induced through stimulation of other local mediators.
Many investigations have examined the interactions between NO and COX-2, due to
their co-expression in many inflammatory situations (Vane et al., 1994; Dennes et
al., 1997), with somewhat contradictory conclusions. It has, however, been proposed
that NO acts to stimulate the inducible isoform of prostaglandin synthase, as
demonstrated by both in vitro and in vivo studies (Salvemini, 1997), although the
concentration of NO may determine the nature of the effect on COX-2 expression
(Swierkosz et al., 1995). Further, as observed in most biological systems, a negative
feedback loop is likely to exist, with stimulation of COX-2 by NO reported to be
downregulated by PGE2 mediated inhibition of iNOS (Tetsuka et al., 1994). A
different situation exists for MCP-1, with two independent research groups
demonstrating an inhibition of the chemokine by NO (Zeiher et al., 1995; Tsao et al.,
1997). This, at least in part, explains the anti-inflammatory and protective role of NO
in atherosclerosis, which is characterised by monocyte infiltrate. The significance of
this in the endometrium is uncertain.
1.56 Prostaglandins
Another family of locally vasoactive substances are the prostaglandins (PGs) [For
reviews see (Mitchell, 1992; Kelly, 1994)]. PGs are produced by de novo synthesis
from fatty acid precursor arachidonic acid (AA) [see review, (Willis et al., 1994)],
which is released from membrane bound phospholipids (phosphatidylethanolamine
and phosphatidylchlone) by the activation of phospholipase A2 (PLA2) during cell
signalling. Prostaglandin H endoperoxide synthase / cyclooxygenase (PGHS / COX)
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catalyses the conversion to prostaglandins (Fraser et al, 1992). The conversion is rate
limiting and consists of two reactions, both catalysed by COX. The first involves a
double oxidation (cyclooxygenase) reaction producing unstable intermediate PGG2,
which is rapidly converted to another biosynthetic intermediate PGH2 by a
peroxidase reaction. PGH2 is rapidly modified by specific isomerases or synthases to
produce specific prostanoids, the five most commonly produced being PGD2, PGE2,
PGF2a, PGI2 (prostacyclin), and TXA2 (thromboxane). PGE2 and PGF2« are the
most abundant prostaglandins in the human endometrium (Smith et al., 1988). PGE2
is a potent vasodilator, and can induce stromal oedema in the presence of histamine
or bradykinin. PGF201 has a contrasting role in stimulating vasoconstriction and cell
activation.
1
Recently an inducible form of COX was discovered, COX-2 (PGHS-2) (see review,
(Goppelt-Streube, 1995)), first identified as a phorbol ester inducible immediate
early response gene in fibroblasts (TIS10) (Kubjubu et al., 1991; O'Banion et al.,
1992). The two isoforms (COX-1 and COX-2), products of distinct genes, share 60%
homology at the amino acid level, with noticeable differences in the regulatory
regions (Kubjubu et al., 1991). COX-2 expression is dynamically regulated, with
rapid transcription of the 4.1kb mRNA in response to many stimuli, including serum,
growth factors (epidermal growth factor (EGF), PDGF), cytokines (EL-1, TNF-a),
hormones (LH, hCG) (Han et al., 1996) and inflammatory mediators (phorbol ester,
LPS) (Jacobs et al., 1994). It can be regulated both at the transcription level and by
increasing the stability of the mRNA prior to translation. COX-2 displays many
characteristics of an inducible gene, including multiple binding sites in the 5'
untranslated region (e.g. TATA box) and rapid degradation of the mRNA, due to the
presence of AUUUA target sequences for ribonucleases in the 3' untranslated end
(Caput et al., 1986; Malter, 1989). It is rapidly degraded, thus conferring a sensitive
response to environmental factors. Furthermore, an inhibition by glucocorticoids has
been described (O'Banion et al., 1991). COX-2 could be very important in mediating
local activation in a tissue and in pathological situations and thus is likely to be
important for the mediation of acute inflammatory situations (Williams et al., 1973).
COX-1, in comparison, is generally constitutively expressed, and has been proposed
to fulfil the housekeeping role of prostaglandin production (Simmons et al., 1991;
O'Banion et al., 1992). It is interesting that the isoforms of the COX enzyme are
expressed at different subcellular compartments, with COX-2 primarily associated
with the nuclear envelope, whilst COX-1 has been localised to the endoplasmic
reticulum (Morita et al., 1995).
47
Well known for their roles in inflammatory responses mediated mainly through
effects on the vasculature and immune system, the actions of prostaglandins in the
uterus has been investigated in great detail. Initial work concentrated on the
involvement of prostaglandins in mediating parturition, both by cervical ripening in
an inflammatory type response, and induction of myometrial contractility (Calder et
ah, 1973; Calder, 1986). More recently the role of PGs and expression in the
nongravid uterus has been studied, with a view to understanding normal and
abnormal uterine function (Smith et al., 1981). Prostaglandins E2 and F2« (PGE2 and
PGF2«) are produced throughout the menstrual cycle, with well documented peaks
in the mid-secretory phase and peri-menstrual period (Downie et al., 1974; Maathuis
et al., 1978). An involvement of these vasoactive factors in menstruation was first
realised by the detection of large amounts in menstrual fluid (Pickles et al., 1965).
Elevated concentrations of vasodilatory prostaglandins, PGE2 and 6-keto-PGF]a
(metabolite of PGI2) are produced from endometrium of women suffering from
menorrhagia (Smith et al, 1981; Cameron et al, 1987). PGs have been implicated in
the changes in vascular tone associated with menses and further in the
decidualisation of the uterine stroma in the mid-late secretory phase. The importance
of the latter process has been discussed earlier with reference to prostaglandins role
in implantation (section 1.14). Prostaglandins have been noted to accentuate the
action of other mediators, for example, PGE has been observed to act synergistically
with IL-8 in the chemotaxis of neutrophils into rabbit skin (Colditz, 1990) and a
similar situation has been hypothesised in the uterus (Kelly et al., 1994).
Prostaglandins could therefore play important roles both in the mediating and
amplifying the inflammatory response which characterises menstruation.
The distribution of COX (before the identification of the second isoform) in the
uterus has been studied by immunohistochemistry, with the majority of
immunoreactivity in the epithelial glands (Rees et al., 1982). Additional expression
of COX enzyme has been reported in the smooth muscle cells and endothelium of
endometrial blood vessels (Rao et al., 1989). A preliminary investigation into the
localisation of COX-2 found the enzyme present heterogeneously in the perivascular
cells of small blood vessels (Kelly, 1994). The production of PGE in this position
would support the proposed synergistic role of assisting neutrophil influx with IL-8,
and also explain the vasodilatory action.
Interleukin-1 (IL-1) is an important modulator of PG production in the uterus,
presumably through induction of COX-2. Decidual stromal cells have been
demonstrated to produce COX-2 in response to IL-1 (3 (Ishihara et al., 1992), and this
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induction can be inhibited by dexamethasone and progesterone (Ishihara et al.,
1995). This is supported by a downregulation of COX-2 by glucocorticoids in other
cell types (O'Banion et al., 1991; Kubjubu et al., 1992). This finding reinforces the
finding that prostaglandin release from endometrium is inhibited by progesterone. In
the secretory phase, the capacity of the endometrium to produce prostaglandins is
increased, with elevated levels of PGF2a reported (Downie et al., 1974; Abel et al.,
1980; Singh et al., 1984). However, it appears that for the full potential to be
realised, progesterone levels must fall, as they do premenstrually (Smith et al.,
1988). In early pregnancy, basal production of PGs is generally low (Maathuis et al.,
1978) and the tissue does not appear to retain the potential for trauma induced
synthesis. Furthermore, in a culture system, prostaglandin production from
proliferative and secretory endometrium is decreased by progesterone (Abel et al.,
1980; Kelly et al., 1987).
Prostaglandins are important modulators of blood vessel tone, inflammation and the
immune system (Williams et al., 1973; Kunkel, 1988). Tight regulation of
prostaglandin activity is ensured both at the production level by cyclooxygenase
expression and by their metabolism to the inactive 13-14-dihydro-15-keto forms by
prostaglandin dehydrogenase (PGDH). PGDH is a progesterone responsive enzyme,
as indicated by constantly elevated levels during pregnancy and in the early and mid
luteal phases of the menstrual cycle (Casey et al., 1980). A peak in immunoreactive
PGDH in the endometrium is observed in the secretory phase and during pregnancy,
localised to the glandular epithelium. Administration of antigestogen RU486 in the
early luteal phase (Cameron et al., 1997) and during early pregnancy acts to
downregulate PGDH (Cheng et al., 1993b), resulting in increased levels of PGE2
around decidual blood vessels (Cheng et al., 1993a). Additionally, treatment of long
term cultured endometrial cells with RU486 results in elevated PGF2a and PGE2
release in a dose dependant manner (Kelly et al., 1986). This helps to explain the
increased sensitivity of the decidua to exogenous prostaglandins (stimulation of
uterine contractions and bleeding), administered after mifepristone for the
termination of pregnancy (Swahn et al., 1987; Brooks et al., 1990).
Prostaglandins are important agents in stimulating myometrial contraction during
parturition. The PG output from amnion rises at the onset of spontaneous labour, and
elevated levels of both PGE2 and PGF2a> and their metabolites have been detected in
amniotic fluid, maternal plasma and urine at this time. COX-2 has been reported to
be the major isoenzyme expressed in amniochorion, and is upregulated during active
labour (Slater et al., 1995). Additionally, COX-2 expression has been shown to be
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higher than COX-1 in myometrium collected from pregnant women, with highest
levels of COX-2 detected at term (Zuo et ah, 1994) and during active labour (Slater
et ah, 1997). This has stimulated renewed interest into the blockade of prostaglandin
production, using selective COX-2 non-steroidal anti-inflammatory agents to delay
or prevent preterm labour (Sawdy et al., 1997). Although the amnion is a major
producer of PGs, access of prostaglandins to the responsive myometrium is restricted
by strong expression of the degradation enzyme PGDH by the intervening chorion.
A further involvement for PGs in labour is in the ripening of the cervix (Calder,
1986).
PGs elicit a response by interaction with a family of G-protein coupled receptors
possessing 7 putative transmembrane domains. To date, 5 classes of PG receptor
have been isolated, DP, EP, FP, IP and TP (Coleman et al., 1994a). These have been
classified by the specificity of binding to the subclasses of PGs, with greatest
binding affinity of PGD to DP etc. Further complexity is achieved by the subdivision
of at least two of the receptors, EP and TP, into subfamilies. Of particular interest are
the EP receptors, comprising EP1, -2, -3 and -4. Differential physiological responses
have been designated to individual receptors, most notably, EP1 and EP3 stimulate
an excitatory response, whilst EP2 and the recently discovered EP4 elicit inhibitory
responses and cause the vasodilatory action which characterises PGE2 (Coleman et
al., 1994b).
1.6 Prolactin
Extra-pituitary prolactin (PRL) is a major product of the pregnant endometrium
(Ben-Jonathon et al., 1996). Decidualised stromal cells have been conclusively
shown to be the sole site of synthesis (Wu et al., 1995). Experimental studies have
recognised that PRL also is produced by the non-pregnant endometrium, from the
mid to late luteal phase until menses (Maslar et al., 1979). This corresponds to the
initiation of decidualisation during which the stromal cells become
pseudodecidualised (Wu et al., 1995), and in vitro decidualisation by stimulation of
oestrogen primed proliferative endometrial cells with progesterone results in PRL
production (Daly et al., 1983). Indeed, PRL expression is now commonly used as a
marker for functional decidualisation. Although pituitary and endometrial PRL are
identical in structure and function, expression is differentially regulated, which has
been attributed to the presence of a distinct promoter region located ~6kb upstream
of the pituitary promoter (DiMattia et al., 1990; Gellerson et al., 1994).
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The significance of PRL expression in the endometrium is uncertain. It is believed
that PRL primarily acts as an autocrine or paracrine rather than endocrine factor. A
similar mechanism has been reported in immune cells, where PRL has a profound
immunomodulatory effect (Draca, 1995). The majority of leukocytes ubiquitously
express the prolactin receptor (PRL-R) (Pellegrini et al., 1992; Dardenne et al., 1994;
Chambers et al., 1995; Wu et al., 1996). Stimulated T cells secrete PRL (Pellegrini et
al., 1992), and in vitro PRL enhances the proliferation of leukocytes previously
stimulated with mitogenic factors, including interleukin-2 (IL-2) and T and B cell
mitogens (Clevenger et al., 1990). Furthermore, this proliferation is inhibited by
exposure to anti-prolactin antibodies (Hartman et al., 1989). Prolactin, produced both
by lymphocytes and from the pituitary, has been postulated as having a role in T and
t
B cell competence and in the activation of T lymphocytes (Leite de Moraes et al.,
1995). In vivo studies indicate an immunosuppressive action, such as the reduced
immune response in lactating or PRL treated castrated rats (Dineen et al., 1972;
Kelly et al., 1973).
The temporal expression of PRL in the endometrium suggests a role in the
preparation for implantation and subsequent placentation. Decidualisation is
essential for implantation to occur and the specialised immune environment within
the decidua plays a major role in achieving a successful pregnancy. Coincidental
with decidualisation is the accumulation of leukocytes in the endometrial stroma, the
majority of which are the uterine specific large granular lymphocytes (LGLs) and
macrophages (Bulmer, 1995; Loke et al., 1995a). PRL may be acting as an
immunomodulatory agent in the endometrium, either by the stimulation of leukocyte
proliferation or differentiation.
1.7 Hypothesis
The present study aims to further investigate the roles and actions of locally
produced and acting inflammatory mediators in the endometrium. From previous
research discussed in the introduction, a hypothesis of mediator interactions can be
postulated (Figure 5).
A leukocyte accumulation is observed in the mid-late secretory phase of the normal
menstrual cycle, corresponding to proposed vital roles in implantation, placentation
and in the absence of pregnancy, in menstruation. Preliminary studies have reported
the expression of the chemokine IL-8 in the non-pregnant and pregnant
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endometrium, localised to blood vessels. Prostaglandin production at a similar site
has been identified, further verifying the proposed synergism in leukocyte
recruitment. In addition, a downregulation of these local factors by the steroid
hormone progesterone has been suggested.
Withdrawal of progesterone in the premenstrual period could have an effect on the
local production of inflammatory mediators, by removal of transcriptional inhibition
of chemokines, IL-8 and MCP-1, and activation of COX-2, whilst downregulating
prostaglandin metabolism by PGDH. This would result in elevated levels of the
chemokines and prostaglandins in the endometrium. Subsequently, chemokine
directed migration of leukocytes into the endometrium could take place, enhanced by
the vasodilatory action of PGE2. Endometrial leukocytes, once activated by
chemokines, produce an array of cytokines, chemokines and prostaglandins, thus
amplifying leukocyte recruitment and stromal oedema. Neutrophils and
macrophages are, in addition, potential sources of MMPs or pro-MMP activating
proteases, and thus may participate in ECM and tissue breakdown prior to menses.
The mechanism of appearance of the unique large granular lymphocyte population
(CD56+CD16") within the endometrium is unknown. The C-C chemokine MCP-1,
along with family members MlP-la and RANTES, has been attributed with NK cell
chemotactic activity and thus it is possible that a circulating precursor NK cell could
be recruited. This is supported by the existence of a putative precursor cell type
(CD56+CD16" agranular cells) which comprise around 1% of the circulating NK
cells (Lanier, et al, 1986). A subsequent activation / differentiation to produce the
LGL phenotype could then be proposed. A possible candidate for the differentiation
is prolactin which in addition to having major immunoregulatory roles in peripheral
immune system, is present in large quantities in the endometrium during
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decidualisation and pregnancy. Furthermore, MCP-1 production is augmented by
prolactin (Bowen et al, 1996). There are many other agents, detectable in the
endometrium, which in vitro stimulate NK cell differentiation, including MCP-1
itself and other local factors such as IL-15, IL-12 and PGE.
The expression of all four local factors, IL-8, MCP-1, COX-2 and PRL, shall be
examined in human endometrium, with particular emphasis on spatial and temporal
expression patterns of these local mediators. Correlation with prevailing steroid
hormone levels and perturbation of progesterone levels both in vitro and in vivo will
help to clarify the complex regulation of local inflammatory mediators.
Increased knowledge of the role and regulation of locally acting mediators will
greatly enhance our understanding of normal uterine function. This in turn has major
implications for the development of novel contraceptive methods and treatments for


































1.8 Aims of Research Project
The aims of this research were to examine the involvement of locally acting factors
in endometrial function, particularly focusing on the processes of implantation and
menstruation. Specifically, the following questions were addressed:
1. Are the local factors, IL-8, MCP-1 and COX-2 detectable at the protein and
mRNA level in the endometrium, throughout the menstrual cycle and in early
pregnancy?
2. How do the spatial and temporal expression patterns of the above local
mediators relate to their putative physiological roles?
t
4. Is there any evidence for steroidal control of these elements, particularly a
progestogenic regulation?
5. Can the physiological pattern of expression be reproduced in vivo by clinical
perturbation of steroid environment and in an in vitro culture system?
6. Does decidual derived prolactin have an immunomodulatory role in the
uterus?
7. Do the above findings help to clarify the complex interactions of locally
acting factors in the endometrium?
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The sources of all materials used for the experiments described in all chapters are





Neutral Buffered Formalin (NBF) See appendix for recipe
Tissue-Tek O.C.T. Compound
(Tissue Embedding Medium)




Polysciences Inc., Warrington, USA
Nunc Cryotubes Gibco, Paisley, UK
RPMI Culture Medium Gibco, Paisley, UK
Isopentane Merck Ltd. (BDH), Lutterworth, UK
IMMUNOHISTOCHEMISTRY SOURCE
Histoclear National Diagnostics, Atlanta, Georgia,
USA
MCP-1 rabbit polyclonal antibody Rabbit Polyclonal made "in house" , see
text for sequence information
IL-8 rabbit polyclonal antibody Rabbit Polyclonal made "in house" , see
text for sequence information
COX-2 rabbit polyclonal antibody PG-27, Oxford biomedical, Biogenesis,
Poole, UK
Prolactin receptor rabbit polyclonal
antibody
Kind gift from Dr P. Ingleton, University
of Sheffield, Sheffield, UK
Phosphate Buffered Saline / Phosphate
Buffered Saline with Tween
PBS / PBS(T)
See appendix for recipes
Tris Buffered Saline / Tris Buffered
Saline with Tween
TBS / TBS(T)
See appendix for recipes
Hydrogen peroxide (H2O2) Merck Ltd. (BDH), Lutterworth, UK
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IMMUNOHISTOCHEMISTRY SOURCE
Normal goat / mouse / rabbit sera Vectastain kits, Vector laboratories,
Peterborough, UK
Biotinylated secondary antibodies
(Goat anti-rabbit / Horse anti-mouse)
Vectastain kits, Vector laboratories,
Peterborough, UK
Rabbit anti-mouse immunoglobulins Z0259, DAKO, High Wycombe, U.K.
ABC-HRP and Elite complexes Vectastain 4002 & Vectastain Elite PK-




Mouse monoclonal, D0651, DAKO,'
High Wycombe, U.K.
3, 3' -diaminobenzidine (DAB) substrate Vector SK-4100, Vector laboratories,
Peterborough, UK
Vector Red substrate Vector laboratories, Peterborough, UK
Sodium citrate buffer See appendix for recipe
Pertex Mounting Medium Cellpath pic, Hemel Hempsted, UK
Harris's Haematoxylin Pioneer Research Chemicals Ltd.,
Colchester, UK
Microscope Glass Slides Merck Ltd. (BDH), Lutterworth, UK
Glass Coverslips Merck Ltd. (BDH), Lutterworth, UK
CELL CULTURE MATERIALS SOURCE
RPMI culture medium Sigma-Aldrich Company Ltd., Poole,
UK
Fetal Calf Serum (FCS) Sigma-Aldrich Company Ltd., Poole,
UK
Penicillin / Streptomycin Sigma-Aldrich Company Ltd., Poole,
UK
Gentamycin Sigma-Aldrich Company Ltd., Poole,
UK
Progesterone Sigma-Aldrich Company Ltd., Poole,
UK
Phorbol 12-Myristate 13-Acetate Sigma-Aldrich Company Ltd., Poole,
UK
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CELL CULTURE MATERIALS SOURCE
Ultraspec™ RNA Isolation System Biotecx, Biogenesis, Poole, UK
Chloroform Sigma-Aldrich Company Ltd., Poole,
UK
24 well culture plates Costar, Ltd. UK, High Wycombe, UK







Avian Myeloblastosis Virus (AMV)
Reverse Transcriptase
Promega Ltd, Southampton, UK
5 x Reverse Transcriptase buffer Promega Ltd, Southampton, UK
PCR Nucleotide mix (premixed lOmM
deoxynucleotide solution)
Boehringer Mannheim, Sussex, UK
Oligonucleotide Primers : GAP-DH Oswell, Southampton, UK - for sequence
data see table 3
Oligonucleotide Primers : IL-8 Oswell, Southampton, UK - for sequence
data see table 3
Oligonucleotide Primers : MCP-1 Oswell, Southampton, UK - for sequence
data see table 3
Oligonucleotide Primers : COX-2 Oswell, Southampton, UK - for sequence
data see table 3
Oligonucleotide Primers : PRL-R Genesis - for sequence data see table 3




Promega Ltd, Southampton, UK
AmpliTaq Polymerase Perkin Elmer, Beaconsfield, UK
10 x PCR buffer Perkin Elmer, Beaconsfield, UK
Magnesium chloride (MgCl2 ;
Molecular Grade)
Perkin Elmer, Beaconsfield, UK








Hybaid Ltd., Middlesex, UK




DNA Molecular weight marker
(72-1353bp)
Sigma-Aldrich Company Ltd., Poole,
UK
Boehringer Mannheim, Sussex, UK
Gel loading buffer See appendix for recipe
TBE buffer See appendix for recipe
ELISA MATERIALS SOURCE
Streptavidin coated microtitre plates
(High Capacity)
Boehringer Mannheim, Sussex, UK
PBS-BSA See appendix for recipe
Tris-EDTA (TE) buffer See appendix for recipe
Denaturing solution See appendix for recipe
5' Digoxigenin labelled probe: GAP-DH Oswell, Southampton, UK - for sequence
data see table 3
5' Digoxigenin labelled probe: IL-8 Oswell, Southampton, UK - for sequence
data see table 3
5' Digoxigenin labelled probe: MCP-1 Oswell, Southampton, UK - for sequence
data see table 3
5' Digoxigenin labelled probe: COX-2 Oswell, Southampton, UK - for sequence
data see table 3
Easy Hyb Hybridisation buffer Boehringer Mannheim, Sussex, UK
Anti-Digoxigenin Fab fragments,
conjugated with peroxidase
Boehringer Mannheim, Sussex, UK
ELISA Wash buffer See appendix for recipe
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ELISA MATERIALS SOURCE
ELISA buffer See appendix for recipe
Peroxidase Substrate See appendix for recipe
Sulphuric Acid (H2SO4) Merck Ltd. (BDH), Lutterworth, UK
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2.2 Methods
2.21 Tissue Collection and Patient Details
Normal endometrium from all stages of the menstrual cycle (n = 83) was collected
by Pipelle suction curette (Laboratoire CCD, Paris, France) from fertile women
undergoing benign gynaecological procedures, including laparoscopic sterilisation
and hysterectomy. All women reported normal regular menstrual cycles (18 - 34
days) and had not received any form of hormonal treatment for the 3 months
preceding biopsy collection. Endometrial biopsies were dated from the patient's last
menstrual period (LMP). Tissue sections were routinely stained with haematoxylin
t
and eosin and examined by light microscopy to ensure that histological appearances
were consistent with the date of LMP. In cases of uncertainty, the stage of cycle was
confirmed by radioimmunoassay of serum concentrations of oestradiol and
progesterone.
First trimester decidua (n = 33) was collected away from the implantation site by
careful curettage prior to termination of pregnancy (gestation 8-12 weeks) by
vacuum aspiration. Decidua parietalis, without trophoblast invasion, was confirmed
by cytokeratin immunostaining of tissue sections (see method in
immunohistochemistry section 2.22).
Written informed consent was obtained prior to tissue collection and ethical approval
was received from Lothian Research Ethics Committee (ref. no. 1702/94/6/1).
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Table 2 Table describing patient details, from whom endometrial samples were
collected. No significant differences were detected in the cycle length described by
women allocated to different stages of the menstrual cycle or early pregnancy.
However, the age of patients consenting to collection of first trimester decidua was
significantly less than that of women from whom non-pregnant endometrium was
biopsied (* p < 0.001 compared to all non-pregnant groups). Additionally,
significantly more patients were nulliparous in the pregnant group compared to all
non-pregnant groups (p < 0.001 - not shown in table).






Menstrual dl -4 9 29 (28-31) 35.6 (25 - 47)
Early Proliferative d5 -7 10 26 (18-29) 34.2 (26-41)
Mid Proliferative d8 - 10 10 27 (20-29) 35.6 (24 - 46)
Late Proliferative dll - 13 5 28 (25-32) 39.3 (33 - 46)
Periovulatory dl4 9 28 (21-32) 40.3 (31 -49)
Early Secretory dl5 - 18 18 27 (21-31) 39.26 (30 - 47)
Mid Secretory dl9 - 24 11 28 (21-34) 38.6 (35 -45)
Late Secretory d25 - menses 11 29 (28-31) 38.9 (34 - 45)
First Trimester 8-12 weeks 33 28 (27-29) 23.3 (16-40) *
Decidua gestation
Tissue samples were divided into four pieces on a sterile surgical swab and were
immediately placed into:
1. 10% Neutral Buffered Formalin (NBF) and fixed overnight at 4°C, then
stored in 70% ethanol prior to routine paraffin embedding.
2. OCT embedding medium in a disposable plastic mould, snap frozen in iso-
pentane precooled with dry ice and stored at -75°C.
3. Cryotube, snap frozen in iso-pentane precooled with dry ice, and stored at
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-75°C prior to RNA extraction.
4. RPMI culture medium on ice, for tissue culture.
A venous blood sample was also collected at the time of biopsy from which serum
was collected by centrifugation at l,500g for 10 minutes. This was frozen at -20°C
until measurement of steroid hormone concentration by radioimmunoassay, for
confirmation of the stage of menstrual cycle (Yong et al., 1992).
2.22 Immunohistochemistry
Immunohistochemical protocols for the detection of MCP-1, IL-8, COX-2 (Jones et
al., 1997) and prolactin receptor (Jones et al., 1998) were optimised to determine the
correct conditions for maximal specific staining. Methodology for the
immunolocalisation of the chemokine IL-8 has previously been reported (Critchley
et al., 1994). Suitable positive and negative controls for immunostaining were
included in every run, to assess the specificity of immunoreactivity and ensure the
comparability of individual staining runs.
IL-8
Immunohistochemical localisation for IL-8 required the use of frozen sections (5pm
in thickness), cut from the OCT embedded blocks. Immediately prior to staining,
frozen sections were lightly fixed in 10% NBF for 10 minutes at room temperature.
Sections were then washed in 0.1M Phosphate Buffered Saline (PBS) pH 7.4 - 7.6.
Endogenous peroxidase activity was quenched by immersion of the slides in 3%
Hydrogen Peroxide (H2O2) in distilled water for 5 minutes at room temperature.
Following 10 minutes washing in PBS, diluted non-immune goat serum was applied
to each slide and incubated for 20 minutes in a humidified chamber. The excess
serum was carefully blotted off and 50|il of anti-EL-8 antibody, at a dilution of 1:500
in PBS, was applied. The IL-8 rabbit polyclonal antisera was raised in rabbits against
a full length synthetic IL-8 peptide (72 amino acids), synthesised by
fluorenylmethoxycarbonyl (FMOC) chemistry. The antigen was administered in
Freund's complete adjuvant (2mg/ml) with three boosts over 12 weeks using
Freund's incomplete adjuvant. The cross reactivity's of the antibody were analysed
by radioimmunoassay resulting in less than 0.25% cross reaction with interleukin's
(IL) -1,-2, -6, and -10 and less than 0.3% against monocyte chemoattractant protein-
1 (MCP-1). Coverslips were placed over the tissue sections to minimise antibody
evaporation and were incubated for 60 minutes at 37°C. Following primary antibody
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binding, an avidin biotin peroxidase detection system was utilised, involving the
sequential application of biotinylated goat anti-rabbit IgG and a complex of avidin
and biotin with horse radish peroxidase (ABC-HRP). The positive binding was then
identified by the application of the peroxidase substrate 3, 3' -diaminobenzidine
(DAB), which produces a brown stain representing the presence of IL-8 protein.
Sections were then washed in distilled water and lightly counterstained with Harris's
haematoxylin, a non-specific purple nuclear stain. Following washing in tap water
the sections were dehydrated in ascending grades of ethanol and mounted from
Xylene with Pertex mounting medium.
Frozen tonsil tissue sections were included as a positive control for IL-8
immunostaining procedures (Critchley et ah, 1994) and were treated in an identical
fashion. The presence of intense immunoreactivity surrounding blood vessels was
indicative of specific immunoreactivity. To exclude the possibility of non-specific
immunoreactivity, serial sections of representative slides were included and either
non-immune rabbit immunoglobulins at matching concentrations or primary
antibody preabsorbed with synthetic IL-8 peptide (lOOpg/ml) was substituted for the
primary antibody.
MCP-1
A similar protocol was used for MCP-1 immunolocalisation, with the exception of
an overnight incubation period (17hrs ± 1 hr) with the primary antibody. MCP-1
rabbit polyclonal antibody was raised in rabbits against a chemically synthesised
77aa MCP-1 and used at a dilution of 1:400 in PBS. Identical positive and negative
controls were used for MCP-1 as for IL-8. Primary antibody preabsorbed with
MCP-1 synthetic peptide (lOOpg/ml) was utilised as a negative control. Further,
western analysis of ovarian tissue for MCP-1 resulted in the detection of a band of
the correct protein weight (lOkDa) (data not shown).
COX-2
Immunostaining for COX-2 was conducted on paraffin sections. These were
dewaxed in for 5 minutes in Histoclear, and then rehydrated through descending
grades of ethanol to distilled water. Prior to endogenous peroxidase blocking, a
microwave antigen retrieval technique was utilised, whereby the sections were
heated in sodium citrate buffer (pH 6.0) for 10 minutes at high power followed by a
20 minute incubation in the oven. A similar protocol as for MCP-1 was then
continued, with the exception of 60 minute incubation periods with the primary
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antibody, raised against COX-2 (PG27) diluted 1:250 at 37°C, and the secondary
biotinylated goat anti-rabbit antibody and the tertiary avidin-biotin-peroxidase
complex (ABC Elite), both at room temperature.
Human term fetal membranes were included as a positive control for COX-2
immunostaining, to ensure that the pattern of immunoreactivity achieved was in
agreement with published data (Gibb et ah, 1996). Serial sections of representative
samples were treated with non-immunised rabbit immunoglobulins at a matching
concentration to the primary antibody to serve as a negative control.
Prolactin Receptor (PRL-R)
I
As for COX-2 immunostaining, paraffin sections were utilised for prolactin receptor
immunohistochemistry. An antigen retrieval technique was not required. Sections
were incubated with the primary antibody (rabbit polyclonal, raised against the
highly conserved extracellular domain of the rat prolactin receptor) at a dilution of
1:50 overnight (17hrs+lhr) at 4°C. The biotinylated secondary goat anti-rabbit
antibody and tertiary avidin-biotin-peroxidase complex were applied for 30 minutes
each prior to substrate development with DAB. As for COX-2, human term fetal
membranes were used as a positive control (Maaskant et ah, 1996) and rabbit
immunoglobulins diluted to 1:50 were substituted for the primary antibody on
negative control sections.
Dual Immunohistochemistry
To co-localise prolactin receptors with endometrial leukocyte subpopulations, dual
immunohistochemistry was conducted. Paraffin sections were treated as for prolactin
receptor single immunostain and then washed in TBS for 20 minutes. An
immunolocalisation for Leukocyte Common Antigen (LCA - CD45) was then
carried out by the application of the primary antibody at a dilution of 1:50 in TBS for
60 minutes at 37°C. An alkaline phosphatase detection system was utilised,
involving the application of the secondary antibody rabbit anti-mouse
immunoglobulins at a dilution of 1:25 for 60 minutes, followed by the tertiary
antibody alkaline phosphatase anti alkaline phosphatase (APAAP) diluted 1:50 in
TBS for 60 minutes. The phosphatase substrate, Vector red was then applied for 30
minutes, producing a bright pink precipitate over the leukocytes isolated by the
CD45 antibody. Sections were counterstained with haematoxylin and examined to
compare localisation of CD45 positive and prolactin receptor positive cells. Serial
sections were treated with either prolactin receptor or CD45 antibody followed by or
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after treatment with mouse IgG / rabbit IgG, to assess the specificity of the single
immunostain. A negative control exposed to mouse IgG and rabbit IgG was also
included.
Cytokeratin
Immunohistochemistry for cytokeratin was performed on first trimester decidua
biopsies to confirm the identify of the tissue as decidua parietalis opposed to basalis,
on the basis of whether trophoblast invasion had occurred. Paraffin or frozen
sections were utilised and were exposed to anti-cytokeratin monoclonal antibody for
1 hour at 37°C at a dilution of 1 in 60 . No pretreatments were required for antigen
exposure. Cytokeratin positive cells were identified by the application of
biotinylated horse anti-mouse immunoglobulins followed by avidin-biotin-
peroxidase complex (ABC-HRP) for 30 minutes at room temperature. DAB was
utilised as the substrate producing a brown precipitate over the antigen-antibody
complex. In all tissues immunoreactivity was detected in both surface and glandular
epithelium. The presence of immunostaining outwith these structures was indicative
of trophoblast invasion, and thus these tissues were not included in any further
studies. Proliferative endometrium with prominent epithelial glands were included to
act as a positive control for the immunostain. Mouse immunoglobulins at a matching
concentration was substituted for the primary antibody to act as a negative control.
2,23 Scoring and Analysis of Immunostaining
A semi-quantitative scoring system was employed for assessment of intensity and
localisation of immunoreactivity in the entire tissue section, utilising a 4 point
scoring system where 0 = no immunostaining, 1 = faint immunostaining, 2 = strong
immunostaining and 3 = very intense immunostaining. Large differences were
observed in staining intensity, and all tissue sections were randomly coded and thus
examined blind to the stage of the cycle by either one or two observers. We are not
aware of any image analysis software which would enable accurate assessment of
diffuse cytoplasmic immunostaining, such as is produced from chemokine and
COX-2 immunohistochemistry. Statistical analysis was conducted on a Apple
Macintosh Computer using the statistical package Statview version 4.5. Analysis of
Variance (ANOVA) with Fisher's PLSD post hoc was utilised to evaluate whether or
not there were significant differences in the expression of the mediators.
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2.24 RNA Extraction from Whole Tissue
Tissue from which RNA was to be extracted was placed directly into a sterile
eppendorf containing 1ml of Ultraspec™ RNA Isolation Medium. Tissue snap
frozen in cryotubes was semi-thawed and treated identically. The tissue was
homogenised and placed at 4°C for 10 minutes to allow complete dissociation of
nucleoprotein complexes. 200|il of chloroform was added to each tube and mixed
thoroughly by shaking for 15 seconds. Following another 10 minutes on ice, the
tubes were centrifuged at 12,000g for 20 minutes at 4°C in a Biofuge refrigerated
centrifuge. The homogenate separates into an upper aqueous phase containing RNA,
and the interface and organic phases containing proteins and DNA. To precipitate the
RNA, the aqueous phase was aspirated into an equal volume of iso-propanol, mixed
and placed at -20°C overnight (17hrs ± lhr). The precipitated RNA was collected in
a white pellet by centrifuging the eppendorf at 12,000g for 15 minutes at 4°C. The
pellet was washed twice to remove contaminating phenol and chloroform with 75%
ethanol, by vortexing briefly and centrifuging at 7,500g for 5 minutes. The pellet
was then air dried and resuspended in 30-50jll of diethylpyrocarbonate (DEPC)
treated water.
An approximation of RNA yield was attained by measuring the absorbance at 260nm
by spectrophometry. RNA concentration was calculated using the following
equation:
RNA Concentration pg/ul = Absorbance at 260nm x 40 x dilution factor
where an optical density (OD) of 1 is equal to an RNA concentration of40 jig/pi
The purity of the extracted RNA was assessed by the ratio of 260nm:280nm, where a
pure RNA sample produces a value of 1.8 - 2.0. The RNA samples were stored at
-75°C until further use.
2.25 Non-Competitive Semi-Quantitative RT-PCR
RT-PCR was utilised to determine the expression levels of the chemokines, COX-2
and prolactin receptor in the endometrium. Insufficient quantities of RNA were
extracted for analysis by northern hybridisation or ribonuclease protection assay, but
the gross amplification and high degree of sensitivity involved in the RT-PCR
technique enables the visualisation of product from very low numbers of mRNA
transcripts. To enable quantitation of the RT-PCR products and assess viability of
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the RNA samples, the expression levels of the housekeeping gene
Glyceraldehydephosphate dehydrogenase (GAP-DH) (Murphy et al., 1990; Belin,
1996) were assessed by RT-PCR from all RNA samples. Antisense oligonucleotide
primers utilised for GAP-DH and mediator amplification by RT-PCR were 5'
labelled with biotin, thus generating biotinylated RT-PCR products. This allowed
specific detection and quantification of the products by enzyme linked
immunoabsorbant assay (ELISA) using a streptavidin coated microtitre plate.
The concentration of GAP-DH RT-PCR products were determined using this
method. This was related to the concentration of initial RNA template loaded into
the reaction, by the production of a standard curve of RNA template (x) plotted
against PCR product (y). A linear relationship was achieved, indicating that the? PCR
yield was proportional to the amount of RNA starting material. This situation can
only be achieved when the PCR reaction is in the exponential phase of amplification,
and thus is not limited by the presence of insufficient reaction components (see
figures 6, 7, 8). This was ensured by optimisation of all RT-PCR reactions.
The protocols of thermal cycling was optimised to produce a single band of the
correct molecular weight for each target mRNA. This involved varying the
temperature at which the oligonucleotide primer anneals to the template, the length
of time allowed for the denaturing, annealing and extension stages and the number of
amplification cycles used. The number of cycles at which the amplification is
exponential was selected by conducting the PCR reaction at a range of cycle
numbers (e.g. from 20 - 35 cycles) with a chosen amount of RNA template (60ng)
(see figures 6, 7, 8). Products were analysed by gel electrophoresis and ELISA. The
relationship between PCR yield and cycle number was examined graphically, and
the number of cycles to be used in future studies was selected from the exponential
region of the plot.
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Figure 6 Optimisation of RT-PCRs for GAP-DH, IL-8 and COX-2. A
representative sample was amplified by RT-PCR for a range of amplification cycles,
to determine when the amplification reaction was exponential in nature. For
GAP-DH, 1 = 20 cycles, 2 = 23, 3 = 26, 4 = 29, 5 = 32 and 6 = 35. For IL-8 and
COX-2, 1 = 25 cycles, 2 = 28, 3 = 31, 4 = 34, 5 = 37, 6 = 40 (IL-8 only). A negative
control is included which was subjected to the maximum number of cycles and
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Figure 7 Optimisation of GAP-DH RT-PCR. The product yield of RT-PCR
reactions shown overleaf were measured by ELISA and expressed graphically, using
l
different detection systems: (A & B) an antibody directed against digoxigenin-
conjugated with peroxidase, and (C & D) a fluorescence (europium) labelled probe.
Figure A shows the absorbance of RT-PCR product plotted against cycle number.
This produces an exponential relationship, confirmed in figure B, where absorbance
of RT-PCR product is expressed on a logarithmic scale, producing a straight line.
The arrow demonstrates the number of cycles chosen for all subsequent reactions,
when the reaction is in the exponential phase of amplification. Figures C & D
illustrate the same findings, but an alternative detection system is utilised. This
further validates the use of 26 cycles for GAP-DH RT-PCR reactions.
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Figure 8 Optimisation of LL-8 and COX-2 RT-PCRs. As for GAP-DH, product
yield was measured by ELISA, adopting the anti-digoxigenin-peroxidase method.
Figure A demonstrates the absorbance of IL-8 RT-PCR product, using an uncultured
sample, plotted against the number of amplification cycles. Although at 40 cycles,
the reaction is becoming limited by reaction components, at 32 cycles (indicated by
the arrow), the reaction is in the exponential phase of amplification. For COX-2 (B),
the reaction also appears to be limiting at 40 cycles for a cultured sample, but is very




The aim of this study was to ensure that all RNA samples to be analysed for IL-8,
MCP-1 and COX-2 mRNA expression were of equivalent concentration. Taking into
account the proposed direct relationship between RNA loading into the RT-PCR and
the product yield, this could be achieved when the concentrations of PCR product
were comparable, as assessed by gel electrophoresis and ELISA. Thereafter, equal
concentrations of sample RNA were analysed for the expression levels of mRNAs of
interest, and the GAPDH product yield was measured once again by gel
electrophoresis and ELISA.
Controls
A number of measures were taken to ensure that all amplification was specific. A
positive or quality control (QC, RNA extracted from a menstrual phase endometrial
sample) was included in every RT-PCR. A negative control was achieved by the
omission of RNA from the RT-PCR reaction. The possibility of amplification of
genomic DNA contaminating RNA samples was excluded either by DNAse
treatment of RNA samples prior to analysis by RT-PCR, amplification of RNA not
reverse transcribed by PCR or where possible by the use of oligonucleotide primers
which span intronic regions of the gene. For all RT-PCR protocols these precautions
were taken, to ensure that the product yield was soley due to amplification of cDNA
generated from RNA template during the RT step.
GAP-DH RT-PCR
To enable the concentration of sample RNA to be calculated, a standard curve was
generated in each RT-PCR. This was created by the inclusion of 5 standards, diluted
from a single RNA standard, in the GAP-DH RT-PCR. A decidual RNA sample was
selected for use as a standard for all GAP-DH RT-PCR reactions, as a more accurate
assessment of RNA concentration by spectrophometry could be obtained due to the
large quantity. A range of standard template concentrations between 15.7ng and
250ng were loaded into an RT-PCR, producing a standard curve of increasing
product concentration (y) with increasing RNA template concentration (x). A similar
curve was loaded into every RT-PCR reaction to reduce the inherent variability of
this technique.
Gene specific cDNA was generated from equal volumes of the RNA samples to be
analysed using AMV reverse transcriptase and the 5' biotinylated GAP-DH antisense
oligonucleotide primer (see table 3, for detailed protocols see Appendix II). A master
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mix of reaction components was made up for each reverse transcription run, so that
each sample tube contained an identical reaction mix. The tubes were overlaid with a
drop of RNAse and DNAse free mineral oil to prevent evaporation of the reaction
components during heating. The eppendorfs were then centrifuged for 10 seconds to
collect all reaction components under the mineral oil, placed in the thermal cycler
(Hybaid Touchdown) and heated to 42°C for 45 minutes.
Following reverse transcription (RT) , the tubes were placed on ice and 30(il of PCR
reaction mix containing 2.5 U AmpliTaq Polymerase was added to the total volume
of RT products (20(0.1). A 1103bp fragment of the GAP-DH cDNA was selectively
amplified by inclusion of the sense oligonucleotide primer (see table 3) and the same
5' biotinylated antisense oligonucleotide prime used for the RT step. The safnples
were subsequently subjected to 26 cycles of 94°C for 1 minute, 60°C for 1 minute
and 72°C for 2 minutes. A final extension of 10 minutes at 72°C was then allowed.
The PCR products were initially analysed by electrophoretic separation on a 1%
agarose gel containing ethidium bromide. A molecular weight marker was included
to allow size comparison with the samples. The gel was examined and photographed
on a UV transilluminator.
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Figure 9 Standard curve for GAP-DH RT-PCR. A single RNA standard, at a
range of RNA concentrations (1 = 250ng, 2 = 125ng, 3 = 62.5ng, 4 = 31.25ng, 5 =
15.7ng, - = negative control) was reverse transcribed and amplified, in every
GAP-DH RT-PCR reaction, alongside samples to be analysed. A signal of 1103bp,
by reference to a molecular weight marker (M), was detected for all samples, with




All RT-PCR products were diluted 1:10 in Tris-EDTA buffer and stored at -75°C
until assayed. 10|il of each product was pipetted into a high capacity 96 well
microtitre plate coated with streptavidin, and a further dilution of 1:10 was achieved
by the addition of 90pl PBS-BSA (0.1%). Specific GAP-DH amplicon binding via
biotin-streptavidin was allowed by incubation of the plate at room temperature on a
plate shaker for 20 minutes. Denaturing solution (50|ll) was added to ensure all DNA
was single stranded. Following a 20 minute incubation with shaking, the contents of
the well were discarded and specifically bound PCR products were detected by
hybridisation, at 50°C for 1 hour, with a 5' digoxigenin labelled oligonucleotide
probe (29 bp) (see table 3) complementary to the mid portion of the GAP-DH
amplicon. Non-specifically bound probe was eliminated by repeated washing in
specially formulated wash buffer. The probe - PCR product complex was detected
by incubation with a polyclonal antibody raised against digoxigenin, conjugated with
horse radish peroxidase (anti-DIG-POD Fab fragments) at a dilution of 1:1000 in
ELISA buffer, for 45 minutes at room temperature with shaking. Following washing,
the plate was developed with a peroxidase substrate for between 5-10 minutes. The
reaction was then quenched with the addition of 2N H2SC>4, and the absorbance read
at a wavelength of 450nm (see figure 13).
Absorbances for product yield from standards and samples were found to be
comparable with the signal intensity observed by gel electrophoresis. A standard
curve was plotted of amount of RNA template loaded into the RT-PCR (x) against
absorbance of standard RT-PCR product (y) (see figures 9 and 10). This generated
the equation y = ax -t-b, which could subsequently be used to calculate sample RNA
loading from their product yield. The RT-PCR and ELISA were subsequently
repeated with corrected amounts of RNA template (60ng), to ensure that all RNA
loading was equal. When all samples produced a measurement of 60ng (+/- lOng),
RT-PCRs for the mediators (IL-8, MCP-1 and COX-2) were conducted. All RT-PCR
programs and ELISA protocols were similar to that described for GAP-DH, with the
differences detailed below for each mediator.
Europium ELISA
Detection of the probe amplicon complex using an antibody-enzyme system
introduces the potential for further variability. To explore the validity of the
optimised technique, fluorescent detection via direct europium labelling of the GAP-
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DH probe, was employed to enable comparison of the two different methods of
ELISA. The advantage of the fluorescence detection system is the fact that fewer
steps are involved in the detection process as the probe is directly labelled with
europium, and thus fewer limitations are imposed. A representative GAP-DH
standard curve was assayed using both methods simultaneously. Samples were
diluted 1:200 in PBS-BSA, and 100(0.1 was loaded into each well of a streptavidin
coated microtitre plate, and incubated for 20 minutes with shaking. After
denaturation of the PCR products, 100 (ll of GAP-DH probe, labelled with Europium
(1:1) was added and incubated at 50°C for 2 hours. Excess probe was removed by
repeated washing and 200(0,1 of fluorescence enhancing solution was pipetted into
each well. After 20 minutes at room temperature, the fluorescence emitted was
i
counted by a fluorimeter, and readings were plotted against the amount of RNA
template. The results, presented in figure 10, correlate well, thus reinforcing the
antibody-peroxidase detection system for ELISA as a suitable method of quantitation
for RT-PCR.
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Figure 10 Standard curve for GAP-DH RT-PCR. Following amplification of
standards for GAP-DH, product yield was measured by ELISA. Two methods were
initially used for GAP-DH ELISA, using either (A) an antibody directed against
digoxigenin-conjugated to peroxidase, or (B) a direct fluorescent labelled probe. A ,
linear relationship was achieved, as the PCR was stopped in the exponential phase of
amplification and thus the product yield is directly related to the amount of starting
material. The antibody-peroxidase detection system was used thereafter and the
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Figure 11 The validity of this technique, for analysing RNA concentrations and
adjusting them appropriately to ensure all samples are loaded equally (60ng), is
illustrated in the composite opposite. The upper panel shows the products obtained
from the first GAP-DH RT-PCR conducted on standards 1 - 5 (250ng - 15.7ng), and
selected samples (6 - 12). For the samples, signals of variable intensity were '
obtained, indicating the uneven loading of the RT-PCR. The lower panel shows the
same samples after adjustment. Again a standard curve (1-5) was included in the
RT-PCR run, and samples yielded products of equal intensity when analysed by gel

















Figures 12 & 13
The figures on the following two pages diagrammatically demonstrate the steps











































































Mediator RT-PCR and ELISA
The non-competitive method utilised in this study does not allow calculation of the
exact number of mRNA transcripts of IL-8, MCP-1 or COX-2. Instead variations
between samples collected at different times points throughout the menstrual cycle,
or different culture treatments can be detected. It was not possible to include a
standard curve of known mediator mRNA concentration as for GAP-DH, but to
allow standardisation between individual RT-PCRs and ELISAs, a quality control
was included in each procedure. The quality control utilised (QC) was a menstrual
RNA sample, which from preliminary investigations proved to contain high numbers
of transcripts for IL-8, MCP-1 and COX-2. Data obtained from measurement of RT-
PCR product yield by ELISA has been presented as a ratio of sample signal': QC
signal unless otherwise stated.
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Table 3
Table describing the sequences of all oligonucleotide primers utilised for RT-PCR,
and ELISA probes complementary to the mid portion of the amplified product. The
product size obtained for each RT-PCR is also provided. The optimised number of
cycles, when the PCR was in the exponential phase of amplification, are in the final
column. For IL-8, MCP-1 and COX-2 two different cycle numbers are given, as
following stimulation of the tissue by culture (Chapter 5), these mediators were
expressed at such high levels that it was impossible to measure mRNA levels
quantitatively using the same PCR program as for unstimulated samples. In each
case, the number of cycles used for unstimulated (uncultured) samples is given first,
followed by the number required for detection of mediators in stimulated samples.
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IL-8 RT-PCR and ELISA
The selective amplification of IL-8 was conducted using a pair of designed
oligonucleotide primers to produce a 298bp fragment. RNA samples (60ng) were
subjected to RT using an identical program as for GAP-DH (for detailed RT-PCR
protocols see Appendix II). The generated cDNA was subsequently amplified by
cycles of 94°C for 1 minute, 63°C for 1 minute and 72°C for 1 minute, with a final
extension at 72°C for 10 minutes. RNA extracted from uncultured samples were
amplified for 32 cycles. The level of expression of IL-8 following a culture period
were many fold those from uncultured tissue samples, necessitating the use of a
much shorter cycling program (23 cycles). Therefore, limited comparisons between
IL-8 expression levels in cultured and uncultured endometrial and decidual cohld be
made.
MCP-1 RT-PCR and ELISA
Oligonucleotide primer pairs were designed to amplify a 210bp fragment of MCP-1
mRNA. These spanned intronic sequences to act as a control for the possibility of
genomic DNA contamination. A thermal cycling program was optimised to produce
a single band corresponding to the region of MCP-1 cDNA selected, comprised of
32 cycles (uncultured biopsies) or 23 cycles (cultured biopsies) of 94°C for 1 minute,
60°C for 1 minute and 72°C for 1 minute. A final extension at 72°C for 10 minutes
was then allowed.
COX-2 RT-PCR and ELISA
A 350bp amplicon was generated using the specific oligonucleotide primers for
COX-2 (Hla et ah, 1992). RT products were amplified by heating to 94°C for 1
minute, 60°C for 1 minute and 72°C for 1 minute. Uncultured endometrial and
decidual biopsies required 35 cycles, whilst cultured biopsies were subjected to 27
cycles of amplification. Once more, a final extension for 10 minutes at 72°C was
allowed.
PRL-R
Oligonucleotide primers complementary to the extracellular domain of the prolactin
receptor flanking base pairs 154 - 798 were used to amplify by RT-PCR a 650bp
product. The primers chosen spanned intronic sequences to ensure against the
possibility of genomic DNA contamination. All samples analysed were uncultured
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and were amplified for 30 cycles of 94°C for 1 minute, 62°C for 1 minute and 72°C
for 1 minute, followed by 10 minutes at 72°C.
RT-PCR & ELISA Variability
The reproducibility and validity of this technique was investigated, and the
variability of the RT-PCR, and intra- and inter-assay variations were calculated. All












GAP-DH 6.52% (1.9%) 1.74% 2.62%
IL-8 4.91% (3.62%) 2.88% 4.23%
MCP-1 3.81% (1.47%) 3.37% 6.89%
COX-2 3.77% (3.23%) 2.11% 2.84%
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CHAPTER 3
LOCALISATION AND TEMPORAL EXPRESSION OF




The marked increase in endometrial leukocytes which coincides with the processes
of implantation and menstruation strongly support a role in the modulation of these
events (Loke et ah, 1995a). Although in situ proliferation of leukocytes does occur in
the endometrium (Pace et ah, 1989; Tabibzadeh, 1990; King et ah, 1991), infiltration
of peripheral circulating leukocytes into the endometrial stromal is likely to
contribute to their accumulation in the late secretory or premenstrual phase of the
normal menstrual cycle (Lea et ah, 1991; Marzusch et ah, 1993). Identification of
specific leukocyte chemoattractants in the endometrium would reinforce this
hypothesis. t
Interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) are two such
chemotactic agents (Baggiolini et ah, 1994; Baggiolini et ah, 1997). IL-8, a C-X-C
chemokine, selectively recruits neutrophils and T lymphocytes and triggers their
subsequent activation upon tissue entry. Conversely, MCP-1 (C-C chemokine) has
no effect on neutrophil chemotaxis, but instead is a potent chemoattractant and
activator of monocytes, T lymphocytes, natural killer cells (NK), basophils and
eosinophils. As neutrophils, macrophages and the NK-like LGLs constitute the
majority of uterine lymphoid cells (Starkey et ah, 1991), the investigation into
temporal and spatial expression of these chemokines is of great interest.
IL-8 has previously been detected in the endometrium, localised to a perivascular
position in endometrium obtained from both non-pregnant and pregnant women
(Critchley et ah, 1994). This preliminary study failed to identify any changes in
expression level throughout the menstrual cycle. Further investigation has focused
on modulation of IL-8 expression in human endometrial cells in culture (Arici et al.,
1993; Arici et ah, 1996). No definitive research into the temporal expression of this
potent stimulator of neutrophil chemotaxis and angiogenesis in the endometrium has
to date been conducted. MCP-1 production by ectopic endometrium biopsied from
endometriotic lesions has been reported (Akoum et al., 1995), and has been related
to the elevated numbers of activated macrophages, thought to contribute to the
pathogenesis of this condition. MCP-1 gene expression by human endometrium and
decidua was investigated, but again no changes directly relating to stage of cycle or
pregnancy were detected (Arici et al., 1995).
The involvement of prostaglandins (PGs) in the regulation of normal endometrial
function has long been recognised (Baird et al., 1996). An increase in PG production
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by the endometrium has been detected in the mid-late secretory phase and during
menses (Downie et ah, 1974; Maathuis et ah, 1978). PGE2 is particularly implicated
in the increased vasculature permeability which is a prerequisite for decidualisation
(Kennedy et ah, 1981) and therefore also implantation (Kennedy, 1986). Although a
specific role for prostaglandins during menstruation has not been established, these
vasoactive substances are presumed to have an integral role in the vasculature
changes that characterise the perimenstrual and menstrual periods. Cyclooxygenase-
2 (COX-2) is believed to be the main isoform responsible for the production of
prostaglandins in situations of acute inflammation, due to its rapid induction by pro¬
inflammatory mediators and short half life (Simmons et ah, 1991; Seibert et ah,
1994). The processes of implantation and menstruation in many ways resemble an
L
inflammatory response (Kelly et ah, 1994). This study investigates the participation
of COX-2 in the production of prostaglandins in the endometrium.
The present study has investigated the localisation and temporal expression of the
chemokines IL-8 and MCP-1 and also COX-2 in normal endometrium throughout
the menstrual cycle and in early pregnancy.
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3.2 Materials and Methods
Endometrial (n = 50) and first trimester decidual biopsies (n = 24) were examined
for immunolocalisation of the chemokines and COX-2 (table 5). All tissue samples
were processed in OCT frozen and paraffin blocks (section 2.21). A further 20
endometrial samples and 5 decidual samples were examined for mediator expression
by RT-PCR. Total RNA was extracted as described earlier (section 2.24) from tissue
frozen in cryotubes.
Table 5
Endometrial and decidual samples utilised. Stage of menstrual cycle at tifne of
biopsy collection.
STAGE OF CYCLE DAYS FROM LMP NUMBER OF
BIOPSIES
Menstrual dl-4 6
Early Proliferative d5-7 4
Mid Proliferative d8-10 4
Late Proliferative dl 1-13 5
Ovulatory dl4 5
Early Secretory dl5-18 10
Mid Secretory d19-24 9
Late Secretory d25-mens 7
First Trimester Decidua 8-10 weeks amenorrhoea 24
Immunohistochemistry
Immunohistochemistry for IL-8, MCP-1 and COX-2 was conducted to detect and
localise the mediators in normal endometrium at all stages of the menstrual cycle
and in early pregnancy, utilising methods described in General Materials and
Methods (section 2.22).
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Immunostaining was examined by light microscopy and staining intensity and
localisation was evaluated by semi-quantitative methods as described earlier (section
2.23).
Semi-quantitative RT-PCR
Endometrial and decidual RNA samples were subjected to RT-PCR and ELISA for
GAP-DH to determine their concentration, relative to a standard curve plotted of
varying RNA template (x) against the absorbance of RT-PCR product (y). The RT-
PCR was repeated with 60ng of each RNA sample as a template as verification of
equal loading. The samples were amplified for IL-8, MCP-1 and COX-2, using
protocols as described in general materials and methods (sections 2.25 and 2.26).
RT-PCR product yield was measured by ELISA, and expressed as a ratio of sample
signal : quality control (QC) signal. Gel electrophoresis was also conducted to
illustrate the changes in mediator RNA expression levels.
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3.3 Results
The local mediators, MCP-1, IL-8 and COX-2 were detected by
immunohistochemistry in samples of endometrium from non-pregnant and pregnant
women. Immunostaining was primarily present in the perivascular cells around all
blood vessel types in the endometrial stroma for MCP-1 and IL-8, although weaker
immunoreactivity was identified in the glandular epithelium for both chemokines
(figures 14 - 17). Additional staining was detected for MCP-1 in a subpopulation of
stromal cells in some decidual biopsies (figure 17). Intense immunoreactivity for
COX-2 was detected in the epithelial glands and perivascular cells (figures 18 and
19). In the menstrual phase and in some of the decidual sections examined, a degree
of stromal staining was observed.
Tonsil sections included as a positive control for MCP-1 and IL-8 immunostaining
also exhibited perivascular immunostaining. Immunoreactivity for COX-2 in third
trimester fetal membranes was detected primarily in the amniotic epithelium and
chorion laeve trophoblast, with slight immunostaining in the attached decidual cells,
in agreement with published data (Gibb et ah, 1996). Antibody preabsorbed with the
appropriate peptide or non-immune rabbit IgG applied to serial tissue sections to act
as a negative control, resulted in an absence of immunoreactivity.
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Figure 14 Immunohistochemical localisation of IL-8 in human endometrium.
IL-8 was localised to the perivascular cells in pregnant and non-pregnant
endometrium, with distinct variations throughout the menstrual cycle. Faint
immunoreactivity is apparent in (A) periovulatory and (B) early secretory phase ,
endometrium around small blood vessels (v). (C) Increased intensity of perivascular
IL-8 immunoreactivity was detected in late secretory endometrium, whilst in first











Figure 15 Positive and negative controls for IL-8 immunohistochemistry. The
upper photomicrograph demonstrates tonsil tissue section immunostained for IL-8.
As in the endometrium, immunoreactivity was restricted to the vasculature. To
ensure the specificity of the immunostaining, the antibody was preabsorbed with
synthetic IL-8 (100[lg/ml) for 24 hours, resulting in an absence of staining.
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Figure 16 MCP-1 immunoreactivity in human endometrium. As for IL-8,
immunostaining for MCP-1 was primarily localised to the perivascular cells in non¬
pregnant and pregnant endometrium. (A) MCP-1 immunoreactivity was prominent
in endometrium collected during the proliferative phase. (B) A marked reduction in t
staining intensity was detected in the ovulatory phase, whilst (C) premenstrual phase
endometrium and (D) first trimester decidua exhibited strong MCP-1
immunostaining in the perivascular cells of all vessels. Scale bars = 50pm, v =
vessel.
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Figure 17 MCP-1 immunoreactivity in human endometrium. (A) The specificity
of the perivascular immunostaining is demonstrated in this photomicrograph taken at
high magnification. (B) A distinct population of stromal cells were found to exhibit
immunostaining for MCP-1 in some decidual samples. (C) Tonsil sections were
included as a positive control, with immunostaining generally limited to blood
vessels. (D) A negative control was included, by the pre-absorption of primary
antibody with synthetic MCP-1 peptide, resulting in an absence of staining. For
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Figure 18 COX-2 immunoreactivity in human endometrium. Immunoreactivity
was generally localised to the glandular epithelium and blood vessels of non¬
pregnant and pregnant endometrium. Maximal COX-2 immunostaining was detected
in menstrual phase endometrium, either (A) restricted to glandular epithelium or (B) t
present in glandular epithelium, stromal cells and the vasculature. (C) Glandular
immunoreactivity was detected in proliferative endometrium, (D) which was
markedly reduced in the periovulatory phase. (E) Faint perivascular immunostaining
accompanied glandular immunoreactivity during the mid secretory phase. (F)
Premenstrual endometrium exhibited intense immunostaining for COX-2 in both
epithelial glands and perivascular cells.
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Figure 19 COX-2 immunoreactivity in human endometrium. COX-2 staining
intensity and distribution was variable in decidua collected during the first trimester
of pregnancy. It was interesting that regions exhibiting strong immunoreactivity
generally displayed characteristics of secretory phase endometrium (A), whilst fully
decidualised endometrium (B) possessed lower levels of immunoreactivity, limited
to the glandular epithelium. (C) Term fetal membranes collected from women
undergoing active labour were included as a positive control and exhibited COX-2
immunostaining in amniotic epithelium A, chorionic trophoblast, C and maternal
decidua, D. (D) Secretory phase endometrium treated with rabbit immunoglobulins
at a matching concentration to the primary antibody served as the negative control
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The intensity of IL-8 immunostaining varied throughout the menstrual cycle (figure
20). Low levels were detected in the perivascular cells in the menstrual and
proliferative phases of the menstrual cycle. A distinct but non-significant reduction
in staining intensity was observed in the periovulatory phase and levels remained
low in the early and mid secretory stages. Immunostaining levels increased slightly
in the early and mid secretory phase, but a highly significant increase (p < 0.001) in
staining intensity was apparent in the late secretory phase in comparison with the
ovulatory and early secretory phase. In the decidua, low levels of IL-8
immunoreactivity were observed. The average immunoreactivity was significantly (p
< 0.01) lower than that observed premenstrually and was consistent with the
expression levels of IL-8 in the mid secretory phase.
MCP-1 Immunohistochemistry
MCP-1 immunoreactivity was detected in a cyclical pattern during the menstrual
cycle (figure 21). Throughout the proliferative phase MCP-1 immunostaining was
relatively intense. As for IL-8, there was a clear reduction in staining intensity in the
periovulatory phase. In the premenstrual or late secretory phase, however,
immunostaining levels increased significantly (p < 0.05) compared to the
periovulatory stage. Strong perivascular immunoreactivity for MCP-1 persisted in
first trimester decidua.
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Figure 20 IL-8 immunoreactivity throughout the menstrual cycle and in early
pregnancy. A highly significant increase in immunostaining occurs in the
premenstrual phase compared to levels in the ovulatory and early secretory phases (p
< 0.001) and the mid secretory phase (p < 0.01). In early pregnancy, significantly ,
lower levels of immunoreactivity were detected than premenstrually (p < 0.01).
Significant differences between groups are denoted by matching letters. Y axis error
bars represent the standard error of the mean (SEM).
Figure 21 MCP-1 immunoreactivity throughout the menstrual cycle and in early
pregnancy. A significant increase in immunoreactivity levels are apparent in the
premenstrual phase with respect to the ovulatory and early secretory phases (p <
0.05). Significant differences between groups are denoted by matching letters. Y axis
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COX-2 immunoreactivity was observed at all stages of the menstrual cycle (Figure
3). Glandular epithelium and blood vessels exhibited intense heterogeneous
immunostaining in the menstrual phase. In the proliferative stage, levels of
immunoreactivity decreased slightly and lower levels still were detected in the
ovulatory phase. This pattern continued through the early and mid secretory phases
and a significant increase in COX-2 immunoreactivity was observed in the late
secretory phase (Glandular p < 0.01, vessels p < 0.05). The degree of glandular
immunoreactivity was for COX-2 was variable in early decidua, with less
immunostaining detected in regions displaying characteristics of fully decidu^lised
endometrium (compared to secretory type endometrium), whilst perivascular
staining appeared to be reduced (not significant).
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Figure 22 COX-2 immunoreactivity throughout the menstrual cycle and in early
pregnancy. Glandular immunostaining is represented by filled bars and perivascular
immunostaining by white bars. Glandular immunoreactivity was significantly
elevated in the menstrual ( p < 0.01) and premenstrual phases (p < 0.001) compared
to the ovulatory phase. Perivascular immunostaining followed a similar pattern, with
a significant increase in the premenstrual phase (p < 0.05) with respect to the early
secretory phase. Significant differences between groups are denoted by matching
letters. Y axis error bars represent the standard error of the mean (SEM).
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Figure 22 a (p< 0.001)
b (p < 0.01)
c (p < 0.05)
Stage of Cycle
Semi-quantitative RT-PCR
All RNA samples selected for GAP-DH RT-PCR were found to contain viable RNA.
The standard curve generated the equation y = 0.005x - 0.003, where x is the amount
of RNA template loaded and y is the absorbance of the probe-product complex at
450nm (figure 23). RNA concentrations were calculated and the RT-PCR for GAP-
DH was repeated with 60ng. Bands of equal intensity corresponding to the amplified
portion of GAP-DH cDNA were detected by gel electrophoresis, indicting equal
product yield and RNA loading and this was confirmed by ELISA (all samples 60
+/- lOng).
RT-PCR for IL-8, MCP-1 and COX-2 resulted in positive signal of expected
molecular weight (IL-8 - 298bp, MCP-1 - 210bp, COX-2 - 350bp)(figure 24). The
identity of the IL-8 and MCP-1 amplicons was confirmed by subcloning into
expression vector pGEM®-T Easy Vector (Promega Ltd., Southampton, U.K.) and
sequencing using the dideoxy chain termination method. Product yield was assessed
by ELISA and expressed as a ratio of sample signal : Quality Control (QC) signal.
High levels of expression for IL-8 and COX-2 were observed in the menstrual phase
samples. In contrast, MCP-1 mRNA levels were low in the majority of menstrual
samples examined. Throughout the proliferative and early-mid secretory phases,
relatively low numbers of mRNA transcripts were detected (statistically significant
with respect to menstrual phase for IL-8 (p < 0.0001) and COX-2 (p < 0.02)),
although a trend of a slight increase was apparent in the late secretory endometrium
(not significant). Low levels of COX-2 mRNA were generally detected in first
trimester decidua (not significant), whereas the IL-8 and MCP-1 signal was slightly
elevated when compared to the proliferative, ovulatory / early secretory and mid
secretory signals (IL-8 p < 0.05; MCP-1 p < 0.05). A large degree of variability was
observed at many stages of the cycle for COX-2 mRNA levels, which is reflected by
the error bars on the histogram representing the standard error of the mean (SEM).
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Figure 23 Standard curve for GAP-DH RT-PCR. (A) Standards amplified for
GAP-DH (1 = 250ng - 5 = 17.5ng) analysed by gel electrophoresis. (B) Product yield
was assessed by ELISA and amount of RNA template (x) was plotted against the
absorbance of the RT-PCR product (y). This generated the equation y = 0.005x -
0.003. A linear relationship between amount of starting template (RNA) and amount
of product generated was obtained, and the loading of subsequent RT-PCR was








Figure 24 Expression of IL-8, MCP-1 and COX-2 mRNA in human
endometrium. RT-PCR products from representative RNA samples throughout the
menstrual cycle are shown (ME = menstrual, P = proliferative, OV/ES = ovulatory /
early secretory, MS = late secretory, LS = late secretory, DE = decidua). A quality (
control (QC) of menstrual phase endometrium was included in each run to allow
consistency between individual RT-PCRs and to standardise subsequent ELISAs.
The upper panel demonstrates samples (60ng) amplified for GAP-DH, indicating the
equal loading of RNA into RT-PCRs for the inflammatory mediators. A signal of
298bp was detected, corresponding to the portion of the IL-8 gene targeted, with
strongest expression in the menstrual and late secretory phases and first trimester
decidual samples. For MCP-1, a signal of 210bp was detected by gel electrophoresis,
which was strongest in the menstrual phase, but present at all stages of the menstrual
cycle and early pregnancy. A single band of 350bp was detected representing the
COX-2 amplicon, with strongest expression in the menstrual and late secretory
phases and first trimester decidua.
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Figure 25 Expression of IL-8 mRNA in human endometrium. Highly elevated
levels of IL-8 mRNA transcripts were present in menstrual phase endometrium (dl-
4), which was highly significant (p < 0.0001) when compared to all other stages.
With cessation of menses, levels of mRNA fell and were barely detectable in the ,
proliferative, periovulatory / early secretory, mid and late secretory phases. The
signal increased slightly in the late secretory endometrial samples and similar levels
were detected from first trimester decidual samples (significant elevation from
proliferative, periovulatory / early secretory and mid secretory phases p < 0.05).
Figure 26 Expression of MCP-1 mRNA in human endometrium. Slight
variations in MCP-1 mRNA levels were detected from samples throughout the
menstrual cycle. The number of MCP-1 transcripts in the late secretory phase and
during menses appeared to be increased with respect to the proliferative,
periovulatory / early secretory and mid secretory phases (not significant). Elevated
MCP-1 levels were detectable in first trimester decidua (p < 0.05) when compared to
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Figure 27 Expression of COX-2 mRNA in human endometrium. Strong 1
expression of COX-2 was detected by RT-PCR in the menstrual phase endometrium.
Levels of COX-2 mRNA transcripts were decreased significantly (p < 0.02) in the
proliferative and mid secretory phases. Slightly elevated levels were detectable in the
periovulatory / early secretory and late secretory phases. Low numbers of COX-2
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MCP-1, IL-8 and COX-2 were localised in the endometrium and decidua by
immunohistochemistry. The localisation of these chemotactic agents to the
perivascular cells in both pregnant and non pregnant endometrium is consistent with
a putative role in the recruitment of specific leukocytes from the vasculature.
Elevated levels of chemokine immunoreactivity were detected in the premenstrual
phase of the menstrual cycle. Supporting evidence was obtained from RT-PCR
studies, with particularly strong expression of IL-8 and COX-2 mRNA in the
menstrual phase. These findings are supportive of the hypothesis that migration of
leukocytes from the peripheral circulation contributes to the significant leucocyte
accumulation observed premenstrually. Furthermore, the co-localisation of COX-2
in the perivascular cells reinforces the proposed interaction of prostaglandins and
chemokines in the local inflammatory response.
The exact cell types in the perivascular region which exhibit immunoreactivity have
not been characterised. Endothelial cells, fibroblasts and smooth muscle cells are
present in this location, and all have been demonstrated to be capable of chemokine
production (see reviews (Matsushima et ah, 1989; Baggiolini et al., 1994)).
Furthermore, specialised myofibroblasts may be responsible for chemokine and
COX-2 expression (McGrath, 1982; Valentich et al., 1994). Future studies could
address this question utilising double immunohistochemistry techniques for
chemokines and a-smooth muscle actin, desmin or an endothelial cell marker (CD34
/ CD31) (Gabbiani, 1992; Abberton et al., 1996). It is possible that the detection of
the chemokines in this position is due to their immobilisation on the endothelial
cells, via proteoglycans or the Duffy antigen, which is necessary for leukocyte
recruitment (Witt et al., 1994; Middleton et al., 1997). Additional immunoreactivity
was identified in a subpopulation of stromal cells in some decidual sections. These
observations may represent a population of leukocytes with the potential for
chemokine production.
Examination of tissues obtained throughout the menstrual cycle and in early
pregnancy revealed a cyclical pattern in the intensity of immunoreactivity for all
three mediators. Most noticeable was the distinct reduction in staining intensity
around the time of ovulation, extending into the early secretory phase. This coincides
with the initiation of progesterone production from the corpus luteum and peak
oestrogen production. At this stage the endometrium is most responsive to the effects
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of oestrogen and progesterone due to maximal steroid receptor expression (Snijders
et al., 1992). Furthermore the perivascular cells identified as the site of chemokine
production strongly express progesterone receptors throughout the cycle (Perrot-
Applanat et ah, 1988; Bouchard et al., 1991). Experimental evidence has
demonstrated that MCP-1 secretion by monocytes and fibroblasts in culture is
inhibited by oestrogen (Kovacs et al., 1993; Kovacs et al., 1996). A similar
regulation may occur in vivo, although the levels of MCP-1 immunoreactivity
detected during the proliferative phase fail to support this. The levels of chemokine
and COX-2 immunoreactivity detected remain low through the early and mid
secretory phases, until the late secretory phase when a significant elevation in
expression is apparent. At this stage in the non-pregnant cycle, regression of the
l
corpus luteum results in a drop in progesterone levels. If pregnancy occurs,
progesterone levels are maintained and this generally corresponds to a lower level of
immunoreactivity for the mediators.
It therefore appears that the staining intensity for all three mediators is related to the
prevailing steroid hormone environment, with a reduction in the presence of
progesterone and an increase when progesterone concentrations decline
premenstrually. These observations are consistent with a downregulation of the
chemokines and COX-2 by progesterone, such as has been demonstrated in vitro (Ito
et al., 1994; Kelly et al., 1994; Ishihara et al., 1995). This immunohistochemical
evidence of a co-localisation of chemokine and COX-2 producing cells with
progesterone receptors suggests a receptor mediated indirect effect of progesterone
in regulating leukocyte migration. This would represent an anti-inflammatory action
of progesterone, in the suppression of a local inflammatory response at the time
when fertilisation and implantation may occur. This is supported by the recent
demonstration of inflammation and hyperplasia in the uterus of a homozygous
mouse deficient for progesterone receptors (Lydon et al., 1995).
The phenotypically unique natural killer-like LGLs (CD56+CD16") are the
predominant leukocyte subtype in the late secretory endometrium and first trimester
decidua. Their origin is uncertain, but it has been suggested that a precursor form
may be recruited from peripheral blood into the endometrial stroma, where a
subsequent activation / differentiation occurs (King et al., 1991). A putative
precursor cell type are the CD56+CD16" agranular cells which comprise around 1%
of the circulating NK cells (Lanier et al., 1986). Chemotactic activity for NK cells
has been attributed to MCP-1 (Allavena et al., 1994). Further investigation is
necessary to determine whether MCP-1 may play a role in the accumulation of LGLs
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in the mid-late secretory phase and in the first half of pregnancy. IL-8 has also been
implicated in the chemotaxis of lymphocytes (Larsen et ah, 1989a), and this has been
linked to the LGL infiltrate in the endometrium (Casey et ah, 1993). However, it has
recently been proposed that only the C-C chemokines (including MCP-1) and not the
C-X-C subfamily, which include IL-8, possess chemotactic ability for T
lymphocytes (Roth et al., 1995).
The co-localisation of IL-8 and COX-2 in the endometrium reinforces the synergistic
action of PGE in the IL-8 stimulated recruitment of neutrophils (Foster et al., 1989;
Rampart et al., 1989; Colditz, 1990). Furthermore, as MCP-1 and IL-8 are closely
related chemokines, it is possible that PGE may also have an enhancing effect on
monocyte infiltration, since the synergistic effect described in all publications
involves a vasoactive property of PGE. Prostaglandin activity is also regulated by
the locally produced metabolising enzyme prostaglandin dehydrogenase (PGDH). A
positive regulation by progesterone has been demonstrated by the reduced
immunoreactivity for PGDH following antigestogen administration in early
pregnancy (Cheng et al., 1993b). Also observed was increased immunoreactivity for
PGE2 around the small blood vessels in the endometrium (Cheng et al., 1993a). Thus
progesterone may affect local prostaglandin concentrations by modulating the
enzymes responsible for both their production and metabolism.
The localisation of COX-2 primarily to the glandular epithelium is supportive of the
in vitro evidence that glands are the major site of prostaglandin synthesis in the
endometrium (Rees et al., 1982; Lumsden et al., 1984; Smith et al., 1988)
Furthermore, whilst the endometrium retains the ability to synthesise prostaglandins
in response to stimuli throughout the menstrual cycle, higher levels of prostaglandins
are released from isolated glands in the proliferative than in the secretory phase
(Smith et al., 1988). First trimester decidua appears to have a reduced capacity for
arachidonic acid metabolism, thus basal levels of PGs are low (Maathuis et al.,
1978). This is consistent with a stimulation of prostaglandin production by oestrogen
(Abel et al., 1980), potentially through cyclooxygenase upregulation (Jun et al.,
1996), and a downregulation by progesterone. The variable nature of COX-2
immunostaining in first trimester decidua may be explained by the different
histological appearance of tissues collected at this stage. The process of
decidualisation is not complete by 8-10 weeks of pregnancy and this is reflected by
the collection of tissue displaying clear characteristics of decidua, and other regions,
presumably collected from deeper regions of decidua (decidua spongiosa), which
resemble secretory endometrium (Bell, 1991). Immunoexpression of COX-2 was
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much higher in the secretory type endometrium, whilst minimal immunoreactivity
was generally detected in true decidua.
The present study has therefore identified and immunolocalised the inflammatory
mediators MCP-1, IL-8 and COX-2 to the perivascular cells in endometrium and
decidua. A cyclical pattern of immunoreactivity has been observed, with maximum
expression of MCP-1, IL-8 and COX-2 occurring perimenstrually and coinciding
with the large increase in leukocytes in the endometrial stroma at this time. These
observations support a role for steroid-regulated chemokines in the mechanisms
determining leukocyte accumulation in endometrium and decidua.
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CHAPTER 4
IN VIVO PERTURBATION OF LOCAL PROGESTOGEN




The expression and localisation of locally active factors IL-8, MCP-1 and COX-2 in
the endometrium has been demonstrated in the previous chapter. Both chemokines
were immunolocalised to the perivascular cells of endometrial and decidual vessels.
Similarly, COX-2 protein was detected in the vasculature, and further
immunoreactivity in glandular epithelium was described. The temporal expression
pattern of all three inflammatory mediators indicates a role in leukocyte recruitment
to the endometrium premenstrually and thus potentially in the initiation of
menstruation. The interesting cyclical pattern observed for both protein and mRNA
levels has prompted further investigation into the role of the sex steroid hormone,
progesterone, in the regulation of these paracrine factors.
A further aspect of these studies has been to consider the clinical application of
these observations in the context of progesterone only contraception and the impact
of progesterone on endometrial function. Modification of progesterone levels is a
useful tool in gynaecology and obstetrics, particularly in the development of
contraceptives and for the termination of pregnancy (Baird, 1993). High continuous
production of progesterone is essential for the establishment and maintenance of
pregnancy, and inappropriately elevated concentrations or withdrawal can prevent or
terminate a pregnancy (Csapo et al., 1973). Women under 9 weeks gestation may
terminate their pregnancy by taking the antigestogen mifepristone (RU486)
followed by a prostaglandin analogue 24 hours later (Van Look et al., 1989). RU486
effectively blocks the action of progesterone by occupying receptor sites, yet not
effecting a cellular response. Recent and ongoing work has been researching into the
use of RU486 as a contraceptive (Baird, 1993), particularly focusing on the
development of a once a month or lose dose daily pill (Gemzell-Danielsson et ah,
1994; Cameron et al., 1995; Cameron et ah, 1996; Cameron et al., 1997; Gemzell-
Danielsson et al., 1997a; Gemzell-Danielsson et al., 1997b).
Progesterone administration, either orally or as a slow release mechanism are
presently used for contraceptive purposes. The oral contraceptive, combining the
effects of oestradiol and progesterone, functions in a number of ways to prevent
pregnancy, through the inhibition of ovulation, alteration of cervical mucus,
disruption of the endometrial receptivity in the 'implantation window' (Kubba et al.,
1993; Somkuti et al., 1996). Recently, slow release subdermal implants (Norplant®,
Leiras, Finland) and an intrauterine system (Lng-IUS; Mirena, Leiras, Finland)
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incorporating the perturbation of the steroid environment, have been licensed in this
country. Both preparations release levonorgestrel (Lng), a progesterone analogue.
Both are highly effective as contraceptives, and the Lng-IUS has the added
advantage of dramatically reducing menstrual blood loss and thus proving useful as
a treatment for menorrhagia and dysmenorrhoea (Nilsson et ah, 1982; Andersson et
al., 1990). Ovulation is not inhibited in most users of Norplant and Lng-IUS
(Nilsson et ah, 1984; Luukkainen et al, 1990), the contraceptive effect is instead
mediated through the prevention of proliferation and differentiation of the
endometrium and thickening of cervical mucus (Silverberg et al., 1986; Barbosa et
al., 1990). The main reason for discontinuation of use of progestin only
contraceptives, however, is the breakthrough bleeding commonly experienced by
users (Sivin et al., 1983; Odlind et al., 1990; Findlay, 1996). This is associated with
decidual transformation of the endometrium and infiltration of leukocyte
subpopulations (Sheppard, 1987). Important research is currently underway to
understand this unacceptable side effect associated with continuous exposure of the
endometrium to progestins (Critchley et al., 1998a; Wang et al., 1997; Critchley et
al., 1998b).
Progesterone withdrawal triggers an inflammatory type response, including the
accumulation of leukocytes, stromal oedema, elevated prostaglandin and cytokine
production and increased production of active MMPs (Finn et ah, 1984; Salamonsen
et al., 1996b). All are believed to have an integral role in the initiation of
menstruation (Kelly et al., 1994). The cellular mechanisms behind breakthrough
bleeding associated with progestogen only contraception and termination of
pregnancy by administration of antigestogens and prostaglandins are unknown.
Antigestogen administration during the luteal phase of the normal menstrual cycle
or in early pregnancy induces bleeding (Herrmann et al., 1985; Swahn et al., 1988;
Swahn et al., 1990), and retards endometrial development (Gemzell-Danielsson et
al., 1997). First trimester decidua collected after withdrawal of progesterone shows
reduced immunoreactivity for PGDH (Cheng et al., 1993b), resulting in elevated
concentrations of PGE2 around blood vessels (Cheng et ah, 1993a). Sensitivity of
the decidua to exogenous PGE is also increased (Brooks et al., 1990). RU486
treatment in vitro stimulates endometrial and decidual cell PG synthesis (Kelly et
al., 1986; Smith et al., 1987), although the mechanism is unknown. Given the
proposed role of chemokines and prostaglandins in normal menstruation, the
question of their involvement in breakthrough bleeding and induced abortion is
raised.
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The present study investigates the effect that modification of progesterone
concentrations has on local endometrial factors. The expression of EL-8, MCP-1 and
COX-2 was examined by means of immunohistochemistry and RT-PCR in
endometrium where the progesterone environment has been artificially perturbed.
These studies include:
1. Model of progesterone withdrawal and maintenance in vivo, to simulate the
onset of menses and provide an opportunity to study the earliest stages of
pregnancy.
2. The pharmacological withdrawal of progesterone by RU486 administration
at varying time points prior to surgical termination of first trimester t
pregnancy.
3. Endometrium constantly exposed to high local concentrations of progestin
via an levonorgestrel releasing intra-uterine system (Lng-IUS).
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4.2 Materials and Methods
Healthy fertile women aged between 20 and 48 years of age, with normal menstrual
cycles (cycle length 25 - 35 days) were recruited to take part in these studies. All
subjects were fertile and had not used any form of hormonal treatment in the
previous three months. Ethical approval for each clinical study was obtained from
Lothian Research Ethics Committee (reference: 1702/94/6/1) and each patient was
required to give written informed consent. These studies were supported by project




Study 1 Endometrium from different stages of the menstrual cycle was
collected from five groups of women:
(i) Normal mid-secretory phase endometrium (day LH + 8 - 10), corresponding
to peak serum progesterone concentrations (Control Group A, n = 5).
(ii) Premenstrual phase endometrium. In order to time the samples accurately,
200mg of the progesterone analogue Cycloogest was administered from day
LH + 8 for four days by vaginal pessary (Cyclogest [Hoechst] 200mg b.d.).
Endometrial biopsies were collected 24 hours after stopping progesterone
(Group B, n = 5).
Endometrium was also collected from a further cohort of women, 48 hours
after exogenous progesterone withdrawal (Group C, n = 5).
(iv) Pseudopregnant endometrium. The lifespan of the corpus luteum (CL) was
extended by daily injections of hCG from day LH + 8 for 14 days,
maintaining progesterone production, to simulate early pregnancy.
Incremental doses of hCG ranging from 125 to 20,000 IU (Illingworth et al.,
1990) were administered over the 14 days (Group D, n = 5).
(v) First trimester decidua from women with tubal pregnancy, ectopic to the
uterus. Women who had experienced vaginal bleeding were excluded from
this study (Group E, n = 5).
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Table 6 Table illustrating the different subgroups used in study 1.



















ectopic to the uterus
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Study 2 Early pregnancy decidua was collected from women (35 - 56 days
amenorrhoea) seeking termination of pregnancy, according to the 1967 Abortion
Act. The effect of progesterone withdrawal on first trimester decidua was
investigated by administration of the antigestogen mifepristone (RU486) prior to
suction termination of pregnancy. Women were randomly allocated to six groups.
An oral dose of 200mg of RU486 was given to groups II, II, IV and V (n = 7 in
each) at 6, 12, 24 and 36 hours respectively before tissue collection. The control
group I (n = 8) did not receive RU486. Decidua parietalis was biopsied as described
earlier (section 2.21) and the absence of trophoblast invasion was confirmed by
immunohistochemistry for cytokeratin (section 2.22).
i
Study 3 This study involved the local exposure of the endometrium to high
local concentrations of synthetic progestin via a levonorgestrel releasing intra¬
uterine system (Lng-IUS). Women (n = 14) were recruited for contraceptive
purposes (n = 10) or for the treatment of menorrhagia (n = 4). The Lng-IUS
(Mirena) consists of a plastic T-shaped frame, surrounded by a levonorgestrel
containing cylinder. A polydimethylsiloxane membrane ensures a daily delivery of
20|lg into the uterine cavity. The Lng-IUS was inserted in subjects in both the
proliferative phase (n = 7) and the secretory phase (n = 7). An endometrial biopsy
was taken prior to insertion of the Lng-IUS and further biopsies were collected at 1,
3, 6 and 12 months post insertion. This was therefore a longitudinal study design,
with each patient acting as her own control.
Tissue Treatment
For all study biopsies, the tissue was divided and a portion fixed overnight in 10%
NBF to be processed into paraffin blocks, whilst another sample was frozen in OCT
embedding medium, as for control endometrial biopsies. When enough tissue was
collected for Study 1 patients (n = 15), a further portion was frozen in a cryotube
and RNA was extracted as described previously (section 2.24). All biopsies were
allocated a random code to enable immunostaining, scoring and statistical analysis
to be conducted blindly and randomly.
Immunohistochemistry
Immunostaining for IL-8, MCP-1 and COX-2 was conducted on all study tissues,
using protocols described earlier (section 2.22). As far as was possible, samples
from a particular study were stained in the same run, to exclude artefactual variation
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in staining intensities. Analysis of staining was conducted blindly by two
independent observers.
Semi- quantitative RT-PCR
RNA was extracted from endometrium collected from 15 patients (n = 3 in each
group) taking part in Study 1. Sample RNA was initially subjected to RT-PCR for
GAP-DH to determine RNA concentration and enable equal loading of subsequent
reactions (section 2.25). RT-PCRs for IL-8, MCP-1 and COX-2 were conducted and




Immunoreactive protein for IL-8 and COX-2 was detected in the endometrium from
all study groups. As in the non-pregnant and pregnant endometrium (Chapter 3), all
were localised to a perivascular position, with additional staining for COX-2 in
detected in glandular epithelium.
Study 1 Histological features of the tissue sections were consistent with the
stage of the cycle (LH dating). Biopsies collected during the secretory phase
possessed characteristics of decidualisation, including LGL accumulation, and Spiral
arteriole formation. Premenstrually timed biopsies (Group C) exhibited signs of
tissue breakdown. Decidua from groups D and E was described as late secretory,
with a greater degree of decidualisation evident when the gestation was ectopic.
Positive immunoreactivity for IL-8 was detected in a perivascular position in all
tissue samples examined (figure 28). Intense perivascular immunostaining was
observed in premenstrual groups B and C, with addition staining evident in
glandular and stromal compartments 48 hours post progesterone withdrawal, in
tissues exhibiting features of tissue breakdown. COX-2 immunoreactivity was
present in endometrium from all study groups (figure 29). Maximal immunostaining
was detected in premenstrual endometrium (group C), with noticeable
heterogeneous glandular immunostaining, as detected in menstrual phase biopsies
(Chapter 3, section). COX-2 immunoreactivity was lowest in early decidua,
pharmacologically maintained by hCG administration.
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Serum Progesterone and Oestradiol Concentrations
Circulatory levels of the steroid hormones in study 1 patients were consistent with
the stage of the simulated or extended menstrual cycle at the time of biopsy (Table
6). A significant reduction in serum progesterone concentrations was detected in
premenstrual groups B (* p < 0.01) and C (** p < 0.001) when compared with
control group A (LH+8-10). Serum oestradiol concentrations followed a similar
pattern but did not reach significance. High serum concentrations of progesterone
and oestradiol were detected in the hCG treated psuedopregnant group (D) and those
with ectopic pregnancy (E), consistent with continuing endogenous steroid
production. t
Table 7 : Serum Progesterone (nmol/1) and Oestradiol (pmol/1) Concentrations
(Study 1)
STUDY GROUP PROGESTERONE OESTRADIOL
Mean ± SEM Mean + SEM
(Range) (Range)
A 50+11 454 ± 166
(28.7-91.6) (234-1102)
B 11.3 ±1.7 * 137 ±49
(8.7 - 17.6) (36 - 280)
C 3.5 + 0.7 ** 54 ±7.5
(2.4 - 6.4) (30 - 75)
D 70.1 ± 15.5 1386 ±353
(28.3 - 112.3) (801 -2731)
E 34.6+10.7 1496 ± 570
(11.9-60.7) (683 - 3091)
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Figure 28 IL-8 immunoreactivity in endometrium collected from study 1
patients. Slight variations in immunostaining intensity and distribution were
detected between the different groups. In the control group (A), IL-8 moderate
immunoreactivity was limited to the perivascular cells. Withdrawal of progesterone
triggered breakdown of the endometrium functionalis, and was associated with
strong immunostaining for IL-8 in vessels and additionally in stromal and glandular
components (B). Maintenance of progesterone produced lower levels of IL-8
immunostaining, although this was found to be lower in hCG induced
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Figure 29 COX-2 immunoreactivity in endometrium collected from study 1
patients. Immunostaining for COX-2 was identical in distribution and intensity as
that collected during the mid secretory phase (Chapter 3). An increase in
immunostaining intensity in glandular epithelium was detected between 24 hours
(A) and 48 hours (B) after withdrawal of exogenous progesterone. In particular, 48
hours after progesterone withdrawal, COX-2 immunostaining was reminiscent of
that observed in menstrual phase endometrium (Chapter 3). Minimal
immunostaining was detected when progesterone concentrations were maintained,
either by administration of hCG or from ectopic pregnancy (C).
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GAP-DH RT-PCR and ELISA was repeated with correction of RNA amounts,
producing signals (1103bp) of equivalent intensity for all samples (figure 31). The
standard curve yielded the equation y = 0.006x + 0.138 (figure 30). 60ng (+/- lOng)
of RNA was loaded into the RT-PCRs for IL-8, MCP-1 and COX-2. A single band
was obtained for IL-8 (298bp), MCP-1 (210bp) and COX-2 (350bp) for the positive
control RNA sample (QC). Distinct variations in signal intensity were observed
between the samples from the different study groups (figure 31). Product yield was
assessed by ELISA and expressed as the ratio of sample signal : QC signal.
A low signal was obtained from the control group (A) for IL-8, MCP-1 and COX-2.
Withdrawal of progesterone resulted in an increase in mediator signal in the
endometrium (groups B and C), which reached significance after 48 hours (C) for
IL-8 (p < 0.01) and COX-2 (p < 0.05). Pharmacological rescue of the corpus luteum
by hCG administration induced pseudo-pregnancy (D) and resulted in a reduction of
IL-8 (p < 0.01 compared to group C) and COX-2 mRNA concentrations,
comparable with the control group (A). MCP-1 mRNA expression remained
elevated. Similar expression levels were detected in decidua collected from cases of
ectopic pregnancy (E), with a slight non-significant elevation in EL-8 mRNA levels.
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Figure 30 Standard curve for GAP-DH amplification. (A) Demonstration of the
changes in signal intensity with varying standard RNA concentrations, by gel
electrophoresis (250ng - 17.5ng). (B) After measurement of product yield by
ELISA, the amount of RNA template included (x) was plotted against the t
absorbance of the GAP-DH RT-PCR product (y) at 450nm. This yields the equation
y = 0.006x + 0.138, allowing calculation of RNA template concentrations. A linear
relationship is achieved, indicating that the RT-PCR is not limited by reaction













Figure 31 Expression of GAP-DH, IL-8, MCP-1 and COX-2 mRNA in
endometrium collected from study 1 patients. Representative RT-PCR products
from each study group are shown:
A = mid luteal, control group
B = 24 hours post progesterone withdrawal
C = 48 hours post progesterone withdrawal
D = hCG maintained pseudopregnancy
E = ectopic pregnancy
QC = quality control
- = negative control
The upper panel indicates the equal loading of the RNA template into the
subsequent mediator RT-PCRs. All bands for GAP-DEI are of comparable intensity.
The same RNA samples were subjected to RT-PCR for IL-8, MCP-1 and COX-2.
For IL-8, no signal was detected in the control group. After withdrawal of
progesterone, a strong signal of 298bp was present (B and C). Faint bands were
detected in progesterone maintenance groups. A similar pattern was detectable for
MCP-1, although signal s of comparable intensity were observed in the progesterone
maintenance groups. No signal was detected for COX-2 in the control group, but a
strong signal was identified from premenstrual phase endometrium (C). Faint bands
were detectable in groups D and E.
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Figure 32 IL-8 mRNA expression in study 1 endometrium. Low levels of
expression of IL-8 were detected in the endometrium from the control group (A).
The signal increased slightly 24 hours after progesterone withdrawal (B), and 48
hours after withdrawal (C) a significant elevation in mRNA transcript expression
was detected (p < 0.01) compared to the control group. In the psuedopregnant group
(D) levels of IL-8 transcripts were low (p < 0.01 to C group) and slightly higher
levels were apparent in the endometrium collected from ectopic pregnancy. A strong
signal was obtained from the quality control (QC) and no signal was detectable for
the negative control.
Figure 33 MCP-1 mRNA expression in study 1 endometrium. Variations were
apparent in the levels of MCP-1 mRNA in the study groups (not significant). The
lowest number of mRNA transcripts were detected in the control group (A), with an
trend towards an increase following progesterone withdrawal (B and C). In the
psuedopregnant (D) and ectopic (E) decidua, expression of MCP-1 remained
elevated compared to mid secretory levels (A). A positive signal was achieved for
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Figure 34 A similar pattern of COX-2 expression levels was detected to IL-8 in
the study patients. Very low levels of COX-2 mRNA were present in the control
group (A), with a significant increase (p < 0.05) observed 48 hours (C) but not 24
hours (B) after exogenous progesterone had been withdrawn. COX-2 mRNA
expression in the psuedopregnant (D) and ectopic (E) pregnancies was consistent
with those during the mid secretory phase (A). A strong signal was obtained from
the quality control (QC) and no signal was detectable for the negative control (-).
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Figure 34 a p < 0.05
□ COX-2
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Study 2 Immunohistochemical analysis of IL-8 and COX-2 expression in first
trimester decidua collected at different time points following administration of
RU486 was examined (figure 35). No significant differences were detectable in the
intensity or distribution of either IL-8 or COX-2 immunoreactivity, although a slight
elevation in COX-2 immunostaining was apparent both 6 and 12 hours after
antigestogen administration, compared to the control group (figure 36). COX-2
immunoreactivity was predominantly localised to the glandular epithelium, and
marked variations in staining intensity were observed within the study groups.
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Figure 35 Immunostaining for IL-8 (A) and COX-2 (B) in first trimester
decidua following pharmacological withdrawal of progesterone (study 2). No
distinct changes in IL-8 or COX-2 immunoreactivity were detected at the different
time points following antigestogen administration. IL-8 immunostaining was
apparent in the perivascular cells in all tissues examined, while COX-2
immunostaining was primarily localised to the glandular epithelium. Scale bars =
50]im.
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Figure 36 Histogram illustrating COX-2 immunostaining in decidual samples
collected at different time points following antigestogen administration (Study 2). A
slight transient increase in the degree of COX-2 glandular immunoreactivity was
detected 6 and 12 hours after pharmacological withdrawal of progesterone when
compared to control group (C), with reduced intensity of staining detected after 24
hours.
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6 12 24 36
Hours after RU486 administration
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Study 3 Preinsertion biopsies were histologically consistent with the stage of
cycle calculated from last menstrual period (LMP). Widespread morphological
changes were observed after insertion of the Lng-IUS, most notably extensive
decidualisation of stromal cells and glandular atrophy. Once the Lng-IUS was in
situ, the histological appearances of the endometrium in the proliferative and
secretory phase were indistinguishable, thus sample data at each of the post-
insertion stages (1, 3, 6 and 12 months post-insertion) was pooled.
IL-8 immunoreactivity was detected around spiral arterioles and other blood vessel
types (figures 37 and 39). A decrease in IL-8 immunostaining was apparent at 3 and
6 months postinsertion. COX-2 immunoreactivity in preinsertion biopsies was
consistent with the stage of the menstrual cycle (figures 38 and 40). High levels of
immunostaining were detected one month post insertion, comparable to
premenstrual expression of COX-2. After 3, 6 and 12 months of exposure to Lng, a
slight reduction in COX-2 immunoreactivity was observed, although marked patient
to patient variations persisted.
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Figure 37 IL-8 immunoreactivity in endometrium exposed to intrauterine
levonorgestrel via an Lng-IUS. (A) Very intense perivascular immunostaining for
I
IL-8 was detected one month after insertion of the Lng-IUS. (B) Immunoreactivity
was slightly reduced after 3 months exposure, and (C & D) a further decline in the
degree of staining was apparent after 6 months exposure to local synthetic progestin.
Scale bars = 50(im.
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Figure 38 COX-2 immunoreactivity in endometrium exposed to intrauterine
levonorgestrel via an Lng-IUS. Strong immunostaining for COX-2 was detected one
month after insertion of the Lng-IUS, in the glandular epithelium (A) and in the
glandular epithelium, vasculature and stroma (B). Markedly reduced
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Figure 39 IL-8 immunoreactivity before and after insertion of a Lng-IUS.
Strong perivascular immunostaining was detected for IL-8 in tissues collected prior
to insertion of the device (separated into proliferative and secretory phases). Intense
immunostaining was detected in endometrial biopsies collected 1 month after ,
insertion of the Lng-IUS, but a marked reduction was evident after 3 months
exposure to local Lng, with a further reduction 6 months post-insertion. Insufficient
tissues were collected in frozen blocks to assess IL-8 immunostaining at 12 months
postinsertion, due to the atrophic nature of the endometrium.
Figure 40 COX-2 glandular immunoreactivity in endometrial biopsies collected
before and after insertion of a Lng-releasing IUS. Preinsertion biopsies displayed
patterns of immunostaining characteristic of the stage of the menstrual cycle, with
strongest glandular immunostaining in the menstrual and premenstrual phases.
Immunoreactivity comparable to that observed in the premenstrual biopsies
persisted at 1 and 3 months postinsertion of the Lng-IUS. After 6 and 12 months of















a p < 0.05

















The current chapter describes the effect on endometrial inflammatory mediator
expression by in vivo perturbation of the progesterone environment. Three separate
and distinct methods of progesterone modulation were utilised to examine the
regulation of IL-8, MCP-1 and COX-2.
Study 1
Study 1 was designed to clarify previous findings (chapter 3) of inflammatory
mediator expression in normal non-pregnant and pregnant endometrium. The
premenstrual period was artificially simulated by administration and withdrawal of
exogenous progesterone at timed intervals before tissue biopsy, to examine events
associated with the onset of menses. Local endometrial events taking place in very
early pregnancy were studied by administration of hCG in incremental doses to
mimic natural production of gonadotrophin by the embryo. This "rescues" the
corpus luteum, allowing continuation of endogenous progesterone production and
induces a state of pseudopregnancy. Finally, decidua from women with a pregnancy
ectopic to the uterus was collected to observed the differences in mediator
expression without the presence of intrauterine trophoblast.
Histological features of tissues from each study group were consistent with the date
of the menstrual cycle and with the prevailing steroid environment. The number and
subtype of leukocytes in the endometrium were examined by Critchley et al (1998c).
CD56+ LGLs formed the major constituent of leukocytes present, with high
numbers of stromal macrophages. Few neutrophils were detectable. This is
compatible with the fact that our biopsies were collected prior to the reported
neutrophil infiltrate in the immediate premenstrual phase (Poropatich et al., 1987).
Sex steroid distribution was also examined and the expression of ER and PgR (A
and B forms) was found to be consistent with published literature for the normal
menstrual cycle (Lessey et al., 1988; Wang et al., 1997b) (see introduction, section
1.2). This is confirmation of the reliability of this study design as a simulation of
menstruation.
The significant elevation in IL-8 and COX-2 mRNA expression levels
premenstrually (B and C), and low numbers of IL-8 and COX-2 mRNA transcripts
in both pregnant groups (D and E) are in agreement with data from the normal cycle
endometrium (chapter 3). Co-workers examined chemokine secretion from study 1
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endometrial explants during a 24 hour culture period by ELISA. Elevations in IL-8
(p < 0.05 compared with control group A) and MCP-1 (not significant) production
from premenstrual endometrium, collected 48 hours post progesterone withdrawal
were reported. The production of chemokines is therefore compatible with the
increased mRNA expression levels observed in the present study. Examination of
PG production by the endometrial explants confirmed that the COX-2 mRNA
detected is being translated and is responsible for elevated PG production
premenstrually. In particular, PGF2a production was significantly increased both 24
and 48 hours following progesterone withdrawal compared to control group A, and
markedly reduced when pseudopregnancy was induced (D).
These data provide supporting evidence for the downregulation of IL-8 and COX-2
by progesterone, and for their proposed involvement in the initiation of
menstruation. Failure to detect a significant rise in MCP-1 expression may indicate
differences in the regulatory effect of progesterone on this chemokine. Higher levels
of expression were observed in the mid secretory (A) and pregnant (D and E)
groups, which suggests that progesterone inhibits MCP-l expression to a lesser
extent than IL-8. First trimester decidua examined for MCP-1 immunoreactivity
(Chapter 3, section 3.3) also exhibited relatively high levels of immunostaining.
Several differences in the regulation of the chemokines IL-8 and MCP-1 have
previously been reported, including stimulation of MCP-1 by PDGF, IFN-y, PRL
and LEF (Yoshimura et al., 1990; Seitz et ah, 1994; Townson et al., 1996; Hartner et
al., 1997). Furthermore, MCP-1 has been demonstrated to be induced preferentially
by Th2 cytokines (Rollins et al., 1991; Warmington et al., 1996; Gu et al., 1997),
which are believed to be predominant in early pregnancy (Wegmann et al., 1993).
This is in contrast to IL-8, whose expression is generally upregulated in response to
Thl inflammatory cytokines, and is negatively regulated by the Th2 cytokine IL-10
(Kunkel, 1996). A delicate balance of regulatory factors is likely to exist in the
uterus to carefully modulate the expression of local inflammatory mediators. It is
interesting that the higher levels of MCP-1 expression in the early pregnant uterus
correlate with the continued increase in the numbers of LGLs and macrophages in
the decidual stroma (Bulmer et al., 1988; Loke et al., 1997). In support of this, a
recent publication strongly supports a relationship between MCP-1 expression and
macrophage recruitment in the peri-implantation mouse uterus (Wood et al., 1997).
Study 2
The effect on decidual mediator expression following the pharmacological
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withdrawal of progesterone by RU486 administration was examined in study 2. No
distinct changes in IL-8 immunoreactive protein were detected at any of the time
points following antigestogen administration. However, when chemokine secretion
by decidua cultured for 24 hours was measured by ELISA, a significant increase in
IL-8 production was detected 6 hours after antigestogen administration (p < 0.019)
with respect to the control group (I). A non-significant increase in MCP-1 was
observed 6 hours post RU486 administration, followed by a significant decrease
between 6 and 12 hours after mifepristone (Critchley et ah, 1996). This method is
likely to be more effective at detecting transient variations in expression levels than
immunohistochemistry.
COX-2 immunoreactivity was examined in decidua collected at each of the'time
points following antigestogen administration. Although no significant differences
were detected in the degree of immunostaining between study groups, there did
appear to be a trend for elevated COX-2 expression 6 and 12 hours after RU486
administration. In addition, distinct variations in COX-2 immunostaining were
observed between subjects, reminiscent of variations detected in first trimester
decidua (Chapter 3, 3.3). This problem is likely to be due to the heterogeneous
nature of this tissue, with incomplete decidualisation resulting in areas of fully
decidualised endometrium whilst other regions maintain secretory type
characteristics.
Co-workers investigated the effect of progesterone withdrawal on leukocyte
subpopulations in first trimester decidua, and reported a significant elevation on the
numbers of macrophages 24 hours after RU486 administration (Critchley et ah,
1996). No significant changes in other subpopulations were reported but LGL
numbers appeared to fall over the time course and by 36 hours a non-significant
increase in neutrophil numbers was observed. These features are consistent with the
inflammatory type response associated with progesterone withdrawal, either
premenstrually or in early pregnancy. It is important to note that progesterone
withdrawal by pharmacological blockade of the receptor is likely to be a more rapid
process than the physiological withdrawal premenstrually. This may explain
differences in leukocyte populations and chemokine dynamics between studies 1
and 2.
Study 3
The effect of uterine progestin delivery, via a Lng-IUS, on local mediator expression
168
was examined. Whilst proving to be an effective long-term contraceptive and
treatment for menorrhagia, this mode of intrauterine contraception is flawed by the
common side effect of breakthrough bleeding experienced by the majority of users
(Sivin et al., 1983; Odlind et al., 1990). Considering the proposed involvement of
the chemokines and PGs in normal menstruation, these are potential candidate
mediators for investigation into the bleeding episodes caused by Lng modulation of
the endometrium.
Following insertion of the Lng-IUS, the endometrium becomes markedly
decidualised and atrophic (Silverberg et al., 1986). Glandular activity is diminished
and vessels appear distended. Leukocyte infiltrate into the endometrium is
augmented by the presence of an IUD (Sheppard, 1987) and macrophages in
particular become adherent to the device and are a potential source of PGs (Myatt et
al., 1975). Characterisation of leukocyte subtypes in the Lng-IUS endometrium by
colleagues revealed the presence of high numbers of CD56+ LGLs and
macrophages, whilst few neutrophils were identifiable. A significant increase in the
numbers of macrophages was identified one month after insertion of the device
(Critchley et al., 1998b). Increased numbers of uterine macrophages have been
correlated with bleeding disorders in Norplant users (Clark et al., 1996). Whilst
endometrial MCP-1 was not examined in the present study, IL-8 and COX-2
immunoreactivity remained high one month after insertion of the Lng-IUS, then was
reduced at 3 and 6 months postinsertion. It was not possible to examine adequate
numbers of biopsies collected 12 months after insertion of the Lng-IUS for EL-8, due
to the atrophic nature of the endometrium by this stage. Similarly, insufficient
endometrium could be collected to extract RNA for RT-PCR studies.
Examination of the steroid receptor content of these tissues has revealed that after
one month of intrauterine exposure to Lng, both ER and PgR are absent in glandular
epithelium and markedly reduced in stromal compartment of the endometrium
(Critchley et al., 1998a). This pattern continues for approximately 6 months, after
which a gradual, but significant return of PgR in epithelial glands is observed.
Immunohistochemical studies indicate that the few PgR remaining in the stroma are
likely to be PgRA (Critchley et al., 1998a), and the return of glandular PgRA
between 6 and 12 months correlates to the restoration of functional activity (as
defined by in vitro activity and immunoreactivity of progesterone sensitive PGDH)
(Critchley et al., 1998a). This is consistent with the expression of the subtypes in the
normal menstrual cycle and first trimester decidua, with a preferential down
regulation of PgRe by progesterone in the secretory phase and early pregnancy
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(Wang et al., 1998).
The significance of differential PgR expression in the endometrium is not
understood. The predominance of PgRA when decidualisation of the endometrium
takes place, both in the normal menstrual cycle and in Lng exposed endometrium,
would suggest that this isoform has a role in mediating the transformation.
Furthermore, from the temporal expression during the menstrual cycle, it would
seem likely that the inhibitory effect of progesterone on chemokine and COX-2
expression is mediated via PgRA.
We have hypothesised that the downregulation of PgR (both A and B subtypes) by
local levonorgestrel delivery could be involved in the cascade of events which
results in breakthrough bleeding, especially as an adjustment in uterine bleeding
patterns seems to accompany the increased expression of the steroid receptors
between 6 and 12 months of use. Progesterone sensitive chemokines and COX-2
could conceivably have a role in such bleeding episodes. This is reinforced by the
strong immunoreactivity for both IL-8 and COX-2 after insertion of the Lng-IUS
and subsequent reduction with continued Lng exposure and the return of PgR. This
argument is, however, complicated by findings from women using subcutaneous
Norplant implants, which release an identical progestin into the peripheral
circulation. Norplant users also experience breakthrough bleeding, yet intense
immunoreactivity for PgR and ER is detectable in the endometrium throughout the
menstrual cycle in these subjects (Critchley et ah, 1993). A slight improvement in
bleeding patterns was reported for women using Norplant following administration
of a single postmenstrual dose of RU486 (Wang et al., 1997a). This might suggest
that a different mechanism is operating depending on the method of levonorgestrel
administration.
The above studies all involved the modulation of the local progesterone
environment, allowing further investigation into the role of this steroid in regulating
local factor expression in vivo. Analysis of endometrial mRNA expression of EL-8,
MCP-1 and COX-2 by RT-PCR following withdrawal of exogenous progesterone
lends support to the hypothesis of a regulatory influence of progesterone on the
mediators. Pharmacological withdrawal by RU486 administration did not produce
such clear results as far as mediator expression was concerned, as mRNA levels
could not be measured. The Lng-IUS provides a complex system of progesterone
manipulation, and the involvement of chemokines and PGs in the breakthrough
bleeding episodes is reinforced by the strong expression of IL-8 and COX-2 after
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insertion of the device. The mechanisms involved in their regulation in this




EXAMINATION OF INFLAMMATORY MEDIATOR




The previous two chapter's findings support the hypothesis that progesterone has a
regulatory role in the expression of inflammatory mediator expression. In this
chapter, the potential modulation is further investigated by employing an in vitro
culture system. In addition, the stimulation and induction of the chemokines and
COX-2 is examined. Much has been learnt about the regulation of chemokine and
prostaglandin production by studying the effects of inflammatory mediators,
mitogens, growth factors and anti-inflammatory agents in vitro. Some investigation
into the mechanisms involved in induction and inhibition of expression has been
conducted. This provides a greater understanding of the expression oft local
mediators and their complex interactions in vivo.
IL-8 and MCP-1 are produced and secreted by a number of cell types, including
fibroblasts, endothelial and epithelial cells, monocytes and other lymphoid cell types
(Baggiolini et al., 1997). Pro-inflammatory mediators, such as IL-1 and TNF-a, are
potent stimulators of IL-8 and MCP-1. A rapid, but transient, induction of mRNA
and protein levels in response to stimuli has been reported by a number of
independent researchers. Using isolated vascular endothelial cells, it was
demonstrated that TNF-a, LPS and IL-1 (3 all stimulated elevated expression of the
1.8 kb IL-8 mRNA (Strieter et al., 1989). An induction was apparent after one hour,
with maximal expression by 4 - 8 hours. This was reinforced by in situ hybridisation
for mRNA in isolated endothelial cells, before and after treatment with TNF-a
(Strieter et al., 1989). Similar findings were obtained by Brown and colleagues with
induction of IL-8 and MCP-1 mRNA from microvascular endothelial cells following
treatment with TNF-a, LPS and IL-1 (3 (Brown et al, 1994). Interestingly, differences
in the potency of the stimulants were detected for EL-8 and MCP-1, with maximal
stimulation of MCP-1 by IL-1 and IL-8 by TNF-a. Further regulatory differences
have been reported, particularly the induction of MCP-1 by PDGF and IFN-y, neither
of which have any effect on IL-8 expression (Yoshimura et ah, 1990; Brown et al.,
1994). It has been concluded that the upstream regulatory regions for both
chemokines must differ significantly, although no differences have been recognised
in the putative transcriptional regulatory elements (Mukaida et al., 1989; Shyy et al.,
1990).
A recent investigation into vascular smooth muscle cells derived from rat kidney
reported the stimulation of MCP-1 mRNA with the cytokine LIF (Hartner et al.,
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1997). This is of prime interest for uterine MCP-1 expression, as LIF appears to play
a vital role in the process of implantation (Chen et ah, 1995a) (see introduction,
section 1.14), and is abundant in the decidualised endometrium. The same study
examined the role of IL-6, a pro-inflammatory mediator closely related to IL-1 and
TNF-a (Hartner et ah, 1997). A transient increase in MCP-1 expression was
observed following exposure to IL-6 for 2 hours. The validity of these in vitro data
was confirmed by a recent investigation, using gene knockout technology to
eliminate IL-6 function in vivo. The IL-6 receptor deficient mice had a reduced
capacity to mount an inflammatory response (Romano et ah, 1997), and in particular,
a distinct reduction in chemokine production (EL-8 and MCP-1) was detected.
Detailed investigation into endometrial expression of IL-8 and MCP-1 has'been
conducted. Isolated stromal and glandular cells were cultured with IL-1, TNF-a
(Arid et ah, 1993) and TGF-(3 (Arid et al., 1996). Marked elevations in IL-8 mRNA
and protein were observed, with synergistic increases with combinations of IL-1 and
TNF-a, TGF-P and IL-1, and fetal bovine serum (FBS) with IL-1. These effects
were dose dependent, and culturing for various lengths of time indicated that
maximal induction occurred by 3 - 6 hours, with a gradual decline back to basal
levels after 6 hours. Similar examination into the regulation of MCP-1 expression
confirmed previous studies on non-reproductive tissues, reporting stimulation with
EL-1, TNF-a, IFN-y (Arid et ah, 1995) and FBS (Kovacs et al., 1996).
The effect of steroids on chemokine expression has previously been examined. A
reduction in the secretion of immunoreactive IL-8 from chorio-decidual and
endometrial cells following a 24 hour incubation with progesterone was described by
Kelly et al, and a similar inhibition was observed for the synthetic progestin MPA
and glucocorticoid dexamethasone (Kelly et al., 1994). This reveals a potential
mechanism for the finding reported by Sinosich et al, that exposure to RU486 results
in stimulation of neutrophil influx into placenta in monkeys (Sinosich et al., 1989).
A similar suppression of IL-8 production occurs in uterine-cervical cells, which can
be reversed by treatment with antigestogen RU486 (Ito et al., 1994). The effect of
oestradiol on IL-8 expression has not been examined, but MCP-1 expression in
macrophages and fibroblasts was found to be markedly downregulated by the steroid
(Kovacs et al., 1993; Kovacs et al., 1996). In ovarian tissue collected from women
being treated for IVF, an elevation in MCP-1 protein levels following hCG
administration was reported (Arici et al., 1997). Treatment with oestradiol and
progesterone did not alter MCP-1 levels, although a previous study by the same
authors reported decreased levels of MCP-1 mRNA in endometrium biopsied from
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women taking oral progestin (Arici et al., 1995). Evidence from our own laboratory
would support a downregulation of MCP-1 by progesterone in chorio-decidual cells
(Kelly et al., 1997b).
Prostaglandin production by the utero-placental unit must be under strict regulation
to prevent inappropriate stimulation of an inflammatory response. PGs are key
mediators in many events necessary for pregnancy, including roles in promoting
decidual cell formation (Kennedy, 1986) and vascular permeability (Kennedy et al.,
1981) at the time of implantation. However, PGs have also been implicated in the
initiation of menstruation and parturition (Kennedy et al., 1981; Baird et al., 1996).
The regulation of PG production has been examined in many culture systems.
t
Stromal cells isolated from first trimester decidua produce elevated levels of PGE2
and PGF2a in response to IL-1 (3 stimulation (Ishihara et al., 1992). A significant
increase is detectable after 8 hours in culture, and corresponds to an elevation in
immunoreactive COX-2 enzyme (Ishihara et al., 1995). The same is true for
endometrial glandular and stromal cells, with significant elevation in PG production
following stimulation with IL-1 and TNF-a (Chen et al., 1995). Phorbol esters,
including PMA, cause a dose dependent increase in PG production, which is
augmented by IL-1 (3 (Cole et al., 1995). Research into dynamics of vascular
endothelial cell COX-2 expression reveals that a marked increase in COX-2 mRNA
is detectable within 2 hours culture in the presence of serum (Pritchard Jnr et al.,
1994). A subsequent decline in mRNA was observed after 6 hours, in line with the
known rapid degradation of the transcripts. The elevated expression of COX-2
mRNA was correlated with a maximal increase in COX-2 enzyme and secreted
PGE2 after 8 hours.
Before the discovery of the second isoform of COX (COX-2), several independent
studies revealed a regulatory role of PG production by ovarian sex steroids
(Blatchely et al., 1974; Castracane et al., 1975). Isolated endometrial glands in the
proliferative and secretory phases produce less PGE2 and PGF20C following culture
for 24 hours with progesterone (Abel et al., 1980), and withdrawal of progesterone
through RU486 administration stimulates PG synthesis from endometrium and
decidua (Kelly et al., 1986; Smith et al., 1987). Recent research has attributed the
downregulation of PG production by glucocorticoids or progesterone to an inhibition
of COX-2 (Kelly et ah, 1986; Smith et al., 1987; O'Banion et al, 1991; Kujubu et al,
1992; Mitchell et al, 1994). Dexamethasone has no effect on COX-1 synthesis or
activity (O'Banion et al., 1992). This conclusion has been confirmed in reproductive
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tissues. In vitro culture of endometrial stromal cells with dexamethasone caused an
inhibition of COX-2, whilst COX-1 remained unaffected (Jacobs et ah, 1994). In
cultured decidual stromal cells dexamethasone and progesterone inhibited IL-1|3
stimulated PG production by 50% (Ishihara et al., 1995), and this again was reflected
by a decrease in COX-2 expression. PMA and other stimulants, serum and IL-1,
stimulate PG production through increased expression of COX-2 (Kubjubu et al.,
1991; O'Banion et al., 1991; Xie et al., 1991). Negligible stimulation of COX-1
occurs (DeWitt, 1991; Simmons et al., 1991; O'Banion et al., 1992; Pritchard Jnr et
al., 1994). This finding reinforces the role of COX-2 as an inflammatory mediator
and COX-1 in the constitutive production of PGs (Simmons et al., 1991; Vane et al.,
1994).
i
In the present study the primary response of IL-8, MCP-1 and COX-2 mRNA
expression by endometrial and decidual explants was examined after treatment with
pro-inflammatory stimulants, phorbol myristate acetate (PMA) and FCS, and
progesterone. PMA, a pharmacological activator of protein kinase C, stimulates all
three inflammatory mediators with similar kinetics to IL-1 or TNF-a (Mukaida et al.,
1990). Detailed studies of the time course of PMA induction of MCP-1 and COX-2
revealed a rapid but transient elevation in mRNA expression, typically with a signal
detectable after 30 minutes, maximal after 2 - 4 hours then reduced to basal levels
after 16-24 hours, consistent with the role of these agents in acute inflammation
(Shyy et al., 1990; Kubjubu et al., 1992). PMA is known to interact with phorbol
ester response elements (TRE) in the upstream region of the genes (Shyy et al.,
1990) and acts, at least in part, to stabilise mRNA transcripts (Ristimaki et al., 1994).
The stimulation of the three mediators with PMA from endometrial tissue collected
throughout the menstrual cycle, and interactions between different stimulators of the
chemokines and COX-2, was examined. Further, the effect of physiological
concentrations of progesterone on the expression of IL-8, MCP-1 and COX-2
mRNA transcripts was investigated.
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Table 8





IL-1, TNF-a Endothelial cells Strieter et al, 1989
IL-1, TNF-a, LPS Endothelial cells Brown et al, 1994
IL-1, TNF-a, Endometrial cells Arid et al, 1993
TGF-(3, serum Endometrial cells Arid et al, 1996
Inhibitors





Ito et al, 1994
MCP-1 Stimulators
IL-1, TNF-a, LPS Endothelial cells Brown et al, 1994
EFN-y
PDGF Fibroblasts Yoshimura et al, 1990
LIF, IL-6 Vascular smooth
muscle cells
Hartner et al, 1997
EL-1, TNF-a, Endometrium Arid et al, 1995
IFN-y















EL-1 [3 Decidual cells lshihara et al, 1992,
1995
EL-1, TNF-a Endometrium Chen et al, 1995b
Phorbol Ester, IL-1 Cole et al, 1995
Serum Endothelial cells Pritchard Jnr et al,
l
1994
RU486 Endometrium, Kelly et al, 1986,
decidua Smith et al, 1987
Inhibitory
Progesterone Decidual cells Ishihara et al, 1995
Dexamethasone Endometrial cells Jacobs et al, 1994
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5.2 Materials and Methods
Tissue Culture
Endometrial (n = 23) and decidual (n = 12) biopsies were transported from the
operating theatre in RPMI culture medium on ice. The tissue was roughly chopped
with a sterile scalpel blade into fragments of 1-2 mm2. The pieces of endometrium
were distributed equally between 4 wells of a 24 well culture plate, each containing
complete medium (RPMI supplemented with 10% fetal calf serum (FCS), penicillin,
streptomycin, gentamycin). The tissue was incubated for 2 hours at 37°C, C02 and
the complete medium was supplemented with the following treatments:
1. Control - no additional treatment
2. Phorbol 12-Myristate 13-Acetate (PMA 0.5|iM) in complete medium
3. Progesterone (0.25|iM) in complete medium
4. Both Phorbol 12-Myristate 13-Acetate (PMA 0.5|iM) + Progesterone
( 0.25jlM)
A further subset of endometrial biopsies (n = 8) were collected and divided into four
treatment groups. One portion was snap frozen at time of collection, and the
remaining three were cultured for 2 hours under similar conditions as before with the
following treatments:
1. Unsupplemented RPMI medium (no FCS)
2. FCS (10%) supplemented RPMI (complete medium)
3. Complete medium supplemented with PMA (0.5jlM) and FCS (10%)
After the culture period, the endometrium and decidua samples were placed into
sterile eppendorf tubes with 1 ml of Ultraspec™ RNA extraction medium and total
RNA was extracted as described previously (Chapter 2, section 2.24).
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Table 10
Table illustrating the numbers of endometrial and decidual biopsies utilised in the
present study, and the stage of the cycle at the time of biopsy.




Ovulatory / Early Secretory dl4-18 5
Mid Secretory d19-24 5
Late Secretory d25-mens 4
First Trimester Decidua 8-10 weeks amenorrhoea 12
Semi-quantitative RT-PCR
RT-PCRs for GAP-DH, EL-8, MCP-1 and COX-2 were conducted on RNA extracted
from non-pregnant and pregnant endometrium cultured in the above conditions.
RNA loading was standardised to 60ng following repeated GAP-DH RT-PCR and
ELISA (sections 2.25-2.26). The same RNA stocks were then reverse transcribed
and cDNA was subjected to PCR for IL-8, MCP-1 and COX-2. A quality control
RNA sample (QC) known to contain mRNA for the inflammatory mediators was
included in each RT-PCR. Quantitative ELISAs were conducted to measure the
relative amount of final amplicon for each mediator, and these were expressed as the
ratio of sample signal: control signal.
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5.3 Results
RNA template loading into the mediator RT-PCRs was standardised by
measurement of GAP-DH expression levels. Bands of equal intensity were achieved
following GAP-DH RT-PCR and gel electrophoresis (figure 41), and readings of
60ng (+/- lOng) were generated by ELISA.
IL-8, MCP-1 and COX-2 RT-PCRs produced single bands of the correct molecular
weight (IL-8 298bp, MCP-1 210bp, COX-2 350bp). Large differences in mediator
expression levels were observed between uncultured samples and endometrium
cultured for 2 hours at 37°C. Different PCR cycling protocols were therefore
required to obtain products during the exponential phase of amplification, e.g. for
IL-8 RT-PCR, 23 PCR cycles were required for uncultured samples compared with
32 cycles for cultured samples (table 3). Limited comparison of expression levels
could therefore be conducted between the two groups of samples. A comparison of
IL-8, MCP-1 and COX-2 mRNA levels however, between a representative
uncultured and cultured endometrial sample is shown in Figures 1, 2 and 3, utilising
PCR protocols optimised for cultured samples.
181
Figure 41 Standard curve for GAP-DH RT-PCR and ELISA, included with
cultured endometrial samples. Loading of mRNA into RT-PCR reaction is shown
along the x axis, and absorbance of RT-PCR product along the y axis. A linear
relationship is achieved, producing the equation y = 0.005x + 0.077, enabling RNA
loading of samples to be calculated.
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1 Effect of culture on endometrial mediator expression
The expression levels of all three mediators in uncultured endometrium varied
according to the stage of the menstrual cycle (figures 42, 44, 45 and 46), in
agreement with previous findings (Chapter 3 section 3.3). An increase in IL-8
mRNA levels was detected following culture in all samples examined, although
again with much variability between endometrium collected from different stages of
the menstrual cycle. In particular, the magnitude of elevation following culture with
10% FCS was considerably less in the secretory phase samples analysed, compared
with menstrual and proliferative samples. COX-2 expression levels followed a
matching pattern, with only a slight increase in mRNA levels after stimulation in
secretory phase biopsies, compared with proliferative biopsies. Similarly, maximal
MCP-1 stimulation by culture was observed in mid proliferative endometrium.
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Figure 42 Effect of culture on IL-8 and MCP-1 mRNA expression. This gel
composite illustrates the marked effect culture has on the expression of mRNA for
the chemokines. Tissue samples were divided into two at the time of collection, so
that RNA could be extracted from one immediately whilst the remaining portion was t
cultured for 2 hours in serum supplemented culture medium prior to RNA extraction.
The RT-PCR product from the cultured and uncultured samples are presented in
neighbouring wells. A dramatic upregulation of IL-8 mRNA expression is detected
after the 2 hour culture period. A similar pattern is observed for MCP-1, although
not so consistent. For both chemokines:
1 = early proliferative phase endometrium cultured
2 = early proliferative phase endometrium uncultured
3 = menstrual phase endometrium cultured
4 = menstrual phase endometrium uncultured
5 = late proliferative phase endometrium cultured
6 = late proliferative phase endometrium uncultured
7 = mid secretory phase endometrium cultured










Figure 43 Effect of culture on IL-8 mRNA expression levels. This histogram
demonstrates the increase in IL-8 mRNA expression levels after a 2 hour culture
period (CULT), compared to uncultured (UN) tissue. Marked differences were
visible in the degree of stimulation following culture in endometrium collected from t
different stages of the menstrual cycle (MEN = menstrual, PR = proliferative,
OWES = ovulatory / early secretory, MS = mid secretory, LS = late secretory).
Most noticeable was the reduced ability for upregulation of IL-8 mRNA expression
by culture in secretory endometrium.
Figure 44 Effect of culture on MCP-1 mRNA expression levels. Slight
variations were detected in the expression levels of MCP-1 mRNA in uncultured
(UN) endometrium collected at different stages of the cycle (MEN = menstrual, PR
= proliferative, OWES = ovulatory / early secretory, MS = mid secretory, LS = late
secretory). After culture in the presence of serum (CULT), a stimulation in MCP-1
mRNA levels was apparent in all but the late secretory phase endometrium. As for
IL-8, the degree of stimulation was greatest in proliferative phase endometrium.
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Figure 45 Effect of culture on COX-2 mRNA expression levels. Elevated 1
numbers of COX-2 mRNA transcripts were detected in uncultured (UN) menstrual
phase endometrium (MEN), compared to those at all other stages examined.
Following culture (CULT) with 10% serum, a marked elevation in COX-2 mRNA
was observed in proliferative (PR) and ovulatory / early secretory phase (OV/ES)
endometrium. Similar treatment of menstrual and mid-late secretory phase (MS and
LS) endometrium had very little effect.
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2. Effect of serum on endometrial mediator expression
To investigate if the elevation in mediator mRNA levels observed was due to the
presence of 10% FCS in the culture medium, a series of experiments were conducted
involving culturing endometrium in the presence and absence of FCS (figure 46).
Considerable variations were detected between the samples, producing confusing
results when presented as average results. Representative results are therefore
displayed in figures. In both mid proliferative and mid secretory endometrium, IL-8
mRNA expression levels increased when cultured in unsupplemented RPMI
medium, compared to expression levels in uncultured biopsies (figure 47). A further
increase was demonstrated with the addition of 10% FCS to the culture medium. A
similar augmentation of MCP-1 and COX-2 expression levels with FCS was
detected in mid proliferative endometrium, although in secretory phase
endometrium, the pattern was not so clear.
3. Induction of mediator mRNA by PMA
The effects on mediator expression of PMA supplementation to the culture medium
was investigated (figure 46). Figure 48 shows the results from three representative
endometrial biopsies. With the exception of the menstrual endometrial sample,
previously demonstrated to have high levels of IL-8 and COX-2 mRNA transcripts,
mediator expression in uncultured endometrium (mid proliferative and mid-secretory
phases) was practically undetectable using this protocol. In general, the elevation in
IL-8 and MCP-1 mRNA expression was augmented by the presence of PMA and
serum in the culture medium. A further increase in the amount of COX-2 mRNA
was not detected following treatment with PMA when compared to with serum
alone.
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Figure 46 Induction of inflammatory mediator mRNA expression in vitro. This
composite illustrates the induction of IL-8, MCP-1 and COX-2 mRNA from
proliferative phase endometrium. The upper panel (GAP-DH expression) illustrates
the equal loading of RNA samples. RNA extracted from (1) uncultured tissue , is
compared with (2) tissue cultured for two hours in unsupplemented medium and (3)
tissue cultured in culture medium supplemented with 10% FCS. mRNA for all three
mediators is stimulated in the absence of serum, with a further elevation in the
number of transcripts when serum is present.
Uncultured endometrium inflammatory mediator mRNA content (4) is also
compared with that cultured with 10% FCS (5) and with 10% FCS plus PMA (6).
Again, IL-8, MCP-1 and COX-2 are induced with exposure to serum, and a further
















Figure 47 Effect of culture in the presence and absence of serum on
inflammatory mediator mRNA expression levels. In mid proliferative phase
endometrium, IL-8, MCP-1 and COX-2 mRNA expression was stimulated by
culturing without serum. A further stimulation was apparent when culture medium t
was supplemented with 10% FCS. A similar pattern was observed for IL-8 and
COX-2 in mid secretory phase endometrium.
Figure 48 Effect of culture in the presence of serum, with or without PMA, on
mediator mRNA expression. At all stages of the menstrual cycle, a clear stimulation
of IL-8 mRNA expression by serum (CULT) is observed compared to uncultured
tissue (UN), which is augmented by the addition of PMA. MCP-1 is similarly
induced in response to culture, although a synergy between serum and PMA is less
clear in the proliferative and secretory endometrium. mRNA for COX-2 is increased
























































































4. Effect of progesterone on endometrial mediator expression
Exposure of endometrium to progesterone (5 x 10_7M) during a 2 hour culture period
had limited effect on the expression levels of IL-8, MCP-1 and COX-2 (figures 49,
50, 51 and 52). The numbers of mRNA transcripts detectable by RT-PCR were
comparable with those without progesterone (control). In some cases, particularly in
the late secretory phases, slight decreases in IL-8, MCP-1 and COX-2 mRNA levels
were detected, but these changes were not significant. The addition of progesterone
to tissue cultured with PMA caused no alterations in the mediator expression levels
(data not shown).
5. Effect of progesterone on decidual mediator expression
Similarly, no significant changes in IL-8, MCP-1 or COX-2 mRNA expression were
observed in decidua cultured with progesterone. The results from representative
samples are illustrated in figures 54, 55, 56 and 57, showing an elevation in decidual
IL-8, MCP-1 and COX-2 expression in response to PMA, but no significant decrease
in the presence of exogenous progesterone. Decidual expression chemokines and
COX-2 exposed to both PMA and progesterone were comparable to with PMA alone
(data not shown).
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Figure 49 Effect of progesterone on IL-8, MCP-1 and COX-2 mRNA
expression in vitro. Three representative endometrial samples are shown in the
composite, collected from the proliferative, secretory and menstrual phase (left -
right). For each sample, tissue cultured with 10% FCS (1, 4, 7) is compared with
tissue cultured with 10% FCS plus PMA (2, 5, 8), and tissue cultured with 10%
FCS and progesterone (3, 6, 9). As described earlier, a stimulation of mediator
mRNA is generally observed with the addition of PMA, but progesterone




Figure 50 Effect of progesterone on IL-8 mRNA expression. Marked variations
were observed in IL-8 expression at different stages of the menstrual cycle, and
patient to patient variations were also noted (Y axis error bars represent SEM).
Addition of progesterone to the culture medium had little effect on mRNA levels.
Figure 51 Effect of progesterone on MCP-1 mRNA expression. As for IL-8
mRNA expression levels, no significant differences in the numbers of MCP-1
mRNA transcripts were detected following culture with progesterone.
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Figure 51 □ MCP-1
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Figure 52 Effect of progesterone on COX-2 mRNA expression. Menstrual »
phase endometrium possessed high numbers of COX-2 mRNA transcripts, compared
to samples collected throughout the menstrual cycle. No significant changes in
COX-2 expression were identified with exposure to progesterone for 2 hours.
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Figure 53 Standard curve for GAP-DH RT-PCR and ELISA, included with
cultured decidual RNA samples. Standards ranging between 250ng and 17.5ng were
loaded into the RT-PCR, producing the standard curve after measurement of product
yield by ELISA. This generated the equation y = 0.006x + 0.038, which was
thereafter used to correct the amount of RNA loading into the RT-PCR.
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Figure 54 Effect of progesterone on decidual inflammatory mediator expression.
Two representative decidual samples amplified for GAP-DH, IL-8, MCP-1 and
COX-2 are presented. Low numbers of messenger transcripts were detected when
decidua was cultured just in the presence of 10% FCS (1 & 4). Addition of PMA to
the culture medium stimulated mRNA expression for the chemokines and COX-2 (2
& 5). Addition of progesterone to the culture medium had little effect on the degree

















Figures 55 and 56 Effect of culture with PMA and progesterone on decidual IL-8 1
and MCP-1 mRNA expression. Marked variations were apparent between individual
decidual samples, and thus representative samples are shown in this histogram.
Treatment with PMA stimulated EL-8 mRNA expression levels. Progesterone had no
significant effect on expression levels.
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Figure 57 Effect of culture with PMA and progesterone on decidual COX-2
mRNA expression. Again, distinct variations were observed between individual
samples. An increase in COX-2 mRNA levels was apparent after stimulation with




A model of in vitro culture of endometrium and decidua was employed to investigate
and examine the mRNA expression of the inflammatory mediators. In this study, IL-
8, MCP-1 and COX-2 mRNA expression levels were examined following a 2 hour
culture period in the presence or absence of PMA and or progesterone. Induction of
all three mediators was recognised even in the absence of PMA, and this was
presumed to be due to the presence of 10% FCS in the culture medium. However, a
representative sample of tissues were cultured in unsupplemented RMPI and a
substantial stimulation of mediator message was detected. This could be explained
by the trauma of tissue collection and subsequent mechanical damage reqeived
whilst tissue was cut into pieces. A similar stimulation of COX-2 mRNA was
reported due to damage received by vascular smooth muscle cells following balloon
de-endothelialisation (Pritchard Jnr et al., 1994). Within 2 hours, a marked increase
in COX-2 mRNA was detectable, declining to basal levels after 6 hours.
The addition of FCS to the culture medium produced an elevation in mediator
mRNA expression, above that detected in its absence and a further stimulation of IL-
8 was obtained when the medium was supplemented with PMA. This suggests a
synergistic action between PMA and FCS in the stimulation of IL-8 mRNA. An
elevation in IL-8, MCP-1 and COX-2 mRNA was detected in all tissues examined
following culture with or without stimulants, although the extent did vary
considerably with the stage of the menstrual cycle. Notably, the degree of
stimulation was markedly reduced for all mediators in secretory phase compared to
proliferative endometrium. This would suggest inherent differences in the regulation
of chemokines and COX-2 in proliferative and secretory phases. A logical
explanation is that the expression of mediators in the secretory phase is suppressed
by endogenous progesterone, which dominates during the second half of the
menstrual cycle. This effect appears to persist during and after the 2 hour culture
period.
No attempts were made in this study to determine the mechanism behind the
elevated numbers of mRNA transcripts following culture. There is an inconsistency
in the literature regarding whether the stimulation consistently reported is due to
increased transcription of the mediators or to stabilisation of existing mRNA
transcripts. Arici et al. describe a system whereby an increase in de novo IL-8
mRNA synthesis is not the major contributory factor, but instead stabilisation of pre-
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existing transcripts occurs (Arici et al., 1993). An opposing explanation was offered
by Dudley (1993) who demonstrated de novo transcription of decidual IL-8 after IL-
la treatment (Dudley et al., 1993). Further inconsistencies appear in the literature as
to the mechanism of stimulation of MCP-1 (Sica et al., 1990) and COX-2 (Jacobs et
al., 1994; Ristimaki et al., 1994).
IL-8, MCP-1 and COX-2 are all believed to be immediate-early response genes
(Maier et al., 1990; Oppenheim et al., 1991; Freter et al., 1995), which are rapidly
transcribed in response to stimuli. To allow greater sensitivity of the response, the
mRNA transcripts have very short half lives due to the presence of an AUUUA
motif in the 3' untranslated region, which confers rapid degradation (Caput et al.,
1986; Shaw et al., 1986; Matsushima et al., 1988). Several substances, including IL-
1, TNF-a and serum, have been reported to extend the half lives of the mRNA by
stabilisation (Malter, 1989; Stoeckle, 1991). Either mechanism could account for the
elevated levels observed in the present study. It is interesting that the tissues retain a
"memory" for the endogenous steroid environment prevailing prior to biopsy, in that
mediator levels vary according to the stage of the menstrual cycle. Moreover, the
degree of stimulation following culture with or without serum and / or PMA differs
in proliferative and secretory endometrium. One explanation would be that
stimulation of the chemokines and COX-2 by culturing causes stabilisation of
existing transcripts. It is possible, however, that the capacity to synthesise the
inflammatory mediators is reduced even after removal from a progesterone
dominated environment.
No changes in chemokine or COX-2 expression levels were detected after treatment
with progesterone. A number of explanations can be offered to understand this
unexpected finding.
1. Most research into the downregulation of chemokines or COX-2 by
progesterone have measured the production of protein rather than mRNA. The
possibility therefore exists that a post-transcriptional mechanism is responsible for
the inhibition. Translational or post-translational mechanisms could be operating to
reduce the levels of immunoreactive protein. This would, however, contradict the
findings described in the previous chapter whereby an increase in mRNA levels for
IL-8 and COX-2 were identified 48 hours after progesterone withdrawal in an in vivo
model. Furthermore, parallel investigations into the downregulation of COX-2 by
dexamethasone have concluded that reduced transcription or destabilisation of
mRNA is responsible.
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2. An indirect regulation may be occurring, not involving direct interaction of
progesterone with promoter regions of the gene. This has previously been described
in decidual cells, where treatment with cyclohexamide, an inhibitor of protein
synthesis, caused an elevation in IL-8 mRNA expression (Dudley et ah, 1993). The
same was reported for COX-2, where addition of actinomycin D stimulated PGF2a
(Smith et ah, 1988). This indicates the requirement for intermediate proteins which
would mediate the inhibition and interact with regulatory elements. All three
mediators do however possess putative progesterone / glucocorticoid response
elements on the promoter sequences (Matsushima et ah, 1989; Mukaida et ah, 1989;
O'Banion et ah, 1992), thus making a direct regulation possible. Additionally, the
cell types of interest, particularly the perivascular cells, all express PgR (Perrot-
Applanat et ah, 1994). The validity of this argument is reduced by the experimental
design utilised, as whole tissue was treated. This model is advantageous in certain
respects as the tissue has not been subdivided into cellular components and therefore
any paracrine interactions from neighbouring cell types should still be allowed. If
certain cell types were isolated, a disruption in physiological regulation of three
mediators would be more likely.
3. It is possible that an inhibition or down regulation of IL-8, MCP-1 and COX-
2 by progesterone cannot be detected in a 2 hour culture period. Although the
mediators are clearly induced in this length of time, it is possible that the
mechanisms involved in their downregulation are slower. Alternatively, because
digested cells were not utilised, the time required for permeation of substances into
the tissue pieces may be longer than originally thought. Several publications have
highlighted the transient nature of chemokine and COX-2 induction (Strieter et ah,
1989; Arici et ah, 1993; Pritchard Jnr et ah, 1994; Arici et ah, 1995; Hartner et ah,
1997). IL-8 mRNA levels in cultured endometrial cells decrease spontaneously
during the culture period. Arici et al describe a reduction in IL-8 mRNA levels from
as early as 3-6 hours of culture (Arici et ah, 1993), and comparable data in the
literature support a similar degradation of MCP-1 (Sach et ah, 1997) and COX-2
mRNA (Pritchard Jnr et ah, 1994). It is important to note that the aim of this study
was to isolate the primary response of the treatments on mediator expression. It was
therefore important in this study to avoid complication between the natural
degradation of mediator mRNA and the possible inhibition mediated via
progesterone.
4. As discussed above, the mechanism behind the elevated levels mRNA in
tissue cultured with serum or PMA is unknown, with previous reports of both
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stimulation of de novo transcription and stabilisation of existing transcripts
synthesised prior to the culture period. It is likely however, that an inhibition of the
chemokines and COX-2 by glucocorticoids and progesterone would be mediated
through a suppression of transcription. Recent evidence implicates the repression of
Nuclear Factor-k B (NF-kB), which is a transcriptional activator of many
inflammatory genes including IL-8, COX-2, IL-6 (van der Burg et al., 1997).
Following stimulation by proinflammatory mediators, such as IL-1, TNF-a and
phorbol esters, cytoplasmic NF-kB disassociates from inhibitory molecule IkB, and
is translocated to the nucleus. NF-kB then binds to target sequences in the promoter
regions of responsive genes and activates transcription. Glucocorticoids and
progesterone may repress NF-kB activation of transcription, either by the formation
i
of an inactive complex with the molecule or alternatively by the upregulation of
inhibitory IkB. In the presence of stabilised mRNA transcripts for the inflammatory
mediators, it is unlikely that such an effect on the inhibition of transcription would
be noticeable, in the time period examined in this study.
It is unfortunate that in this study no significant decrease in mediator levels were
detected following treatment with progesterone. It is clearly shown however, that all
three mediators are rapidly induced or stabilised in response to FCS, PMA and even
trauma from tissue collection and handling. Additionally, the limited response of IL-
8, MCP-1 and COX-2 in secretory endometrium to induction by serum and PMA
indicates an effect of endogenous progesterone in inhibiting mediator expression. To
learn more about the mechanism involved in the down regulation observed in other
systems, the above described methodological problems need to be overcome, to
develop a model in which a progesterone effect can be studied effectively in vitro.
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CHAPTER 6
LOCALISATION AND TEMPORAL EXPRESSION OF
PROLACTIN RECEPTOR IN HUMAN ENDOMETRIUM
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6.1 Introduction
Prolactin is a major product of the decidualised endometrium, synthesised soley by
the decidualised stromal cells (Wu et ah, 1995). This is also true for
pseudodecidualised stromal cells which differentiate during the mid-late secretory
phase of the menstrual cycle, and in vitro decidualisation of oestradiol primed
stromal cells with progesterone results in prolactin expression (Daly et ah, 1983).
Indeed, prolactin is commonly used as a marker for functional decidualisation .
Prolactin has numerous functions in tissues around the body, as described in more
detail in the general introduction (section 1.6). Possible functions of interest with
i
respect to uterine function are its roles in immunomodulation, cell proliferation and
differentiation and osmoregulation (Chilton, 1985; Healy, 1985; Draca, 1995). In the
peripheral circulation, prolactin acts via the membrane bound receptor (PRL-R) to
stimulate a wide range of leukocyte functions, including the proliferation of
leukocytes previously stimulated with mitogenic factors, including interleukin-2
(IL-2) and T and B cell mitogens (Clevenger et ah, 1990). An immunosuppressive
action has also been indicated by the reduced immune response in lactating or PRL
treated castrated rats (Dineen et al., 1972; Kelly et al., 1973). Prolactin has a unique
function in initiating lactation in the mammary glands, stimulating the development
of glandular components during pregnancy and in the regulation of milk production
(Houdebine et al., 1985). Finally, a prolactin receptor defect in the amniotic
epithelium of the amniochorion has been linked with the incidence of
polyhydramnios, supporting a role in the regulation of amniotic fluid volume (Healy,
1985).
The role that prolactin plays in the endometrium is uncertain. Specific binding sites
for the locally produced hormone have been identified in the amniochorion, third
trimester decidua and in the decidua capsularis surrounding the first trimester fetal
membranes (Healy, 1985; Tadokoro et al., 1995; Maaskant et al., 1996). However, a
conclusive investigation into the spatial localisation of the receptors in non-pregnant
and early pregnant decidua (decidua parietalis, lining the uterus) has not been
conducted.
This study aims to examine prolactin receptor expression in the endometrium by
immunolocalisation of the protein and RT-PCR to determine the temporal expression
of the mRNA transcripts. Particular emphasis will be placed on the possible
expression of the receptor by endometrial leukocytes with the aim to gain a greater
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understanding of the functions that prolactin fulfils in the uterus. In addition,
endometrium exposed to levonorgestrel (synthetic progestogen) via an intra-uterine
system (Lng-IUS) shall be included in the study (Chapter 4, section 4.2). As
previously described (Chapter 4, section 4.3), the presence of the steroid releasing
system causes extensive decidualisation of the endometrium. The effect of extensive
decidualisation on PRL-R expression and localisation shall therefore be examined.
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6.2 Materials and Methods
Normal endometrial tissue at all stages of the menstrual cycle (n = 32) and first
trimester decidua parietalis (n = 10) were investigated in this study (see table 11). In
addition, endometrium exposed to progestogen via an Lng-IUS for 1, 3, 6 and 12
months (n = 14 patients), was examined for prolactin receptor expression (see
chapter 4, section). Tissue samples were fixed in 10% NBF overnight and processed
into paraffin blocks.
RNA was extracted from frozen control endometrium (proliferative n = 12, secretory
n = 12) and first trimester decidua (n = 6) as described previously.
I
Table 11 Table illustrating endometrial and decidual biopsies used in the
present study.





Early Secretory dl5-18 4
Mid Secretory d19-24 7
Late Secretory d25-mens 6
First Trimester Decidua 8-10 weeks amenorrhoea 10
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Immunohistochemistry
Endometrium collected from all stages of the menstrual cycle, early pregnancy and
in endometrium exposed to local Lng were examined for PRL-R immunoreactivity.
Paraffin sections (5pm) were subjected to immunohistochemistry for prolactin
receptor, using a rabbit polyclonal antibody raised against the highly conserved
extracellular domain of the prolactin receptor. The immunostaining protocol is
described in General Materials and Methods.
Human term fetal membranes were included as a positive control for the PRL-R
immunohistochemistry (Maaskant et al, 1996). A matching concentration of non-
i
immunised rabbit IgG was substituted for the primary antibody to exclude the
possibility of non-specific binding.
Dual Immunohistochemistry
Dual immunohistochemistry was utilised to investigate the relationship between
prolactin receptor positive cells and endometrial leukocytes in representative
secretory phase endometrium samples (n = 5). The method is described in general
methods and materials, section 2.22.
Semi-quantitative RT-PCR
Semi-quantitative RT-PCR was conducted to examine PRL-R mRNA transcript
expression in human endometrium. Biotinylated antisense oligonucleotide primers
complementary to the prolactin receptor were unavailable, meaning that quantitative
ELISAs could not be conducted. The RNA samples were however subjected to
amplification for GAP-DH to assess viability of RNA and to allow approximate
equal loading of RNA template.
GAP-DH RT-PCR
A sample of 400ng of total RNA (as calculated by optical density measurement, see
section, 2.24) was included as the template for reverse transcription to cDNA. The
detailed protocol is described in General Materials and Methods. Analysis of
products by electrophoresis enabled assessment of viability of RNA and bands of
comparable intensity indicated comparable RNA loading into the RT-PCR.
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PRL-R RT-PCR
Gene specific cDNA for PRL-R was generated by the reverse transcription of 400ng
of total RNA from identical stocks as for GAP-DH. The total volume of reverse
transcriptase products was subsequently amplified by PCR for 30 cycles to produce
a 650bp product as described in General Materials and Methods (sections 2.25 -
2.26). The products were analysed by comparison with a molecular weight marker
on a 1% agarose gel containing ethidium bromide. The bands were visualised on a
UV transilluminator and photographed.
The identity of the RT-PCR product was confirmed by subcloning into expression
vector pGEM®-T Easy Vector (Promega Ltd., Southampton, U.K.) and sequencing
using the dideoxy chain termination method.
Southern Hybridisation
The identity of the amplified PRL-R product was confirmed by Southern
hybridisation (Southern, 1975). Representative RT-PCR products, amplified from
RNA extracted at different stages throughout the menstrual cycle, were selected for
analysis. The products were separated by electrophoresis on a 1% agarose gel and
blotted overnight onto a nylon membrane by capillary transfer. Hybridisation was
conducted overnight at 42°C with a 562bp cDNA, labelled with a32P[dCTP] by
random priming, encoding the conserved extracellular domain (82% homology with
human PRL receptor cDNA) of the red deer PRL receptor (between base pairs 96
and 657) (Clarke et al, 1995). Posthybridisation washes in SSC and SDS were
conducted with increasing stringency and the membrane was thereafter exposed to
autoradiographic film for 3 weeks.
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6.3 Results
Specific immunoreactivity for PRL receptor was detected in control endometrium
and decidua by immunohistochemistry (Figure 58). In the proliferative and early
secretory phases of the non-pregnant cycle, immunostaining was weak or absent in
the stroma, with minimal immunoreactivity visible in the luminal region of the
glandular epithelium. From the mid-late secretory phase and in early pregnancy,
intense immunoreactivity was apparent in both the glands and a subpopulation of
stromal cells. In addition, positive immunostaining was identified in the blood
vessels in these stages.
t
Dual immunohistochemistry with an antibody recognising the leukocyte common
antigen (LCA - CD45) did not conclusively demonstrate the presence or absence of
PRL-R expression by endometrial leukocytes. A subset of CD45+ cells appeared to
exhibit immunostaining for PRL-R, but these were in the minority. Further, the
majority of PRL-R+ cells exhibited characteristics of large decidualised stromal
cells. It is interesting to note however, that a portion of leukocytes present in blood
contaminating the tissue section, as a result of biopsy collection, did possess
immunoreactivity for PRL-R (not shown).
Fetal membranes included to act as a positive control exhibited positive
immunoreactivity in the amniotic epithelium, chorion-laeve trophoblast and in the
decidual layer as previously reported (Maaskant et al., 1996). Substitution of the
primary antibody with rabbit IgG resulted in an absence of staining in fetal
membranes, endometrial and decidual sections.
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Figure 58 Prolactin receptor immunolocalisation in human endometrium.
Minimal immunoreactivity is observed in the proliferative phase (A) and early
secretory phase (B) endometrium. In the mid-late secretory phase (C & D) intense
immunostaining is present in the epithelial glands and a sub-population of stromal t
cells. This pattern persists in first trimester decidua (E) and at higher power (F) the
decidualised stromal cells clearly exhibit strong immunoreactivity. (G = Glandular
epithelium;V = vessel; Scale bars = 50pm)
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Figure 59 Prolactin receptor immunoreactivity in human endometrium. (A)
Term fetal membranes were included as a positive control and exhibited
immunostaining in the amniotic epithelium, chorionic trophoblast and maternal
decidua. (B) Rabbit immunoglobulins, at a matching concentration, were substituted
for the primary antibody to act as a negative control, resulting in an absence of stain.
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Progestogen exposed endometrium was also found to exhibit immunostaining for
prolactin receptor. The presence of the Lng-IUS causes the endometrium to become
extensively decidualised, as described in chapter 4 (section 4.3). The epithelial
glands become atrophic and inactive, and stromal cells resemble large round
decidualised cells with surrounding oedema (Silverberg et al., 1986; Luukkainen et
ah, 1990). Immunoreactivity in the pre-insertion endometrium was identical spatially
and temporally to that observed in control endometrium. A significant increase (p <
0.05) in glandular staining intensity was observed in the endometrium biopsied
during the secretory phase compared to those from the proliferative phase. Glandular
immunoreactivity remained high following insertion of the Lng-IUS (p < 0.05 when
compared to proliferative preinsertion). A significant increase in stromal
immunostaining was detected postinsertion with respect to preinsertion proliferative
(p < 0.05) and secretory (p < 0.05) phase immunostaining levels. The majority of the
immunopositive stromal cells exhibited features of decidualised cells.
Immunoreactivity was particularly pronounced in perivascular regions. A "patchy"
pattern of staining was frequently observed in post-insertion endometrium, with
areas of intense immunoreactivity and those with slight immunostaining within the
same section. There were no significant differences in immunoreactivity at the
different time points after insertion of the IUS or between postinsertion biopsies
collected at different stages of the menstrual cycle.
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Figure 60 Prolactin receptor immunoreactivity in endometrium exposed to intra¬
uterine levonorgestrel. Immunostaining for PRL-R in preinsertion biopsies was
consistent with the stage of the menstrual cycle, as described earlier. After insertion
of the Lng-IUS, intense immunoreactivity was detected in glandular epithelium and
in the decidualised stromal cells, particularly around blood vessels, at all time points.
Photomicrograph (A) demonstrates immunoreactivity for PRL-R 1 month after
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Figure 61 Prolactin receptor immunoreactivity preinsertion and 1, 3, 6 and 12 '
months postinsertion of Lng-IUS. Stromal immunostaining is significantly elevated
at 1, 3, 6 and 12 months postinsertion compared to preinsertion proliferative biopsies
(p < 0.05). A further elevation in stromal PRL-R immunoreactivity occurs between
preinsertion secretory phase and 1 month postinsertion (p < 0.05). Glandular
immunoreactivity is increased from the proliferative to secretory phase preinsertion
(p < 0.05).
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Following PRL-R RT-PCR, a single band of molecular weight 650bp was detected
by gel electrophoresis, corresponding to the region of the PRL receptor gene
amplified. Confirmation of it's identity was obtained by Southern hybridisation
(Figure 2); and sequence analysis verified that the amplicon encoded human PRL-R.
A band representing PRL-R was detected in the tissue biopsied during the menstrual
phase (dl-4). During the proliferative and early secretory stages, the signal was
either weak or absent. From the mid to late secretory phase, however, a strong signal
was detected, with increasing intensity in samples obtained from early pregnancy
(Figure 3). A GAP-DH signal of comparable intensity (1103bp) was obtained from
all samples, indicating that equivalent amounts of RNA were loaded into the RT-
PCR. Furthermore, the presence of a GAP-DH signal in the absence of a PRL-R
signal indicate that this was not due to an absence of viable RNA, but to the inability
to detect PRL-R mRNA in the RNA sample. Overall, although this method is not
totally quantitative, these data suggest that prolactin receptor expression is




Figure 62 Southern hybridisation for PRL-R RT-PCR product. RT-PCR for
PRL-R generated a 650bp amplified product, as identified by comparison with a
molecular weight marker. The identity of the amplicon was confirmed by Southern
Blotting (SB) and hybridisation with a cDNA probe raised against the extracellular
domain. (LS = late secretory, DE = decidua).
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Figure 63 Temporal expression of PRL-R mRNA throughout the menstrual
cycle. RNA extracted from tissues from each stage of the menstrual cycle and early
pregnancy was subjected to RT-PCR to determine the temporal expression of PRL-
R. The upper panel shows representative RNA samples amplified for GAP-DH
(amplicon size = 1103bp), indicating the comparable loading of viable RNA into the
prolactin receptor RT-PCR. The lower panel shows the same RNA samples
amplified for PRL-R (amplicon size = 650bp). No signal was obtained in either the
menstrual (Me), proliferative (P), ovulatory (OV) and early secretory (ES ) phases.
From the mid and late secretory phase (MS / LS), a signal was achieved, increasing
in intensity into early pregnancy (DE = decidua). Pituitary (Pit) RNA was included
as a positive control, yielding a band of identical size. No signal was observed for
the negative control (-).
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This study confirms the expression of the prolactin receptor in endometrium and
decidua. Immunohistochemical localisation revealed that the PRL-R is strongly
expressed by the glandular epithelium and stromal cells in pseudodecidualised and
decidualised endometrium. Immunostaining was minimal or absent in proliferative
and early secretory phase endometrium. This temporal pattern of expression was
confirmed by the amplification of PRL-R mRNA by RT-PCR, with the detection of
a strong signal from the mid to late secretory phase of the non-pregnant cycle and in
early pregnancy. Thus, the temporal expression of the receptor appears to mirror that
of PRL by the decidualised endometrium. A further increase in the number of
immunopositive cells was detected in endometrium exposed to intrauterine
levonorgestrel, correlating with extensive decidualisation of the stroma.
It seems likely that progesterone has a role in the regulation of PRL receptor
expression (Jikihara et ah, 1996). It is unlikely to be a direct regulation, however, as
is the case for PRL, whose production is stimulated and maintained by the
progesterone-mediated decidualisation of the endometrium (Markoff et ah, 1983;
Wu et ah, 1990). Regulation via decidual derived factors (Gu et ah, 1994) or even
prolactin itself may be envisaged (Posner et ah, 1975; Dijane et al., 1979; Amit et
al., 1984; Muccioli et al., 1994). An indirect regulation by progesterone is firmly
supported by the absence of progesterone receptors in the glandular epithelium in
normal secretory phase endometrium, when PRL-Rs are expressed. This is further
supported by the intense immunoreactivity observed in Lng exposed endometrium at
a time when PgR are markedly downregulated (Critchley et al., 1998a) in both
glandular epithelium and stroma.
The detection of strong immunoreactivity for the receptor in the epithelial glands
suggest a paracrine action for PRL. During the early secretory phase, the endometrial
glands become tortuous and actively produce uterine secretions, which are vital for
preparing the endometrium for implantation (Noyes et al., 1950). During the
decidualisation of the uterine stroma and continuing into pregnancy, the glandular
epithelium becomes atrophic and glandular secretory activity ceases. This is also
observed following local exposure to Lng. PRL has been reported to possess
osmoregulatory activity, and the large amounts of PRL detectable in amniotic fluid
act as a regulator of amniotic fluid volume. This was demonstrated by a link between
defective PRL-R expression in amniotic epithelium and the incidence of
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polyhydramnios (Healy, 1985). The presence of PRL receptors in the glandular
epithelium during decidualisation implicates a similar role for PRL, that is in the
downregulation of glandular activity.
Additional immunoreactivity was observed in a subset of stromal cells. The identity
of these stromal cells is unknown, although the majority display morphological
characteristics of decidualised stromal cells. This further supports the likelihood of
the existence of an autocrine and / or paracrine interaction between PRL and its
receptor, in decidual transformation. A role for prolactin in stimulating
decidualisation, rather than being produced as a consequence of the transformation,
is strongly reinforced by the multiple reproductive abnormalities displayed by the
prolactin receptor knockout mouse, including failure of the endometrium to undergo
decidualisation or implantation (Ormandy et ah, 1996). Further co-localisation
studies are required to determine whether the PRL producing cells concurrently
express the receptor.
Prolactin interacts with its membrane bound receptor, a member of the
haematopoitin / cytokine receptor superfamily, including growth hormone (GH), IL-
2, IL-2, IL-4, IL-6, and LIF (Yu-Lee, 1997). Signal transduction occurs via
interaction of the dimerised receptor with intracellular protein tyrosine kinases,
including Janus kinase 1 (Jakl), 2 and 3. These phosphorylate intracellular regions
of the PRL-R and cytoplasmic Stat proteins (signal transducer and activator of
transcription). Phosphorylated and dimerised Stat proteins then translocate to the
nucleus, where they are potent activators of target genes (Schindler et al., 1995). The
specificity of the response is governed by the association of specific combinations of
Jak and Stat proteins, which although is not fully understood, is believed to be
determined by the amino acid sequence surrounding the phosphorylated tyrosine of
the receptor, and by transcriptional regulation of the Jak and Stat proteins
themselves. A clear involvement of Jak2 and Stat5 in prolactin signalling in the
mammary gland has been demonstrated (Watson et al., 1996). A recent investigation
by colleagues of the Jak/Stat pathway in the human endometrium has demonstrated
that in vitro stimulation of isolated glandular and stromal elements by prolactin
induces the phosphorylation of Jak2, and Stat-1 and -5, reinforcing the expression of
fully functional PRL-R within the endometrium (Jabbour et al., 1997).
Extensive decidualisation of stromal cells is a characteristic of Lng exposed
endometrium via an IUS. This correlates with elevated immunoreactivity for PRJL-R
in these cells, after one month with the Lng-IUS in situ. Continuous exposure to
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Lng, over a period of 12 months, does not appear to alter the degree of PRL-R
expression. A similar study investigating the immunoexpression of insulin-like
growth factor binding protein-1 (IGFBP-1), a major product of decidualised cells
(Bell, 1991), reported increased production of the binding protein after intra-uterine
Lng delivery (Pekonen et al., 1992). Interestingly, they drew attention to the
"patchy" nature of the immunostaining, relating to the degree of decidualisation and
glandular activity. In the normal cycle, synthesis of IGFBP-1 is initiated when the
first predecidual signs are apparent and increases with the progression of
decidualisation (Bell, 1991). The effects of the Lng-IUS appear to be localised,
endometrium in the direct vicinity of the device are more decidualised (Dallenbach-
Hellweg, 1987). This explains the variations observed in immunoreactivity for
I
PRL-R within a single tissue section.
Positive immunostaining for the receptor was detected in the vasculature of some
decidualised endometrial samples examined. The perivascular cells frequently
exhibited immunostaining as expected, as this is the site of initiation of
decidualisation in the endometrium. Occasional staining was also observed that
appeared to be endothelial in nature. A 16KDa N-terminal fragment of human PRL
has been noted to be a potent inhibitor of angiogenesis (Clapp et al., 1993) and a
high affinity binding site has been previously identified on endothelial cells (Clapp
et al., 1992).
PRL has important immunoregulatory functions in the peripheral immune system,
including leukocyte proliferation, differentiation and function. An important feature
of the premenstrual endometrium and first trimester decidua is the accumulation of
leukocytes within the decidualised stroma. These are believed to be essential for
successful implantation and placentation (Loke et al., 1995b), but the mechanisms
responsible for the premenstrual increase is not fully understood. The presence of an
Lng-IUS in the uterus stimulates the accumulation of high numbers of leukocytes
throughout the endometrium. Of particular interest are the uterine specific large
granular lymphocytes (LGLs). It has been speculated that PRL may have a role in
their proliferation and / or differentiation, especially after the discovery that these
cells although clearly under the influence of progesterone (Inoue et al., 1996), do not
express sex steroid receptors (King et al., 1996b). The effect of prolactin treatment
on these decidual lymphocytes has been examined (Inoue et al., 1996; King et al.,
1996b), but both studies failed to observe a resultant proliferation or differentiation.
It is not unlikely, however, that prolactin may have an effect on decidual leukocytes,
acting indirectly through autocrine / paracrine factors produced by neighbouring
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cells. The failure of this study to clearly demonstrate the expression of prolactin
receptors by the endometrial leukocytes may be due to the use of two enzyme
detection systems. This introduces problems, as both protocols result in cytoplasmic
immunostaining of target cells. A further approach may be to isolate the LGLs from
the endometrium or use fluorescent detection system. It has recently been
demonstrated, however, that the prolactin receptor is downregulated following
stimulation in the prolactin dependant Nb2 T cell line (Elgberg et al., 1990), thought
to be due to internalisation of the receptor-ligand complex or a decrease in mRNA
levels (Clevenger et al., 1990; Perrot-Applanat et al., 1997).
It is probable that migration of specific leukocytes from the peripheral circulation
also contributes to the increase in leukocyte numbers. This is supported by the
elevated levels of the chemokines interleukin-8 (IL-8) and monocyte chemoattractant
protein-1 (MCP-1), in the endometrium during leukocyte accumulation (Jones et al.,
1997). Prolactin may be involved indirectly in enhancing this recruitment, as recent
data reveals that the production of MCP-1 is stimulated by prolactin in ovarian tissue
(Bowen et al., 1996). A number of roles for prolactin in the immunomodulation of
the uterine leukocytes can thus be visualised, with a potential for augmenting
lymphocyte migration, differentiation and proliferation.
In third trimester amniochorion, PRL has been implicated in the enhancement of
matrix metalloproteinase (MMP) activity (Koay et al., 1986; Maaskant et al., 1996).
During menses and placentation in early pregnancy, a dramatic reorganisation of
extracellular matrix must occur to allow endometrial shedding and trophoblast
invasion respectively. These processes invariably involve the action of MMPs, and it
is possible that prolactin may participate as one of the factors capable of altering the
activity of these enzymes in the endometrium.
In summary, this study clearly demonstrates the expression of prolactin receptors in
the decidualised non-pregnant and pregnant endometrium, with a similar temporal
pattern to prolactin. Immunohistochemical studies have isolated the glands and a
subset of stromal cells as sites of action for prolactin. Prolactin has multiple
functions throughout the body, including roles in growth, differentiation and immune
response and it is therefore difficult to isolate a single function for PRL in the uterus.
It is, however, likely that prolactin plays an important role in immunoregulation and
additionally in the decidualisation of both the stromal and glandular cells of the
endometrium. The increased expression of PRL-R corresponding to extensive






7.1 Expression of Inflammatory Mediators in Human Endometrium
This thesis describes and reports findings concerning the expression of
immunomodulatory and inflammatory agents in the human endometrium. The
expression of chemokines, IL-8 and MCP-1, in human endometrium was examined.
Immunoreactive protein was localised to the perivascular cells of all blood vessel
types in non-pregnant and pregnant endometrium. This is consistent with a role in
leukocyte recruitment and migration from the peripheral circulation into the
endometrium.
Marked variations in intensity of immunoreactivity were detected at different stages
l
of the menstrual cycle, most notably, with a reduction in immunostaining in the
ovulatory and early secretory phases, followed by a significant elevation in the late
secretory / premenstrual phase. IL-8 was additionally reduced in first trimester
decidua, whilst strong MCP-1 immunoreactivity persisted. This temporal pattern
was confirmed by monitoring mRNA expression levels using semi-quantitative RT-
PCR. The upregulation of the chemokines in the premenstrual phase coincides with
leukocyte accumulation in the endometrial stroma. In particular, IL-8 was strongly
expressed in the premenstrual phase when an increase in the number of neutrophils
has been reported. The high levels of MCP-1 protein and mRNA expressed in early
pregnancy, corresponds to a continued elevation in the numbers of LGLs and
macrophages. This temporal expression pattern is indicative of a negative regulation
by the steroid hormone progesterone, as upregulation of IL-8 and MCP-1 mRNA
and protein occurs in the premenstrual phase when concentrations of progesterone
markedly decline.
Using a model of progesterone withdrawal and maintenance in vivo, it was
demonstrated that IL-8 mRNA expression was upregulated following the withdrawal
of exogenous progesterone and suppressed when endogenous progesterone was
maintained. In contrast, MCP-1 mRNA was expressed in a progesterone
environment, although a non-significant elevation was detected after exogenous
steroid withdrawal. This is further evidence for the downregulation of IL-8 by
progesterone in the human endometrium and is consistent with the anti-inflammatory
actions of progesterone. MCP-1 also appears to be negatively regulated by
progesterone, but to a lessor extent as the chemokine persists at high levels during
progesterone dominated pregnancy. It is important to note that MCP-1 is
differentially regulated to IL-8. In particular, MCP-1 is upregulated in response to
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paracrine factors IL-4, LIF and PRL, all of which are prevalent during the mid
secretory phase and first trimester decidua.
The inducible isoform of cyclooxygenase, COX-2, was detected by
immunohistochemistry in the perivascular cells and in glandular epithelium. Again,
weakest immunostaining was observed in the periovulatory phase, with significantly
increased levels both premenstrually and menstrually. First trimester decidua
examined possessed relatively low levels of expression of COX-2, although marked
patient to patient variations were identified. COX-2 mRNA followed a similar
expression pattern.
The localisation of COX-2 to the vasculature is consistent with the frequently
described effects of prostaglandins in the modulation of vascular tone. Furthermore,
the co-localisation of COX-2 with the chemokines is supportive of synergism
between PGE (vasodilator) and IL-8 in neutrophil recruitment, and suggests a
possible synergy with closely related MCP-1. Additional immunoreactivity in the
glandular epithelium is in keeping with reports in the literature describing maximal
secretion of prostaglandins by the glandular as opposed to the stromal components of
the endometrium.
The expression patterns identified indicate lower production of prostaglandins
during the early and mid secretory phases, when implantation may occur, and
elevated production following withdrawal of progesterone in the absence of
pregnancy. This is consistent with a regulated inflammatory type reaction occurring
in the peri-implantation period, although this is obviously suppressed with respect to
the amplified inflammatory reaction following steroid withdrawal premenstrually.
An involvement of COX-2 in decidualisation and implantation is reinforced by the
recent publication which investigated in great detail the reproductive failures
associated with targeted disruption of the COX-2 gene in mice (Lim et al., 1997b).
Deficiencies were described in the COX-2 -/- homozygous female during oocyte
maturation and therefore also ovulation and fertilisation. Transferral of wild type
blastocyst to recipient COX-2 -/- mice resulted in unsuccessful implantation, which
is was attributed to the failure of the endometrium to pseudodecidualise following
artificial stimulation. These findings were reinforced by the generation of a similar
phenotype by the administration of a selective COX-2 inhibitor and detection of
COX-2 mRNA expression by in situ hybridisation in the wild type mouse peri-
implantation uterus. Together these data are strong evidence for the involvement of
tightly regulated COX-2 in normal endometrial functioning, particularly during
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decidualisation and implantation.
Progesterone has previously been implicated in the regulation of prostaglandins.
Whilst the steroid appears to increase the capacity of the tissue to produce PGs
during the secretory phase, the full potential is not realised until withdrawal of
progesterone premenstrually (Smith et al., 1988). Moreover, the main metabolising
enzyme, PGDH, is positively regulated by progesterone, resulting in low local
concentrations of PGs during the secretory phase and throughout pregnancy (Casey
et al., 1980). The data presented here indicate an opposing regulation for COX-2,
with a suppression by progesterone. Withdrawal of exogenous progesterone in vivo
resulted in significant upregulation of COX-2 mRNA, whilst maintenance of
progesterone concentrations inhibited COX-2 mRNA expression. Thus removal of
the inhibitory effect of progesterone on COX-2 expression premenstrually triggers
an inflammatory response, characterised by elevated production of prostaglandins,
whilst PG synthesis is downregulated during early pregnancy mediated by
progesterone suppression of COX-2.
IL-8 and COX-2 immunoexpression was examined in endometrium exposed to high
local doses of a synthetic progestin, levonorgestrel, via an intra-uterine releasing
system. Following insertion of the Lng-IUS, an initial rise in IL-8 expression was
detected, with a decline at 3 and 6 months postinsertion. Similarly, COX-2 was
present at high levels 1 and 3 months after insertion of the device, with a subsequent
decrease observed at 6 and 12 months postinsertion. Breakthrough bleeding is
associated with progestin-only contraception, typically more frequent during the first
6 months of use. The strong expression of IL-8 and COX-2 in the initial biopsies
collected after insertion of the device indicates that these local inflammatory
mediators may have a role in the breakthrough bleeding episodes. The mechanisms
involved in their upregulation during this period is uncertain, although it is
noteworthy that expression of PgRs by both glandular and stromal compartments is
suppressed during the first 6 months of exposure to Lng. Moreover, the Lng-IUS had
been reported to dramatically reduce the amount of menstrual blood loss, thus
proving to be a useful clinical management of menorrhagia. Prostaglandins are
known to have a role in regulating vasculature tone during menstruation, and the
reduction of COX-2 expression observed after 6 months of exposure to intrauterine
Lng may be a contributory factor to the reduced blood loss reported.
Pharmacological withdrawal of progesterone via antigestogen (RU486)
administration during first trimester pregnancy had no significant effect on
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chemokine and COX-2 expression as assessed by immunohistochemistry, although
transient elevations of immunoreactive IL-8 and MCP-1 were detected by ELISA.
Blockade of the receptor is likely to result in a much more rapid downregulation of
progesterone than is observed with the gradual decline of progesterone production
premenstrually. Therefore, any changes may not have been identifiable at the time
points examined.
Using an in vitro culture system, IL-8, MCP-1 and COX-2 mRNA could be induced
in response to trauma, fetal calf serum and phorbol ester. Variations in the degree of
stimulation were apparent, consistent with previous measurements of mediator
expression during the normal menstrual cycle. In particular, tissue collected during
the secretory phase had a lower capacity to synthesise mRNA for IL-8, MCP-4 and
COX-2. This indicates that there may exist an intrinsic inhibitory mechanism for
inflammatory mediator expression by secretory phase endometrium, possibly
mediated through progesterone. Alternatively, the upregulation of mRNA expression
may be a consequence of increased stability of existing mRNA transcripts, rather
than de novo transcription. Thus the reduced stimulation of chemokines and COX-2
would reflect the low number of transcripts identified consistently throughout the
secretory phase.
No significant changes in expression levels were detectable following exposure to
progesterone for 2 hours. This is likely to be due to the short time span of exposure
to the steroid. Progesterone has been described to interact with the upstream
promoter sites through its transcription factor receptor, to directly inhibit
transcription. If the increase observed in the presence of serum is increasing the
stability of the normally transiently expressed mediators, then an inhibition of
transcription would effectively be masked. The majority of COX-2 mRNA would,
by reference to immunohistochemical studies, be transcribed in the glandular
epithelium. During the secretory phase, these cells do not possess PgR and thus
treatment with the steroid would not be able to have a direct effect.
Prolactin is a major product of the decidualised endometrium, yet its site of action
and function within the endometrium is unknown. Prolactin receptors were localised
by immunohistochemistry to the glandular epithelium and a subset of stromal cells,
the majority of which exhibited characteristics of large decidualised stromal cells.
This temporal expression pattern was confirmed by semi-quantitative RT-PCR, and
mimics that of the ligand prolactin by the endometrium. Local exposure of the
endometrium to levonorgestrel stimulates extensive decidualisation, reminiscent of
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early pregnancy. This results in a significant increase in the number of PRL-R
positive stromal cells. The expression of both ligand and receptor by the
decidualised stromal cells indicates an autocrine loop in promoting decidualisation.
This is supported by the recently described prolactin receptor knockout mouse
(Ormandy et al., 1996). The homozygous mouse deficient for prolactin receptor was
infertile, due to failed blastocyst implantation. The endometrium did not undergo
decidualisation, and thus implantation was unsuccessful. The identification of the
epithelial glands as a target for prolactin suggests a role for prolactin in the
regulation of glandular activity.
It was not possible to identify receptor expression on specific leukocyte populations,
although blood contaminating tissue sections frequently included leukocytes strongly
positive for the prolactin receptor, in line with its function as a potent
immunomodulatory agent in the peripheral immune system. It remains a possibility
that PRL may have a stimulatory action on endometrial leukocytes.
7.2 Roles for Locally Acting Mediators in Preparation of the Endometrium
for Implantation
The endometrium undergoes decidualisation in the mid-late luteal phase to provide a
suitable environment for implantation. Stromal cells differentiate and become
enlarged, glandular activity is reduced and an accumulation of leukocytes is apparent
in the oedematous stroma. These changes are mediated by progesterone, likely to be
acting indirectly via expression of local mediators.
PRL is likely to act in an autocrine / paracrine manner to stimulate decidual changes
in stromal and glandular elements. PGE2 has been linked with the vasodilation
which is a necessary prerequisite for decidualisation, and in facilitating the decidual
cell reaction (Kennedy et al., 1981; Kennedy, 1986). COX-2 expression would
appear to be essential for the production of PGs in the peri-implantation uterus (Lim
et al., 1997b). Furthermore, in the uterus, PGE2 is upregulated by PRL through
elevated expression of COX-2 (Prigent-Tessier et al., 1996).
MCP-1 expression in a perivascular location is appropriate for a role in leukocyte
recruitment, and co-localisation with COX-2 supports the opportunity for a
synergism between PGE and MCP-1. In addition, PRL has been described to
stimulate MCP-1 expression in the ovary, thereby augmenting leukocyte recruitment
(Bowen et al., 1996). A number of locally acting factors, including MCP-1, PRL and
PGE2 (Linnemeyer et al., 1993), have been demonstrated to activate NK cells,
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potentially to induce an LGL-like phenotype. Thus together, the effect on the
endometrium would be decidualisation of the stroma and glands, vasodilation
producing oedema and leukocyte infiltration. The co-expression of the three local
mediators, PRL, MCP-1 and COX-2, suggests interactions in the endometrium to
promote decidualisation and implantation.
There is evidence that production of Th2-type cytokines by endometrial T cells and
macrophages is favourable for pregnancy (Wegmann et ah, 1993, Lim et ah, 1998).
A number of Th2 cytokines have been detected in the maternal-fetal unit, where a
humoral response as opposed to an inflammatory response is favoured. PGE2 can
stimulate a switch from inflammatory cytokine production (Thl) to a humoral
immune response (Th2 cytokine profile) (Snijdewint et al., 1993; Strassmann'et ah,
1994; Hilkens et al., 1995; Kraan et al., 1995, Huang et ah, 1998). The balance of
Thl and Th2 cytokines regulates chemokine expression, with MCP-1 preferentially
upregulated by Th2 type cytokines (IL-4, IL-10) (Rollins et ah, 1991; Gu et ah,
1997) and in Th2 type situations (Chensue et ah, 1996; Warmington et ah, 1996).
Moreover, expression of MCP-1 appears to induce a Th2 response (Gu et ah, 1997),
through the differentiation of naive T cells to Th2 cells (Karpus et ah, 1997a; Karpus
et ah, 1997b) and upregulation of IL-4 (Lukacs et ah, 1997), whilst downregulating
Thl cytokine IL-12 (Chensue et ah, 1996). This may also be the case for other CC
chemokines, as gene targeting to knock-out the CCR1 receptor (ligands include
MCP-3, MlP-la and RANTES), resulted in impaired host defence when challenged
and a bias towards Thl cytokine production (Gao et ah, 1997). In contrast, EL-8 is
generally inhibited by Th2 cytokines (Standiford et ah, 1990; de Waal Malefyt et ah,
1991; John et ah, 1998) and upregulated in inflammatory situations characterised by
Thl cytokine expression (Edwards et ah, 1997). Expression of COX-2, consistent
with its involvement in inflammatory response, is downregulated by IL-10 and IL-4
(Mertz et ah, 1994; Niiro et ah, 1997). The expression patterns of inflammatory
mediators within the endometrium reported in this thesis, i.e. reduced expression of
IL-8 and COX-2 during pregnancy, and elevated MCP-1, are therefore in agreement










7.3 Involvement of Inflammatory Mediators in the Initiation of
Menstruation
The fall in progesterone concentrations due to regression of the corpus luteum
initiates the breakdown and shedding of the endometrium during menstruation. This
process in many ways resembles an inflammatory response, with increased vascular
permeability, accumulation of neutrophils and elevated prostaglandin production.
The strong expression of COX-2 in the perimenstrual period reinforces a role for the
inducible isoform in normal endometrial physiology. The elevated expression of IL-
8 and MCP-1 at a time when leukocyte numbers increase is strongly supportive of
the hypothesis that leukocytes migrate from the peripheral circulation. All three
inflammatory mediators are to some degree downregulated by progesterone, thus the
premenstrual withdrawal of progesterone would stimulate an increase in expression
of both mRNA and functional protein. This conceivably could result in leukocyte
infiltration, accompanied and possibly facilitated by vasodilation mediated through
prostaglandins. Simultaneous with the upregulation of COX-2, the metabolising
enzyme PGDH is suppressed by progesterone withdrawal, resulting in high local
concentrations of PGs. Leukocytes are potent sources of MMPs and cytokines,
together capable of degrading the components of the endometrium and amplifying
an inflammatory response. The chemokines and COX-2, through the production of
inflammatory prostaglandins may therefore be envisaged to have major role in the
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7.4 Future Studies
This thesis provides strong evidence for leukocyte recruitment to the endometrium,
directed by chemokines, contributing to the leukocyte increase observed in the mid-
late secretory phase. The mechanisms involved in the appearance of the LGLs is of
particular interest, and the temporal expression patterns described here along with
evidence in the literature suggests that a precursor cell type (subset of circulating NK
cells) may be recruited by MCP-1 to the endometrium. This is of prime interest
within the field of endometrial immunology and this possible connection could be
investigated in greater depth to confirm a relationship between circulating NK cells,
chemokine and LGLs.
The strong expression of the chemokines and COX-2 immediately before and during
menses is consistent with the inflammatory type response which characterises
menstruation and confirms the importance of these inflammatory mediators in the
process of menstruation. An obvious continuation of these studies would be to
examine the expression of the chemokines and COX-2 in endometrium collected
from women experiencing dysfunctional menstrual bleeding. The aetiology of
menstrual disorders such as menorrhagia (uncomplicated by organic or endocrine
disorders) and inter-menstrual bleeding caused by progestin-only contraceptives is
not known (Cameron, 1989). There is evidence for elevated production of
vasodilatory prostaglandins in endometrium from women with menorrhagia
(Cameron et ah, 1986b) and the preliminary evidence provided in the present study
for the expression of IL-8 and COX-2 in Lng exposed endometrium reinforces a role
for these local mediators in the breakthrough bleeding episodes, and similarly, the
chemokines have been linked with the inflammatory condition endometriosis.
These studies contribute to the understanding of the paracrine interactions within the
endometrium, and it is conceivable in the future that knowledge of normal
endometrial function will lead to development of non-hormonal methods of
contraception, fertility treatment or treatment of menstrual disorders (Nie et ah,
1997). In the recent years, much interest has been placed on the development of
chemokine antagonists (Wells et ah, 1996a; Wells et ah, 1996b), with emphasis
placed on preventing infection with HIV, for which CC chemokine receptors are a
cell entry co-factor (Feng et ah, 1996). This technology may also have a role in the
reproductive system and other inflammatory situations (Harada et ah, 1996).
Since the discovery of the inducible isoform of cyclooxygenase (COX-2) and its
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identification as the isoform predominantly expressed in inflammatory situations,
work has been conducted to develop non steroidal anti-inflammatory agents
(NSAIDs) which selectively target COX-2, whilst leaving COX-1 unaffected, thus
avoiding the gastrointestinal side effects (Bennett et ah, 1995; Vane et ah, 1995). A
number of compounds, nimesulide, NS-398 and Dup-697 all preferentially inhibit
COX-2 activity (Futaki et ah, 1994; Gierse et ah, 1995; Tarvares et ah, 1995), and an
example of the potential of such substances is the case study presented earlier this
year where preterm labour was delayed by administration of nimesulide (Sawdy et
ah, 1997). The strong expression of COX-2 in the perimenstrual period indicate that
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All chemicals were purchased from Merck Ltd. (BDH), Lutterworth, UK unless
stated otherwise:





0.01M Sodium Citrate Buffer pH 6.0
2.94g tri-sodium citrate
1 Litre distilled H20




1 litre distilled H20
PBS-Tween (PBS-T) pH 7.4 - 7.6
1 litre of PBS supplemented with lOOfll Tween-20 and 8g NaCl




1 litre distilled H20
TBS-Tween (TBS-T) pH 7.4 - 7.6
1 litre of TBS supplemented with lOOpl Tween-20 and 8g NaCl
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ELISA Buffer pH 7.2
lOOmM Tris
0.125g 2-methylisotiazolone (Boehringer Mannheim,
Sussex, UK)
0.125g Bromonitrodioxane (Boehringer Mannheim,
Sussex, UK)
2mg Bovine Serum Albumin (fatty acid free) (Sigma, Poole, UK)
300pl NaCl (Sigma, Poole, UK)
2mM EDTA (Sigma, Poole, UK)
1.5mls 20% Tween-20
1 litre distilled H20
t
ELISA Wash Buffer pH 7.0 - 7.5
250|Ol Tween-20
4.5g NaCl
1 litre lOmM Tris
ELISA Peroxidase Substrate
lOmls lOOmM Sodium Acetate (pH 6.0)
lml Tetramethylbenzidine in DMF (3mg/ml)
lml 0.5% Urea hydrogen peroxide in 50mM Acetate pH 6.0
PBS-BSA
lOOmls Sterile PBS (Gibco)
O.lg BSA (Sigma, Poole, UK)
0.1ml Preservative (Boehringer Mannheim, Sussex, UK)
ELISA Denaturing Solution
0.5mls lONNaoH (lOOmM)
0.2mls 0.5M EDTA (2mM)
49.3mls distilled H20
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1 litre distilled H2O
Diluted 1 in 20 for working dilution of 0.5 X TBE
Gel Loading Sample Buffer
3 mis 10 X TBE buffer
3.2mls Glycerol
0.3mls Bromophenol blue




Detailed protocols for RT-PCRs
Reverse Transcriptase reaction mix for GAP-DH:
11.5JJ.1 DEPCH20
4)ll1 5 x reverse transcriptase buffer
l|ol dNTPs (premixed, lOmM each dNTP)
lpl Biotinylated GAP-DH antisense oligonucleotide primer (10|lM)
0.25(0.1 RNAsin (RNAse inhibitor)
0.25(0.1 AMV Reverse transcriptase
PCR reaction mix for GAP-DH:
20.5|ol DEPC H20
5(ol 10 x PCR buffer
3|ol MgCl2
ljol GAP-DH sense oligonucleotide primer (10|iM)
0.5jol AmpliTaq Polymerase (5U/jol)
Differences in reaction mixes for EL-8, MCP-1, COX-2 and PRL-R:
Reverse Transcriptase reaction mix for IL-8:
0.8(Ol Biotinylated IL-8 antisense oligonucleotide primer
PCR reaction mix for IL-8:
0.8jol IL-8 sense oligonucleotide primer
MCP-1
Reverse Transcriptase reaction mix for MCP-1:
0.3|ol Biotinylated MCP-1 antisense oligonucleotide primer
PCR reaction mix for MCP-1:
0.8(0.1 MCP-1 sense oligonucleotide primer
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COX-2
Reverse Transcriptase reaction mix for COX-2:
0.8)11 Biotinylated COX-2 antisense oligonucleotide primer
PCR reaction mix for COX-2:
0.8(il COX-2 Sense oligonucleotide primer
2jll1 MgCl2
PRL-R
Reverse Transcriptase reaction mix for PRL-R:
l|il PRL-R antisense oligonucleotide primer
PCR reaction mix for PRL-R:
lp.1 PRL-R sense oligonucleotide primer
307
CONFERENCE PRESENTATIONS
Jones, R.L., Critchley, H.O.D., Kelly, R.W. & Baird, D.T. (1997) Downregulation
of IL-8 and COX-2 by progesterone in human endometrium. Journal of Reproduction
and Fertility, Absract series 20, pl4.
Jones, R.L. (1997) Immunomodulatory agenst in peri-implantation human
endometrium. Blair Bell Jubilee Competition, Royal College of Obstetricians and
Gynaecologists, London, December 1997.
(Theodore Ogg Prize winner, chosen to represent Edinburgh University at the Blair
Bell Jubilee Competition). 1
Critchley, H.O.D., Jones, R.L., Wang, H., Kelly, R.W., McNeilly, A.S., Gebbie,
A.E. & Glasier, A.F. (1997) Endometrial sex steroid and prolactin-receptor
localisation following intra-uterinc levonorgestrel delivery. Human Reproduction,
12, Abstract Book 1, P-228
Jones, R.L., Critchley, H.O.D. & Kelly, R.W. (1996) Chemokine Expression in
Human Endometrium. Journal of British Fertility Society 2: (1) Human
Reproduction, Natl. Suppl. 6A (S14)
Critchley, H.O.D., Lea, R.G., Kelly, R.W., Jones, R.L., Drudy, T.A. & Baird, D.T.
(1996) Antigestogen administration increases macrophage influx into first trimester
human decidua. Journal of Endocrinology, 148 (Suppl). Abstract No. P22
Critchley, H.O.D., Lea, R.G., Jones, R.L., Cameron, S.T., Gebbie, A.E. & Glasier,
A.F. (1995) The effect of continous intra-uterine levonorgestrel upong enodmetrial
sex steroid receptor distribution, interleukin-8 expression and leukocyte populations.
Journal of Endocrinology, 144 (Suppl) P136
Jones, R.L., Critchley, H.O.D., Jabbour, H.N., Brooks, J. & McNeilly, A.S. (1996)
Prolactin receptor expression in human endometrium. 8th Simpson Symposium,
Edinburgh, Scotland, August 1996
(Poster Presentation - won first prize for best poster).
Jones, R.L., Kelly, R.W. & Critchley, H.O.D. (1996) Immunolocalisation of
monocyte chemoattractant protein-1 (MCP-1) and Cyclooxygenase-2 (COX-2) in
human endometrium and decidua. 4th European Congress on Prostaglandins and
308
other Locally Active Factors in Reproduction. Stockholm. Sweden. Free
Communication Fl.
Critchley, H.O.D., Glasier, A.F., Gebbie, A. E., Jones, R.L., Cameron, S.T., Carr,
G.C. & Kelly, R.W. (1996) Anomalous endometrial prostaglandin (PG) metabolism
with local intrauterine levonorgestrel delivery. 4th European Congress on
Prostaglandins and other Locally Active Factors in Reproduction. Stockholm.
Sweden. Free Communication P5.
309
PUBLICATIONS
Jones, R.L., Critchley, H.O.D., Brooks, J., Jabbour, H. N. & McNeilly, A.S. (1998)
Localisation and Temporal Expression of Prolactin Receptor in Human
Endometrium. Journal of Clinical Endocrinology and Metabolism. In Press.
Jones, R.L., Kelly, R.W. & Critchley, H.O.D. (1997) Chemokine and
Cyclooxygenase-2 Expression in Human Endometrium Coincides with Leukocyte
Accumulation. Human Reproduction, 12 (6) 1300 - 1306.
Critchley, H.O.D., Jones, R.L., Lea, R.G., Drudy, T.A., Kelly, R.W., Williams, A.R.
& Baird, D.T. (1997) The role of progesterone in expression of inflammatory
mediators in human endometrium. Journal of Clinical Endocrinology and
Metabolism. Submitted.
Critchley, H.O.D., Wang, H, Jones, R.L., Kelly, R.W., Drudy, T.A., Gebbie, A.E.,
Buckley, C.H., McNeilly, A.S. & Glasier, A.F. (1997) Morphological and functional
features of endometial decidualisation following long term intra uterine
levonorgestrel delivery. Human Reproduction. Submitted.
Critchley, H.O.D., Kelly, R.W., Lea, R.G., Drudy, T.A., Jones, R.L. & Baird, D.T.
(1996) Sex steroid regulation of leukocyte traffic in human decidua. Human
Reproduction. 11,2257-2262.
Baird, D.T., Cameron, S.T., Critchley, H.O.D., Drudy, T.A., Howe, A., Jones, R.L.,
Lea, R.G. & Kelly, R.W. (1996) Prostaglandins and menstruation. European
Journal of Obstetrics and Gynaecology and Reproductive Biology. 70, 15-17
310
Human Reproduction vol.11 no. 10 pp.2257-2262. 1996
Sex steroid regulation of leukocyte traffic in human
decidua
H.O.D.Critchlevu, R.W.Kelly2, R.G.Lea1,
T.A.Drudv1, R.L.Jones1 and D.T.Baird1
'Department ot' Obstetrics and Gynaecology. University of
Edinburgh and :Medicai Research Council. Reproductive Biology
Unit. Centre for Reproductive Biology. 37 Chalmers Street.
Edinburgh EH3 9EW. UK
-'To whom correspondence should be addressed
Endometrial leukocyte subpopulations vary over the repro¬
ductive cycle, but no data exist on the mechanism regulating
their recruitment into uterine tissue. This study has evalu¬
ated the role of progesterone in the recruitment of selected
leukocyte populations in early pregnancy decidua. Decidua
was collected from women in early pregnancy at the time
of vacuum aspiration of the uterus 6. 12. 24 and 36 h after
taking 200 mg mifepristone (RU486). Standard immuno-
histochemical techniques were employed to demonstrate
the selected leukocyte populations in decidual tissue and
these were analysed using image analysis. Fresh decidua
was incubated in medium for 24 h and supernatants assayed
for interleukin (IL)-8 (neutrophil chemotactic factor) and
MCP-1 (monocyte chemoattractant protein-1) content.
Analysis of variance demonstrated a significant increase
in tissue monocyte number in decidua 12-36 h after
mifepristone administration. No significant changes in other
leukocyte subpopulations were observed. Decidual IL-8
concentrations were significantly increased (P = 0.019) 6 h
after mifepristone and decidual MCP-1 concentration rose
(non-significant) and fell significantly (P = 0.029) between
6 and 12 h after mifepristone. Progesterone withdrawal may
initiate a local cascade of events involving inflammatory
mediators which in turn are responsible for the influx of
monocytes. This influx may be essential in the process of
shedding of endometrium or decidua since monocytes
and neutrophils are important sources of proteases and
collagenases. Furthermore, these cells are potential local
sources of immunomodulatory cytokines.
Key words: antigestogens/decidua/leukocytes/progesterone
Introduction
Although the precise local mechanisms controlling implanta¬
tion, decidualization and menstruation are unknown, there are
several lines of evidence to suggest chat interaction between
steroid hormones, leukocytes and locally produced cytokines
and growth factors are involved. The local tissue response to
withdrawal of progesterone resulting in menstruation shows
many features characteristic of an inflammatory response, that
© European Society tor Human Reproduction and Embryology
is release of prostaglandins, increased permeability of blood
vessel walls and an influx of leukocytes in the endometrium
(Kelly, 1994). The number and type of leukocytes in human
endometrium and decidua varies with the stage of the menstrual
cycle, with implantation and throughout pregnancy, suggesting
a measure of endocrine and paracrine control of leukocyte
migration to and/or replication in these tissues (Lea and Clark.
1991). Leukocytes make a significant contribution to the
stromal compartment of human endometrium, both during the
menstrual cycle and in early pregnancy. In the first trimester
30% of cells in the decidual stroma are leukocytes, of which
20-30% are macrophages (Buimer. 1995; Loke and King.
1995). The major contributors to the leukocyte infiltrate are
the CD56 positive large granular lymphocytes (LGL) which
account for up to 70% of the leukocyte population in first
trimester decidua (Klentzeris et al., 1992; Buimer, 1995). It is
most interesting that the latter cell type accumulate in areas
of stromal decidual change, for example near spiral arteries.
The inconsistency in the literature concerning numbers and
distributions of macrophages, may reflect the various surface
markers utilized to identify macrophage populations and also
whether or not the leukocyte is activated. Buimer et al. (1988)
described the localization of macrophages in the basal and
functional layers throughout the cycle, failed to observe any
fluctuations over the cycle, and concluded that macrophage
recruitment was not under hormonal control. In contrast. Kamat
and Isaacson (1987) have reported a pre-menstrual increase in
endometrial macrophage populations. Klentzeris et al. (1992)
also reported an increase in macrophage numbers in the late
secretory phase (luteinizing hormone (LH) + 10 to LH + 13],
The population of phenotypically unique LGL (CD56".
CD16t CD3") are reported to increase in the late luteal phase
and are localized near glands and spiral arteries (Buimer et al..
1991). The cell population increases further in the first trimester
of pregnancy and numbers decline in the third trimester. Their
role is unknown, but a participation in the implantation process
has been proposed. It remains to be established whether the
increase in this unique subpopulation of LGL is a consequence
of in-situ proliferation or due to migration from the circulation
(Kientzeris et al.. 1992; Marzusch et al.. 1993).
Progesterone, however, seems to be essential for the appear¬
ance of CD56+ LGL. Indeed, in ovariectomized women,
treatment with both oestrogen and progesterone is necessary
for their appearance (Loke and King, 1995). In the absence of
pregnancy these unique cells apoptose prior to the influx of
neutrophils characteristic of menstruation (Loke and King.
1995). Withdrawal of ovarian progesterone in sheep produced
an influx of polymorphonuclear (PMN) leukocytes 24 h after
ovariectomy and increased by 48 and 72 h after surgery (Staples
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Table I. Age. gestational duration and body mass index of control group
and four groups of women (II—V) administered mifepristone 16-36 h) prior
to surgical termination of pregnancy. (Values are median, with range in
parentheses I
Group Age Gestational Body mass
I years) duration (days) index t'kg/m-)
f (control) ;3 53.5 21.6
(H = 8) 118-38) i5i-66) i [9.8-29.7)
[[ (mifepristone 20 60.5 25.1
6 h; n = 7V '• "" (18-31) (54-67) (19.3-27.3)
III (mifepristone 21 56 25.0
12 h: /i = 7) (17-27) (44-671 119.1-28.9)
(V (mifepristone m 53 24.S
24 h; n = 7) (20-27) (51-68) (21.5-32.6)
V (mifepristone 20 59 21.2
36 h: n = 7) (17-29) (33—65i 118.6-27.21
et al.. 1983). Data conce rning neutrophil subpopulations in
human endometrium and early decidua are scarce and there
are no data on the mechanism of recruitment.
The purpose of this study has been to evaluate the role of
progesterone (using a model of progesterone antagonism
in vivo, that is, administration of the antigestogen mifepristone.
RU486) in the recruitment of selected ieukocyte subpopulations
in early pregnancy decidua.
Materials and methods
Ethical approval for the study was obtained from Lothian Research
Ethics Committee (ref no: 1702/94/6/1). Informed consent was
obtained from 36 women undergoing surgical termination of preg¬
nancy by vacuum aspiration between 35 and 63 days amenorrhoea.
The women were randomly allocated to five groups (a list was
constructed of randomly allocated treatments and patients were
assigned to the list as recruited): eight women participated in the
control group (group [) and there were seven women in each of four
treatment groups: groups II, III, IV and V were administered 200 mg
mifepristone (RU486. an antigestogen) at 6. 12. 24 and 36 h
respectively before vacuum aspiration. Under general anaesthesia the
cervix was dilated using Hegar dilators and decidual tissue away
from the implantation area was obtained by careful curettage of the
uterine waii prior to vacuum aspiration of the products of conception
with a suction catheter. Decidual panetalis (without trophoblast) was
subsequently confirmed by examination of haematoxylin and eosin
stained sections of each biopsy. Tissue sections were also stained
with cytokeratin to confirm the presence or otherwise of trophoblast
cells within the decidual tissue. The characteristics of patients in each
of the five groups are detailed in Table I.
Immunohistochemistry
All biopsies were fixed in 10% neutral buffered formalin at 4°C
overnight, rinsed and stored in 70% ethanol and thereafter routinely
wax embedded. Sections (5 urn) were cut for immunohistochemicai
localization of (i) CD45 leukocyte common antigen: (ii) macrophages;
(iii) neutrophils: (iv) CD56 positive lymphocytes. Commercially
available monoclonal antibodies were used for detection of the
leukocyte common antigen CD45 (Dako Laboratories. High
Wycombe. UK) macrophages (Dako. CD68. Code M876); neutrophils
(DAKO. neutrophil elastase) and CD56 positive lymphocytes (Zvmed,
San Francisco. CA. USA).
Tissue sections were dewaxed and rehydrated in descending grades
of alcohol. Non-specific endogenous peroxidase activity was blocked
by treatment with 3% hydrogen peroxide in distilled water for 5 min
at room temperature. Pretreatment of the sections was necessarv for
localization of macrophages and CD56~ lymphocytes as follows.
Macrophage immwwlocalization
Tissue sections were subjected to an enzyme digestion with 0.1%
trypsin in 0.1% calcium chloride at pH 7.8. The digestion was
conducted at 37°C for 25 min and subsequently enzyme activity
destroyed by washing in tap water.
CD56' lymphocyte unmunolocatiration
In order to expose the epitope, tissue sections were microwaved at
high power in 0.01 .VI sodium citrate buffer IpH 6.0) for 20 min and
then allowed to stand for a further 20 min. Sections were subsequently
washed in buffer prior to a non-immune block.
CD45 leukocyte common antigen and neutrophil elastase
No pretreatment of the tissue was necessary for demonstration of the
ieukocyte common antigen (CD45) or neutrophil elastase.
All tissue sections were exposed to a non-immune block with
normal horse serum performed for 20 min at room temperature.
Tissue sections were then incubated with the appropriate primary
antibody as follows: (i) leukocyte common antigen (CD45) dilution
of antibody I in 50 for 60 min at 37°C; (ii) macrophages (CD63)
dilution I in 50 for 60 min at 37°C; (iii) CD56 dilution I in 250 for
60 min at 37°C; (iv.) neutrophil elastase dilution I in 50 for 60 min
at 37°C.
Negative controls were performed by replacing the primary antibody
with mouse immunoglobulin at the same concentration as the primary
antibody. Sections were labelled with an avidin-biotin-peroxidase
detection system (Vector Stain. Vector Laboratories. Peterborough.
UK). Tissue sections were incubated for 2-10 min with diammobenzi-
dine (DAB) solution (DAB Kit, Vector Laboratories) for colour
development. Thereafter sections were counter-stained with
haematoxviin. dehydrated and cleared in xylene and mounted in
Pertex.
Image analysis
The immunoreactivity of each leukocyte subpopulation in the stroma
of decidual tissue was assessed using image analysis. The system
employed an Olympus BH2 microscope (X20 objective) connected
to a Macintosh Quadra 700 computer, using Colour Vision software
(supplied by Improvision. Coventry, UK).
Quantification was performed on the digitized image of systematic
randomly selected field from which non-stromal elements (epithelium)
had been interactively removed by drawing around the glands. Using
colour discrimination software, the totai area of positively staining
cells (brown reaction product) was measured, and expressed as a
ratio to the area of ail stromal nuclei (blue haematoxylin). The
running mean of the ratio stabilized after measuring 12 fields
(Lowrey et al., 1995). In order to represent the amount of positive
immunoreactivity in terms of number of cells, the average dimensions
of each leukocyte were estimated. Ratios were then converted by a
conversion factor such that the data could be expressed as percentages
of cells in the stroma.
Samples of decidua were transported to the laboratory in ice-cold
RPMI 1640 and then cultured for 24 h in RPMI containing 10%
fetal calf serum (Gibco, Paisley, UK) and antibiotics (penicillin/
streptomycin and gentamycin). After 24 h culture in 5% CO; in air,
media were removed, divided into aliquots and stored at -20°C until
assayed. Tissue weight was determined after the incubation period.
Granulocyte-macrophage colony stimulating factor was assayed using
an enzyme-linked immunoassay (ELISA) kit (RandD Systems.
Oxford. UK), interleukin-8 (IL-8) and monocyte chemoattractant
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Figure 1. CD45 (leukocyte common antigen) positive lymphocytes
in control decidua and 6. 12. 24 and 36 h after progesterone
withdrawal in vivo. No significant change in cell numbers was
observed. Values expressed as mean = 1 SEM: it = 3 for control
subjects and n = 7 subjects for other time points.
protein-1 iMCP-1) were assayed by ELISA following the method of
Ida et al. {1992) for IL-8 and Ida et al. (1994) for MCP-1. Antisera
and standards were the kind gift of Dr M.Naruto. All concentrations
of cytokines were corrected for decidual weight.
Analysis of data
Analysis of variance (parametric and non-parametric) was used to
evaluate whether or not there were significant differences in leukocyte
subpopulation number. Regression analysis was also performed.
Results
There were no significant changes in the total numbers of
leukocytes positive for leukocyte common antigen (LCA.
CD45) (Figure 1). However, there was a progressive increase
in the number of macrophages (CD680 12. 24 and 36 h after
administration of mifepristone (P < 0.01 and < 0.05. analysis
of variance) (Figure 2). The macrophages were randomly
distributed throughout the decidua (Figure 3a and b). There
were few neutrophils in decidua and no significant change in
numbers was observed after mifepristone (Figure 4). As
expected. LGL CD56^ were abundant in control decidua
(Figure 5). There was a slight statistically insignificant decline
in numbers after the ingestion of mifepristone. Regression
analysis also showed these results to be non-significant.
In-vitro studies
Decidual IL-8 concentrations were significantly increased (P =
0.019) 6 h after antigestogen administration (Figure 6). Decid¬
ual MCP-1 concentrations rose (non-significant) and fell signi¬
ficantly (P = 0.029) between 6 and 12 h after mifepristone
administration (Figure 7).
Discussion
The present study has demonstrated a significant increase in
the numbers of monocytes in the decidua parietalis following
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Figure 2. Appearance of monocytes (CD68~) in decidual tissue
after administration of mifepristone: "'P < 0.01. *P < 0.05
difference from control. Values expressed as mean r 1 SEM:
n = 8 for control subjects and n = 7 subjects for other time points.
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Figure 3. Photomicrographs of first trimester decidual tissue.
(upper) Control biopsy showing only few monocytes (brown);
(lower) 24 h after administration of mifepristone. Note increased
numbers of tissue monocytes (brown). Scale bar = 50 urn.
contrast, no significant changes in CD45 positive (LCA)
leukocytes, neutrophils or CD56" LGL were observed.
CD45 (LCA) is a pan-leukocyte marker and since the major
contributors in the leukocyte infiltrate are the CD56 large
granular lymphocytes (up to 70% of leukocytes) we were not
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Figure 4. Neutrophil accumulation in control decidua and 6, 12. 24
and 36 h after mifepristone administration. No significant change
observed. Values expressed as mean r I SEM: n = 8 for control
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Figure 5. CD56 positive lymphocyte accumulation in control
decidua and 6, 12, 24 and 36 h after progesterone antagonism. No
significant decrease in numbers was observed. Values expressed as
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Hours after Mifepristone
Figure 6. Interleukin (IL)-8 release from cultured explants (ng/mg
per 24 h). A significant increase (P = 0.019) was observed 6 h
post-mifepristone administration. Values expressed as mean ± 1
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Hours after Mifepristone
Figure 7. Monocyte chemoattractant protein-1 (MCP-1) release
from cultured explants (pg/mg per 24 h). A non-significant rise is
observed followed by a significant fall (P = 0.029) in MCP-1
concentration between 6 and 12 h post-mifepristone administration.
Values expressed as mean r 1 SEM; n = 8 for control subjects
and u = 7 subjects for other time points.
of CD45 positive cells after progesterone withdrawal in vivo.
Indeed our observations are in concordance, in this respect, to
the only other published data on CD56+ leukocyte populations
in decidua exposed to antigestogen. by Wang et al. (1995).
In contrast there was a striking increase in the number of
macrophages by 12 h after mifepristone administration. Our
findings differ from a previous abstract which reported no
change in the number of macrophages or large granulated
lymphocytes (CD56~) in decidua collected from women at
the time of vacuum aspiration 48 h after 200 mg mifepristone
(Wang et al., 1995). It is possible that the changes in the
number of macrophages which we observed prior to 48 h play
an important role in the local cellular responses which lead
eventually to abortion.
The local cellular events taking place during decidualization,
and indeed menstruation, in the absence of pregnancy, parallel
morphological events during an inflammatory process (Finn,
1986; Kelly, 1994). It is likely that steroid dependent events
are regulated by a cascade of inflammatory mediators, these
being cytokines, growth factors and prostaglandins, which
may have their origin in leukocyte sub-populations, i.e the
macrophage and/or non-haematopoietic cells. There are con¬
flicting data on studies of macrophage distribution at the
murine matemal-fetal interface. De and Wood (1990) report
data to support the role for oestrogen and progesterone in the
quantitative and distributional changes observed in uterine
macrophage populations. Specifically, ovariectomy in this
mouse model caused a significant reduction in macrophage
number. More recently, observations by Brandon (1995) have
concluded that macrophages are not normally found at the
matemal-fetal interface in mice. In the murine mode! of early
embryo loss, Duclos et al. (1995) have reported that decidual
infiltration with maternal macrophages precedes spontaneous
abortion of the early embryo. It is unclear however whether
macrophage migration is a result of locally produced tissue
signals or whether the migration is a completely random
Leukocyte traffic in human decidua
process. Care, however, must be taken in extrapolating observa¬
tions in an animal model to mechanisms in vivo in the human.
Perhaps one of the earliest observations on the effect of
steroids on leukocyte subpopulations is that published in 1928
by Fluhmann. This report noted an increase in macrophage
numbers after castrated rabbits were injected with oestrogen.
Further support of a role for oestrogen in the regulation of
both leukocyte migration, and indeed the production of local
inflammatory mediators, is that published recently by Robert¬
son et at. (1996). These authors report that oestrogen is
the principal regulator of granulocyte-macrophage colony
stimulating factor (GmCSF) synthesis by predominantly uterine
epithelial cells. Furthermore, administration of mifepristone
to ovariectomized non-pregnant mice given oestrogen and
progesterone is reported to up-regulate GmCSF synthesis. This
important inflammatory mediator may well be responsible for
macrophage migration and activation (Wang et al.. 1987).
There is no evidence as yet which has co-localized an oestrogen
receptor on macrophage populations and it is possible therefore
that the movement of tissue monocytes is indirectly regulated
via steroids. In the context of the present study, antigestogen
administration is well known to up-regulate both steroid
receptors (Maentausta et al., 1993: Cameron et al.. 1996). It
is possible therefore that the reported increase in macrophage
number in the present study reflects the up-regulation of
oestrogen receptor of these decidual tissues in vivo after
administration of mifepristone (Shi et at.. 1993a). In normal
decidua oestrogen receptor expression is negligible in both the
epithelium and stroma (Shi et al.. 1993b).
We have recently observed immunostaining for GmCSF in
both control and mifepristone-exposed decidua localized to
glandular and surface epithelium. There is a marginal increase
in stromal immunoreactivity, especially in the vicinity of blood
vessels at 12 h after antigestogen delivery (own unpublished
observations). Our present studies (in vitro) of GmCSF and
other potential local inflammatory mediators showed only a
significant increase in decidual IL-8 concentration (P = 0.019)
at 6 h after mifepristone a'nd a non-significant rise followed
by a significant fall in MCP-1 concentration (P = 0.029)
between 6 and 12 h after mifepristone (Figures 6 and 7).
The present study failed to demonstrate any change in other
leukocyte sub-populations. In the absence of pregnancy, CD56"
LGL apoptose prior to the influx of neutrophils, i.e. at a
time when progesterone concentrations are falling prior to
menstruation. Thus the survival of CD56^ cells in the uterus
may be progesterone dependent (Loke and King, 1995).
Apoptosis of this unique cell population has been observed on
days 26 and 27 of the menstrual cycle and in decidua from a
failing pregnancy, that is when progesterone concentrations
are falling (King et al.. 1989: Loke and King, 1995). There is
no evidence to date that progesterone causes proliferation of
decidual CD56~ cells and progesterone receptors have not. as
yet, been co-localized on this unique cell type (Loke and King,
1995). In this study there was no evidence of changes in
CD56~ cells but this may not preclude apoptotic changes
having occurred.
Although it is reported that the proportions of lymphoid
populations do not differ between the decidua parietalis and
decidua basalis (Haller et al.. 1995). an indirect effect of
steroids on leukocytes may occur through the release of
cytokines by trophoblast. This may occur via the progesterone
receptor recently shown to be present on both villous and
extravillous trophoblast populations (Wang et al.. 1996). It is
possible therefore that effects of mifepristone on leukocyte
populations in decidua basalis may differ to that seen in the
decidua parietalis. The decidua parietalis. however, covers a
vast expanse of fetal membranes in later pregnancy. Both the
decidua basaiis and parietalis contain cells with morphological
features of antigen presenting lymphocytes and lymphocytes
capable of immune reactivity with the potential for benefit or
harm to the fetal placental unit. Haller et al. (1995) have
reported that leukocyte patterns in human decidual stroma of
basal and parietal decidua are similar. Specifically, macro¬
phages and CD56 positive lymphocytes were the predominant
cell populations and evenly distributed.
Thus in summary, we observed a significant increase in
tissue monocyte number but not in neutrophils or CD56" LGL
in the decidua parietalis after progesterone antagonism in vivo.
Progesterone withdrawal may therefore initiate a local cascade
of events involving inflammatory mediators which, in turn,
are responsible for the influx of monocytes. Macrophages and
neutrophils may be essential in the process of shedding of
endometrium or decidua since they are important sources of
proteases and collagenases. These cells in turn are potential
local sources of immuno-modulatory cytokines.
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The endometrium contains a resident population of leuko¬
cytes, the number and subtype of which vary throughout the
menstrual cycle and in early pregnancy. Factors controlling
these fluctuations are unknown,' but a combination of
proliferation in situ and migration from the vasculature
has been proposed. Locally acting inflammatory mediators,
including specific chemokines and prostaglandins, have
been implicated in these processes. Interleukin-8 (IL-8) and
monocyte chemoattractant protein-1 (MCP-1) are potent
chemoattractants and activators for neutrophils and mono¬
cytes respectively. Locally acting prostaglandins modulate
vascular permeability, and a synergistic action of prosta¬
glandin E (PGE) with IL-8 has been described. In the
present study IL-8, MCP-1 and cyclooxygenase-2 (COX-2),
the inducible isoform of prostaglandin synthase, were all
localized in the endometrium by immunohistochemistry
throughout the menstrual cycle and in early pregnancy.
All three inflammatory mediators were localized to the
perivascular cells of blood vessels in endometrium and
decidua, and additional immunoreactivity for COX-2 was
identified in the glandular epithelium. The intensity of
immunostaining was reduced in the periovulatory, early
and mid-secretory phases and significantly increased pre-
menstrually. These results further support the hypothesis
that there is a premenstrual migration of leukocytes into




The human endometrium undergoes rapid proliferation and
differentiation under the control of the ovarian steroid hor¬
mones oestrogen and progesterone. Associated with the pro¬
gesterone mediated decidualization in the mid-late secretory
phase is the accumulation of leukocytes in the endometrial
stroma (Bulmer et al., 1991a; Starkey et al., 1991). These
comprise macrophages and the uterine specific large granular
lymphocytes (LGLs), and both subtypes persist in early preg¬
nant decidua (Loke and King, 1995). In the absence of
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pregnancy, a distinct influx of neutrophils is observed in the
immediate premenstrual phase (Poropatich et al., 1987).
The exact function of the endometrial population of leuko¬
cytes is unknown, although a role in the regulation of implanta¬
tion and placentation and also in the initiation of menstruation
has been suggested (Bulmer et al., 1991b; King and Lokc.
1991). The factors controlling their mode of appearance
and fluctuation throughout the menstrual cycle are similarly
uncertain. The cyclical pattern of leukocyte presence is sug¬
gestive of steroidal control, but the recent demonstration thai
they do not possess either oestrogen or progesterone receptors
implies that this regulation is exerted indirectly (King et a!..
1996). Co-localization studies have revealed that the stromal
leukocytes express the cell proliferation marker Ki67 (Pace
et al., 1989; King et al., 1991), indicating that their increase
in numbers is due at least in part to in-situ proliferation. It is
likely, however, that the migration of leukocytes from the
peripheral circulation also contributes to leukocyte accumu¬
lation.
Migration is a multistep process involving both the simul¬
taneous expression of leukocyte adhesion molecules and their
corresponding receptors on endothelial cells, and additionally
the production of specific chemotactic agents (Springer, 1990;
Schall and Bacon, 1994). A family of cytokines exhibiting
chemotactic activity for specific leukocytes are the chemokines
(for reviews see Matsushima et al., 1992; Baggiolini et al..
1994). Interleukin-8 (IL-8), a potent chemoattractant and
activator of neutrophils, has been detected in the human cervix
(Barclay et al., 1993), endometrium (Arid et al., 1993;
Critchley et al., 1994), chorio-decidua (Dudley et al., 1993)
and the placenta (Saito et al., 1994). Increased production of
IL-8 in the cervix coincides with neutrophil influx prior to
ripening at term (Kelly et al., 1992; El Maradny et al., 1996).
IL-8 has been localized to the perivascular cells of blood
vessels in non-pregnant and pregnant endometrium (Critchley
et al., 1994), where it could participate in recruitment ol
neutrophils and additionally in the process of angiogenesis
(Koch et al., 1992).
A suppression of IL-8 production by the endometrium (Kelly
etai, 1994) and cervix (Ito etal., 1994) in vitro by progesterone
has been demonstrated, acting either through the glucocorticoid
response element in the promoter region of the gene or directly
through progesterone receptors present within the cell. If n
similar downregulation by progesterone occurs in vivo, the
withdrawal of progesterone premenstrually would remove the
inhibitory effect, resulting in an increased production of IL-8
and accompanying neutrophil influx.
A closely related chemokine is monocyte chemoattractant
protein-1 (MCP-1). MCP-1 displays no chemotactic activity
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tor neutrophils; instead it is a potent attractant and activator
for macrophages. T cells (Cai et at., 1995; Roth et at., 1995),
basophils, mast cells (Feliciani et at.. 1995) and also natural
killer cells (Allavena et at., 1994). It is positively regulated
by pro-inflammatory stimuli, such as interleukin-1 (IL-1) and
tumour necrosis factor (TNF)-a, as is IL-8 (Baggiolini et at.,
1994), but is additionally induced by platelet derived growth
factor (PDGF) in fibroblasts (Yoshimura and Leonard, 1990).
This growth factor has no effect on IL-8 production, indicating
that regulatory differences in the gene expression of these
chemokines exist. Little is known about the downregulation
of MCP-1. with the exception of an inhibition by glucocortico¬
ids in certain cell lines (Brach et at., 1992; Shyy et at., 1995).
MCP-1 production by endometriotic cells has recently been
described (Akoum et at.. 1996), but a role for MCP-1 in
leukocyte recruitment to the normal endometrium has not been
investigated.
The infiltrate of leukocytes into tissue is frequently accom¬
panied by the leakage of plasma producing stromal oedema.
Permeability of blood vessels is modulated by vasoactive
substances including prostaglandins (PGs). Prostaglandin E
(PGE), a potent vasodilator, and the antagonist vasoconstrictor
prostaglandin F2a (PGF2a), have been implicated in the modula¬
tion of blood vessel tone prior to and during menses (Baird
et at., 1996). A role in the initiation of menstruation is further
reinforced by the observed synergism between PGE and IL-8
in the infiltration of neutrophils from the peripheral circulation
(Colditz, 1990). Prostaglandins are synthesized by the cyclo-
oxygenase (COX) enzyme, which exists in two differentially
regulated isoforms (Goppelt-Streube, 1995). COX-1 isconstitu-
tively expressed in most cell types, whilst COX-2 is induced
transiently in response to inflammatory stimuli (Zweifel et at.,
1995). Decidual cells have been demonstrated to produce
COX-2 in response to IL-1 (3, and this induction can be inhibited
by dexamethasone and progesterone (Ishihara et at., 1995).
This finding reinforces the observation that prostaglandin
release from proliferative and secretory endometrium is
decreased by progesterone (Abel and Baird, 1980; Kelly and
Smith, 1987).
The present study has investigated the localization and
temporal expression of the chemokines IL-8 and MCP-1 and
also COX-2 in the endometrium throughout the menstrual
cycle and in early pregnancy.
Materials and methods
Tissue collection
Endometrial biopsies (n = 44) were collected by Pipelle suction
curette (Laboratoire CCD. Paris, France) from women undergoing
minor gynaecological procedures (Table I). All women reported
normal regular menstrual cycles (25-35 days) and had not received
any form of hormonal treatment for the preceding 3 months. Biopsies
were dated from the patient's last menstrual period (LMP) and tissue
sections were examined to ensure that histological appearances were
consistent with the date of LMP. In addition, first trimester decidua
(n = 17) collected away from the implantation site was biopsied by
curettage prior to suction termination of pregnancy. Decidua parietalis.
without trophoblast invasion, was confirmed by cytokeratin immuno-
staining. Written informed consent was obtained prior to tissue
Table I. Stages of menstrual cycle at time of biopsy collection
Stage of menstrual cycle Number of biopsies
MenstruaJ^fdays 1-4) 6
Early proliferative (days 5-7) 3
Mid-proliferative (days 8-10) 4
Late proliferative (days 11-13) 0
Peri-ovuiatorv (day 14) 0
Early secretory (days 15-18) 10
Mid-secretory (days 19-24) 9
Late secretory (days 25 to menstruation) 7
Decidua (8-10 weeks) 24
collection and ethical approval was received from Lothian Research
Ethics Committee. Tissue samples were immediately placed in OCT
embedding medium (Tissue-Tek; Miles Inc., Elkhart, USA) and snap
frozen in iso-pentane precooled with dry ice. Additionally, a sample
was immersion fixed in 10% neutral buffered formalin (NBF) over¬
night at 4°C, prior to paraffin embedding. Subsequently, 5 um
sections were cut from both the frozen and paraffin blocks for
immunohistochemical investigation.
Immunohistochem istry
Immunohistochemical protocols for the detection of MCP-1 and
COX-2 were optimized to determine the correct conditions for
maximal specific staining. Methodology for the immunoiocalization
of the chemokine IL-8 has previously been reported (Critchiey
et al., 1994).
MCP-1
Immediately prior to staining, frozen sections were lightly fixed in
10% NBF for 10 min at room temperature. Sections were then washed
in 0.1 M phosphate-buffered saline (PBS) pH 7.4-7.6. Endogenous
peroxidase activity was quenched by immersion of the slides in 3%
hydrogen peroxide (FLO;! BDH Laboratory Supplies, Poole. UK) in
distilled water for 5 min at room temperature. Following 10 min
washing in PBS, diluted non-immune goat serum (Vectastain Elite
PK-6101; Vector Laboratories. Peterborough, UK) was applied to
each slide and the slides were incubated for 20 min in a humidified
chamber. The excess serum was carefully blotted off and 50 pi of
MCP-1 antibody (raised in rabbits using a chemically synthesized 77
amino acid MCP-1 as the antigen) was applied at a dilution of 1:400
in PBS. Coverslips were placed over the tissue sections to minimize
antibody evaporation and the slides were incubated overnight (17 h —
1) at 4°C. Following primary antibody binding, an avidin-biotin
peroxidase detection system was utilized, involving the sequential
application of biotinyiated goat anti-rabbit IgG (Vectastain Elite PK-
6101, Vector Laboratories) and a complex of avidin and biotin with
horseradish peroxidase (ABC Vectastain 4002; Vector Laboratories).
The positive binding was then identified by the application of the
peroxidase substrate 3, 3'-diaminobenzidine (DAB, Vector SK-4100;
Vector Laboratories) which produces a brown stain representing the
presence of MCP-l. Sections were then washed in distilled water and
lightly counterstained with Harris's haematoxylin (Pioneer Research
Chemicals Ltd. Colchester, UK), a non-specific purple nuclear stain.
Following washing in tap water, the sections were dehydrated in
ascending grades of ethanol and mounted from xylene with Pertex
mounting medium (Cellpath pic, Hemel Hempsted. UK).
IL-8
A similar protocol was used for IL-8 immunoiocalization, with the
exception of an incubation period of 60 min at 37°C with the primary
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rabbit polyclonal antibody raised against the IL-8 peptide, at a dilution
of 1:500.
COX-2
Immunostaining for COX-2 was conducted on paraffin sections.
These were dewaxed in Histoclear (National Diagnostics. Atlanta.
Georgia. USA), and rehyarated through descending grades of ethanol.
Prior to endogenous peroxide blocking, a microwave antigen retrieval
technique was utilized, whereby the sections were heated in sodium
citrate buffer (pH 6.0) for 10 min at high power followed by a 20
min incubation in the oven. A similar protocol as for MCP-l was
then continued, with the exception of 60 min incubation periods with
the primary antibody (PG27. rabbit polyclonal: Oxford Biomedical.
Biogenesis. Poole. UK) diluted 1:250 at 37°C. the secondary antibody
and the tertiary ABC Elite (Vectastain Elite PK-6101: Vector Laborat¬
ories), both at room temperature.
Controls
Frozen tonsil tissue sections were included as a positive control for
both chemokine immunostaining procedures, and were treated in an
identical fashion. COX-2 immunoreactivity was confirmed by the
inclusion of third trimester fetal membranes in each staining run. To
assess the specificity of the immunoreactivity. serial sections of
representative slides were also included and either non-immune rabbit
IgG or primary antibody preabsorbed with the appropriate synthetic
peptide (IL-8 or MCP-l) (100 ,ug/ml) was substituted for the
primary antibody.
Scoring and analysis of immunostaining
A semi-quantitative scoring system was employed for assessment of
intensity and localization of immunoreactivity in the entire tissue
section, where a score of 0 indicates an absence of immunoreactivity,
1 faint immunoreactivity, 2 strong immunoreactivity and 3 veiy
intense immunoreactivity. Scoring was conducted blind to the stage
of the cycle, randomly by one observer. Analysis of variance (ANOVA)
with Fisher's PLSD to assign significance was used to evaluate
whether or not there were significant differences in the expression of
the mediators.
Results
The local mediators, MCP-l, IL-8 and COX-2, were detected
by immunohistochemistry in samples of endometrium from
non-pregnant and pregnant women (see Figure 1). Immuno¬
staining was primarily present in the perivascular cells around
all blood vessel types in the endometrial stroma for MCP-l
and IL-8, although weaker immunoreactivity was identified in
the glandular epithelium. Additional staining was detected for
MCP-I in the cytoplasm of a subpopulation of stromal cells
in occasional aggregates in some decidual biopsies. Intense
immunoreactivity for COX-2 was detected in the epithelial
glands and perivascular cells. In the menstrual phase and in
some of the decidual sections examined, a degree of stromal
staining was observed.
Tonsil sections included as a positive control for MCP-l
and IL-8 immunostaining also exhibited perivascular immuno-
staining. Immunoreactivity for COX-2 in third trimester fetal
membranes was detected primarily in the amniotic epithelium
and chorion laeve trophoblast, with slight immunostaining in
the attached decidual cells, in agreement with published
data (Gibb and Sun, 1996). Antibody preabsorbed with the
appropriate peptide, or non-immune rabbit IgG applied to
serial tissue sections to act as a negative control, resulted in
an absence of immunoreactivity.
MCP-l
MCP-l immunoreactivity was detected in a cyclical pattern
during the menstrual cycle (Figure 2). Throughout the prolifer¬
ative phase MCP-l immunostaining was relatively intense. A
distinct reduction in staining intensity was observed in the
periovulatory phase and levels remained low in the early and
mid-secretory stages. In the premenstrual or late secretory
phase, however, immunostaining increased significantly (P <
0.05) compared with the periovulatory stage. First trimester
decidua exhibited reduced immunoreactivity with respect to
premenstrual levels, comparable with mid-secretory immuno¬
staining.
IL-8
The intensity of IL-8 immunostaining also varied throughout
the menstrual cycle (Figure 3). Low levels were detected in
the perivascular cells in the menstrual and proliferative phases
of the menstrual cycle. As for MCP-I, there was a clear
reduction in staining intensity in the periovulatory phase,
although this did not reach significance. Immunostaining levels
increased slightly in the early and mid-secretory phase, but a
highly significant increase (P < 0.001) in staining intensity
was apparent in the late secretory phase in comparison with
the ovulatory and early secretory phase. In the decidua.
lower levels of IL-8 immunoreactivity .compared to MCP-l
immunostaining levels were observed. The average immuno¬
reactivity was significantly (P < 0.01) lower than that observed
premenstrually and was consistent with the expression of IL-8
in the mid-secretory phase.
COX-2
COX-2 immunoreactivity was observed at all stages of the
menstrual cycle (Figure 4). Both glands and vessels exhibited
intense immunostaining in the menstrual phase. In the prolifer¬
ative stage, levels of immunoreactivity decreased slightly and
lower levels still were detected in the ovulatory phase. This
pattern continued through the early and mid-secretory phases
and a significant increase in COX-2 immunoreactivity was
observed in the late secretory phase (glandular P < 0.01,
vessels P < 0.05). Glandular immunoreactivity remained high
in early decidua whilst perivascular staining appeared to be
reduced (not significant).
Discussion
MCP-l, IL-8 and COX-2 were localized in the endometrium
and decidua by immunohistochemistry. The localization of
these chemotactic agents to the perivascular cells in both
pregnant and non-pregnant endometrium is consistent with a
putative role in the recruitment of specific leukocytes from the
vasculature. Elevated levels of chemokine immunoreactivity
were detected in the premenstrual phase of the menstrual
cycle. These findings support the hypothesis that migration of
leukocytes from the peripheral circulation contributes to the
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Figure 1. Immunohistochemical localization of IL-8, MCP-1 and COX-2 in human endometrium. (A) Periovulatory endometrium
irimiunostained for IL-8. Faint immunoreactivity is apparent around small vessels. (B) Increased intensity of perivascular IL-8
immunoreactivity in late secretory endometrium. (C) MCP-1 immunoreactivity in periovulatory endometrium, demonstrating an absence of
iimmtuostaining. (D) First trimester decidua exhibits a marked increase in MCP-1 immunostaining intensity, in the perivascular cells of all
vessels. (E) COX-2 immunoreactivity in periovulatory endometrium. Faint immunostaining is observed in the glandular epithelium and
vessels. (F) Premenstrual endometrium exhibits intense immunostaining for COX-2 in both epithelial glands and perivascular cells.
(G) Additional stromal immunoreactivity is observed in menstrual endometrium. (H) Negative control for MCP-1, decidual section treated
with antibody preabsorbed with MCP-1 peptide. Scale bars, 50 pm, V = vessel.
significant leukocyte accumulation observed premenstrually.
Furthermore, the co-localization of COX-2 in the perivascular
cells reinforces the proposed interaction of prostaglandins and
chemokines in the local inflammatory response.
The exact cell types in the perivascular region which exhibit
immunoreactivity have not been characterized. Endothelial
cells, fibroblasts and smooth muscle cells are present in this
location, and all have been demonstrated to be capable of
chemokine production (see reviews by Matsushima and
Oppenheim, 1989; Baggiolini et al., 1994). Additional
immunoreactivity was identified in a subpopulation of stromal
cells in some decidual sections. These observations may
represent a population of leukocytes with the potential for
chemokine production.
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Figure 2. MCP-1 immunoreactivicv throughout the menstrual cycle
and in early pregnancy. A significant increase in immunoreactivity
levels is apparent in the premenstrual phase with respect to the
ovulatory and early secretory phases (P < 0.05). Significant
differences between groups are denoted by matching letters. Y-axis
error bars represent the standard error of the mean (SEM).
ME. menstrual: EP, early proliferative; MP, mid-proliferative;
LP. late proliferative: OV, periovulatory: ES, early secretory;
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Figure 3. IL-8 immunoreactivity throughout the menstrual cycle
and in early pregnancy. A highly significant increase in
immunostaining occurs in the premenstrual phase compared to
levels in the ovulatory and early secretory phases (P < 0.001) and
the mid-secretory phase (P < 0.01). In early pregnancy,
significantly lower levels of immunoreactivity were detected than
premenstrually P < 0.01). Significant differences between groups
are denoted by matching letters. Y-axis error bars represent the
standard error of the mean (SEM). Abbreviations as in Figure 2.
Examination of tissues obtained throughout the menstrual
cycle and in early pregnancy revealed a cyclical pattern in the
intensity of immunoreactivity for all three mediators. Most
noticeable was the distinct reduction in staining intensity
around the time of ovulation, extending into the early secretory
phase. This coincides with the initiation of progesterone
production from the corpus luteum and peak oestrogen produc¬
tion. At this stage the endometrium is most responsive to the
effects of oestrogen and progesterone due to maximal steroid
receptor expression (Snijders et al., 1992). Furthermore, the
perivascular cells identified as the site of chemokine production
strongly express progesterone receptors throughout the cycle
(Perrot-Applanat et al., 198S; Bouchard era!.. 1991). Experi¬
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Figure 4. COX-2 immunoreactivity throughout the menstrual eve
and in early pregnancy. Glandular immunostaining is represented
by filled bars and perivascular immunostaining by white bars.
Glandular immunoreactivity was significantly elevated in the
menstrual (P < 0.01) and premenstrual phases (P < 0.001)
compared to the ovulatory phase. Perivascular immunostaining
followed a similar pattern, with a significant increase in the
premenstrual phase (P < 0.05) with respect to the early secretory
phase. Significant differences between groups are denoted by
matching letters. Y-axis error bars represent the standard error of
the mean (SEM). Abbreviations as in Figure 2.
monocytes and fibroblasts in culture is inhibited by oestrog
(Kovacs et al., 1993, 1996). A similar regulation may occ
in vivo, although the levels of MCP-1 immunoreactiv
detected during the proliferative phase would not suppi
this. The levels of chemokine and COX-2 immunoreactiv
detected remain low through the early and mid-secretc
phases, until the late secretory phase, when a significt
elevation in expression is apparent. At this stage in the nc
pregnant cycle, regression of the corpus luteum results in
drop in progesterone concentrations. If pregnancy occu
progesterone values are maintained and this corresponds tc
lower level of immunoreactivity for all three mediators. Thi
it appears that the staining intensity for all three mediators
reduced in the presence of progesterone and increased wi
declining progesterone concentrations premenstruaily. The
observations are consistent with a downreguiation of t
chemokines and COX-2 by progesterone, such as has be
demonstrated in vitro (Ito et al., 1994; Kelly et al., 199
Ishihara et al., 1995). This would represent an anti-inflai
matory action of progesterone, in the suppression of a Loc
inflammatory response at the time when fertilization ai
implantation may occur. The method by which progestero
may achieve this downreguiation is as yet unknown, b
this immunohistochemical evidence of a co-localisation
responsive cells and progesterone receptors suggests a recept
mediated indirect effect of progesterone in leukocyte migratic
Supporting evidence for a downreguiation of chemoki
expression by progesterone is the increase in the numbers
macrophages in first trimester decidua, following the pharmac
logical withdrawal of progesterone by administration of ti
antigestogen mifepristone (Critchley et al., 1996). This obser
ation may be related to an increase in chemokine expressio
The phenotypically unique natural killer-like LGI
(CD56^CD16~) are the predominant leukocyte subtype in tl
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late secretory endometrium and first trimester decidua. Their
origin is uncertain, but it has been suggested that a precursor
form may be recruited from peripheral blood into the endo¬
metrial stroma, where a subsequent activation/differentiation
occurs (King et al., 1991). A putative precursor cell type are
the CD56~CDI6~ agranular cells which comprise -1% of the
circulating NK cells (Lanier et al.. 1986). Chemotactic activity
for NK cells has been attributed to MCP-1 (Allavena et al..
1994). Further investigation is necessary to determine whether
MCP-1 may play a role in the accumulation of LGLs in the
mid-late secretory phase and in the first half of pregnancy.
IL-8 has also been implicated in the chemotaxis of lymphocytes
(Larsen et al.. 1989), and this has been linked to the LGL
infiltrate in the endometrium (Casey and MacDonald, 1993).
However, it has recently been proposed that only the C-C
chemokines (including MCP-1) and not the C-X-C subfamily,
which includes IL-8. possess chemotactic ability for T lympho¬
cytes (Roth et al., 1995).
The co-localization of IL-8 and COX-2 in the endometrium
reinforces the synergistic action of PGE in the IL-8 stimulated
recruitment of neutrophils (Colditz. 1990). Furthermore, as'
MCP-1 and IL-8 are closely related chemokines, it is possible
that PGE may also have an enhancing effect on monocyte
infiltration. Prostaglandin activity is also regulated by the
locally produced metabolizing enzyme prostaglandin dehydro¬
genase (PGDH). A positive regulation by progesterone has
been demonstrated by the reduced immunoreactivity for PGDH
following antigestogen administration in early pregnancy
(Cheng et al., 1993b). Also observed was increased immuno¬
reactivity for PGEi around the small blood vessels in the
endometrium (Cheng et al., 1993a). Thus progesterone may
affect local prostaglandin concentrations by modulating the
enzymes responsible for both their production and metabolism.
The localization of COX-2 primarily to the glandular epithe¬
lium supports the in-vitro evidence that glands are the major
site of prostaglandin synthesis in the endometrium (Lumsden
'et al., 1984; Smith and Kelly, 1988). Furthermore, whilst the
endometrium retains the ability to synthesize prostaglandins in
response to stimuli throughout the menstrual cycle, higher
levels of prostaglandins are released from isolated glands in
the proliferative than in the secretory phase and early pregnancy
(Smith and Kelly, 1988) This is consistent with a stimulation
of prostaglandin production by oestrogen (Abel and Baird,
1980), potentially through cyclooxygenase upregulation (Jun
et al., 1996), and a downregulation by progesterone.
The present study has therefore identified and immuno-
localized the inflammatory mediators MCP-1, IL-8 and COX-2
to the perivascular cells in endometrium and decidua. A
cyclical pattern of immunoreactivity has been observed, with
maximum expression of MCP-1, IL-8 and COX-2 occurring
premenstrually and coinciding with the large increase in
leukocytes in the endometrial stroma at this time. These
observations support a role for steroid-regulated chemokines
in the mechanisms determining leukocyte accumulation in
endometrium and decidua.
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.ABSTRACT
Extrapituitary PRL is synthesized by the decidualized endometrial
stromal cells from the mid to late secretory phase in the nonpregnant
cycle and throughout pregnancy. The function of PRL in the uterus
is unknown, but the temporal expression indicates a role in implan¬
tation and placentation. PRL is a powerful immunoregulatory agent,
and thus, a role in modulating endometrial leukocytes may be en¬
visaged. To investigate' the site of action of PRL. immunohistochem-
istry was conducted to localize the PRL receptor (PRL-R). In addition,
ribonucleic acid was extracted and reverse transcriptase-PCR for
PRL-R was conducted. PRL-R protein was immunolocaiized to the
glandular epithelium and a subset ofstromai cells from the mid to late
secretory phase of the menstrual cycle and in early decidua. PRL-R
transcripts were also detected from the late secretory phase and first
trimester decidua. These findings indicate that the receptor is ex¬
pressed in a temporal pattern similar to that of PRL. PRL-R expres¬
sion in the glandular epithelium is consistent with a role in regulating
glandular activity. Furthermore, immunoreactivity for PRL-R in a
subset of stromal cells may be evidence for paracrine interactions
between decidualized cells or an immunoregulatory role for PRL.
[.J Clin Endocrinol Me tab 83: 2-53—262, 1998)
EXTRAPITUITARY PRL is produced and secreted by thedecidua during pregnancy (1). The decidualized stro¬
mal cells have been conclusively shown to be the sole site of
synthesis (2). Furthermore, experimental studies have rec¬
ognized that PRL is produced by the nonpregnant endome¬
trium from the mid to late luteal phase until menses (3). This
corresponds to the initiation of decidualization during which
the stromal cells become pseudodecidualized (2), and in vitro
deciduaiization by stimulation of estrogen-primed prolifer¬
ative endometrial cells with progesterone results in PRL pro¬
duction (4). Indeed, PRL expression is now commonly used
as a marker for functional decidualization. Although pitu¬
itary and endometrial PRL are identical in structure and
function, expression is differentially regulated, which has
been attributed to the presence of a distinct promoter region
located ~6 kilobases upstream of the pituitary promoter
(5,6).
The significance of PRL expression in the endometrium is
uncertain. It is believed that PRL primarily acts as an auto¬
crine or paracrine, rather than endocrine, factor. A similar
mechanism has been reported in immune cells, where PRL
has a profound immunomodulatory effect (7). The majority
of leukocytes ubiquitously express the PRL receptor (PRL-R)
(8-11). Stimulated T cells secrete PRL (10), and in vitro PRL
enhances the proliferation of leukocytes previously stimu¬
lated with mitogenic factors, including interleukin-2 and T
and B cell mitogens (12). Furthermore, this proliferation is
inhibited by exposure to anti-PRL antibodies (13). In vivo
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studies indicate an immunosuppressive action, such as the
reduced immune response in lactating or PRL-treated cas¬
trated rats (14, 15).
The temporal expression of PRL in the endometrium sug¬
gests a role in the preparation for implantation and subse¬
quent placentation. Decidualization is essential for implan¬
tation to occur, and the specialized immune environment
within the decidua plays a major role in achieving a suc¬
cessful pregnancy. Coincidental with decidualization is the
accumulation of leukocytes in the endometrial stroma, the
majority of which are the uterine-specific large granular lym¬
phocytes and macrophages (16, 17). These persist into early
pregnancy and are believed to have a role in regulating
implantation and placentation (18). PRL may be acting as an
immunomodulatory agent in the endometrium by stimula¬
tion of either leukocyte proliferation or differentiation.
Although the production of PRL by the endometrium has
been thoroughly investigated, its site of action in the endo¬
metrium has not been fully elucidated. PRL-R have been
detected in the amniochorion, where PRL is believed to have
an osmoregulatory effect on amniotic fluid volume (19), and
additionally in third trimester decidua (20, 21). The exact
cellular localization and temporal expression in the nonpreg¬
nant and early pregnant endometrium have not been clearly
examined. The present study, by means of immunohisto-
chemistry and reverse transcriptase-PCR (RT-PCR), investi¬
gates PRL-R expression in the human endometrium at dif¬
ferent stages of the menstrual cycle and early pregnancy.
Materials and Methods
Tissue collection
Normal endometrial tissue (menstrual, n = 3; proliferative, n = 7;
ovulatory, n = 3; early secretory, n = 3; mid secretory, n = 5; late
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secretory, n = 6) was collected from fertile women with regular men¬
strual cycles (25-35 days) who were undergoing minor gynecological
procedures. Decidua parietalis (n = 8) was obtained by curettage before
surgical termination of first trimester pregnancies. Written informed
consent was received before tissue collection, and ethical approval was
received from Lothian research ethics committee. Tissue samples were
fixed by immersion in 10% neutral buffered formalin overnight at 4 C
and stored in 70% ethanol before routine paraffin embedding. In addi¬
tion, a sample was snap-frozen in isopentane precooled with dry ice and
stored at -70 C. Ribonucleic acid (RN'A) was subsequently extracted
using U'ltraspec RN'A Isolation System (Biogenesis, Pooie, UK). The
RN'A yield was estimated by measuring absorbance at 260 nm by spec-
trophometrv, and Duritv was assessed bv the ratio of absorbance at
260:280 nm.'
[mmunohistochemistry
The conditions for optimal specific immunoreactivitv were deter¬
mined. Paraffin sections (5 ,u.m) were dewaxed in Histociear (National
Diagnostics, Atlanta, GA) and rehydrated through descending grades
of ethanol to distilled water. Endogenous peroxidase activity was
quenched by immersion in 3% hydrogen peroxide (H20:, BDH Labo¬
ratory Supplies, Poole, UK) in distilled H30 for 5 min. Nonspecific
binding was reduced by a 20 minute incubation with nonimmune goat
serum (Vectastain Elite, Vector Laboratories, Peterborough, UK) in a
humidified chamber at room temperature, after which the primary an¬
tibody (rabbit polyclonal raised against a rat peptide sequence common
to the short and long forms of the receptor, supplied by Dr. P. Ingieton,
University of Sheffield, Sheffield, UK) (22) was applied at a dilution of
1:50. The slides were incubated overnight (17 r: 1 n) at 4 C. Antibody
binding was detected by the sequential application of biotinylated goat
antirabbit IgG and an aviain-biotin-peroxidase complex (ABC Vec¬
tastain, Vector Laboratories, Peterborough, UK). The substrate 3,3'-dia-
minobenzidine (Vector Laboratories) was then used to visualize positive
immunoreactivitv. Finally, sections were counterstained with Harris's
hematoxylin (Pioneer Research Chemicals, Colchester, UK), dehydrated
in ethanol, and mounted from xylene (BDH Laboratory Supplies).
Human term fetal membranes were included as a positive control for
the PRL-R immunohistochemistry (21). A matching concentration of
nonimmunized rabbit TgG was substituted for the primary antibody to
exclude the possibility of nonspecific binding.
RT-PCR
Total RNA extracted from tissue collected at all stages throughout the
menstrual cycle (proliferative, n = 12; secretory, n = 12) and in early
pregnancy (n = 6) was subjected to RT-PCR for PRL-R.
Glyceraldehyde phosphate dehydrogenase (GAP-DH)
To ensure equivalent loading of viable RNA for the PRL-R RT-PCR,
the expression level of the housekeeping gene GAP-DH was monitored
by RT-PCR. Oligonucleotide primers for GAP-DH (sense; 5'-TGA AGG
TCG GAG TCA ACG GAT TTC GT-3'; antisense, 5'-CAT GTG GGC
CAT GAG GTC CAC CAC-3') were designed to produce a 1103-bp
product. A sample of 400 ng total RNA was reverse transcribed to
complementary DNA (cDNA) using avian myeloblastosis virus RT (Pro-
mega, Southampton, UK) and subsequently amplified by PCR using
AmpliTaq DNA polymerase (Perkin-Elmer, Beaconsfield, UK) for 28
cycles at 94 C for 1 min, 60 C for 1 min, and 72 C for 2 min, followed
by a final extension for 10 min at 72 C. Analysis of products by elec¬
trophoresis enabled assessment of viability of RNA, and bands of com¬
parable intensity indicated comparable RNA loading into the RT-PCR.
PRL-R
Oligonucleotide primers complementarv to the extracellular domain
of the PRL-R were used (sense, 5'-CCA GAT GCA GGA CTT CCT ACC
AAT TA-3' antisense, 5'-GCA GGT CAC CAT GCT ATA GCC CTT-3'),
flanking bp 154-794, to amplify by RT-PCR a 650-bp product. The
primers chosen spanned intronic sequences to ensure against the pos¬
sibility of genomic DNA contamination. Firstly, gene-specific cDNA for
PRL-R was generated by the reverse transcription of 400 ng total RNA
from stocks identical to those used for GAP-DH, using the antisense
oligonucleotide primer at 42 C for 45 min. The total volume of RT
products was then amplified by PCR for 30 cycles at 94 C for 1 min, 62
C for 1 min. and 72 C for 2 min, followed by a 10-min final extension
at 72 C. Sheep pituitary RNA was included as a positive control for the
RT-PCR (23), and the omission of template RNA served as a negative
control. The products were analyzed by comparison with a mol wt
marker (PCR Marker, Sigma, Poole. UK) on a 1% agarose gel containing
ethidium bromide.
The identity of the RT-PCR product was confirmed by subcloning into
expression vector pGE.M-T Easy Vector (Promega) and sequenced using
the dideoxy chain termination method.
Southern hybridization
The identity of the amplified PRL-R products were further confirmed
by Southern hybridization (24). Representative RT-PCR products, am¬
plified from RNA extracted at different stages throughout the menstrual
cycle, were selected for analysis. The products were separated bv elec¬
trophoresis on a 1% agarose gel and blotted overnight onto a nylon
membrane by capillary transfer. Hybridization was conducted over¬
night at 42 C with a 562-bp cDNA, labeled with (a-32P]deoxv-CTP by
random priming, encoding the conserved extracellular domain (82%
homology with human PRL-R cDNA) of the red deer PRL-R (between
bp 96 and 657) (25). Posthvbridization washes in SSC (standard saline
citrate) and SDS were conducted with increasing stringency, and the
membrane was thereafter exposed to autoradiographic film for 3 weeks.
Results
Specific immunoreactivitv for PRL-R was detected in en¬
dometrium and decidua by immunohistochemistry (Fig. 1).
In the proliferative and early secretory phases of the non¬
pregnant cycle, immunostaining was weak or absent in the
stroma, with minimal immunoreactivity visible in the lumi¬
nal region of the glandular epithelium. From the mid to late
secretory phase and in early pregnancy, intense immunore¬
activity was apparent in both the glands and a subpopulation
of stromal cells. In addition, positive immunostaining was
identified in the blood vessels of some of the deciduaiized
endometrial tissues. Fetal membranes included to act as a
positive control exhibited positive immunoreactivity in the
amniotic epithelium, chorion-laeve trophoblast, and decid¬
ual laver as previously reported (21). Substitution of the
primary antibody with rabbit IgG resulted in an absence of
staining in fetal membranes and endometrial and decidual
sections.
After PRL-R RT-PCR, a single band of 650 bp was detected
by gel electrophoresis, corresponding to the region of the
PRL-R gene amplified. Confirmation of its identity was ob¬
tained by Southern hybridization (Fig. 2), and sequence anal¬
ysis verified that the amplicon encoded human PRL-R. A
band representing PRL-R was detected in the tissue biopsied
during the menstrual phase (days 1-4). During the prolif¬
erative and early secretory stages, the signal was either weak
or absent. From the mid to late secretory phase, however, a
strong signal was detected, with increasing intensity in sam¬
ples obtained from early pregnancy (Fig. 3). A GAP-DH
signal of comparable intensity (1103 bp) was obtained from
all samples, indicating that equivalent amounts of RNA were
loaded into the RT-PCR (Fig. 3). Furthermore, the presence
of a GAP-DH signal in the absence of a PRL-R signal indi¬
cated that this was not due to an absence of viable RNA, but
to the inability to detect PRL-R messenger RNA in the RNA
sample. Overall, although this method is not totally quan-
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Fig. 1. PRL-R immunolocalization in
human endometrium. Minimal immu-
noreactivity is observed in the prolifer¬
ative phase (A) and early secretory
phase (B) endometrium. In the mid to
late secretory phase (C), intense immu-
nostaining is present in the epithelial
glands and a subpopulation of stromal
cells. This pattern persists in first tri¬
mester decidua (D), and at higher power
(E) the decidualized stromal cells
clearly exhibit strong immunoreactiv-
ity. Immunostaining is also apparent in
the decidual vasculature (v). The nega¬
tive control (F), in which the primary
antibody was substituted with nonim¬
mune rabbit IgG, results in an absence
of staining. G, Glandular epithelium.
Scale bars = 50 p.m.
RT-PCR
650bp —jjjjj
LS DE LS DE
Fig. 2. RT-PCR for PRL-R generated a 650-bp amplified product, as
identified by comparison with a mol wt marker. The identity of the
amplicon was confirmed by Southern blotting (SB) and hybridization
with a 562-bp cDNA probe raised against the conserved extracellular
domain. LS, Late secretory; DE, decidua.
titative, these data suggest that PRL-R expression is up-
regulated in the mid to late secretory phase and continues in
early pregnancy.
Discussion
This study confirms the expression of the PRL-R in endo¬
metrium and decidua. Immunohistochemical localization re¬
vealed that the PRL-R is strongly expressed by the glandular
epithelium and stromal cells in pseudodecidualized and de¬
cidualized endometrium. Immunostaining was minimal or
absent in proliferative and early secretory phase endome¬
trium. This temporal pattern of expression was confirmed by
the amplification of PRL-R messenger RNA by RT-PCR, with
the detection of a strong signal from the mid to late secretory
phase of the nonpregnant cycle and in earlypregnancy. Thus,
the temporal expression of the receptor appears to mirror
that of PRL by the decidualized endometrium.
It seems likely that progesterone has a role in the regula¬
tion of PRL-R expression (26). It is unlikely to be a direct
regulation, however, as is the case for PRL, whose produc¬
tion is stimulated and maintained by the progesterone-me¬
diated decidualization of the endometrium (27, 28). Regu¬
lation via decidua-derived factors (29) or even PRL itself may
be envisaged (30-32). An indirect regulation by progesterone
is firmly supported by the absence of progesterone receptors
in the glandular epithelium when PRL-Rs are expressed.
The detection of strong immunoreactivity for the receptor
in the epithelial glands suggests a paracrine action for PRL.
During the early secretory phase, the endometrial glands
become tortuous and actively produce uterine secretions,
which are vital for preparing the endometrium for implan¬
tation (33). During the decidualization of the uterine stroma
and continuing into pregnancy, the glandular epithelium
SB
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Me P OV ES MS IS LS OE OE Pit - M
GAP-DH
- 1103bp
Me P OV ES MS LS LS DE OE Pit - M
Fig. 3. RNA extracted from tissues from each stage of the menstrual
cycle and early pregnancy was subjected to RT-PCR to determine the
temporal expression of PRL-R. The upper panel shows representative
RNA samples amplified for GAP-DH (amplicon size, 1103 bp), indi¬
cating the comparable loading of viable RNA into the PRL-R RT-PCR.
The lower panel shows the same RNA samples amplified for PRL-R
(amplicon size, 650 bp). No signal was obtained in the menstrual (Me),
proliferative (P), ovulatory (OV), or early secretory (ES) phases. From
the mid and late secretory phases (MS/LS), a signal was achieved,
which increased in intensity in early pregnancy (DE. decidual. Pitu¬
itary (Pit) RNA was included as a positive control, yielding a band of
identical size. No signal was observed for the negative control (—).
becomes atrophic, and glandular secretory activity ceases.
PRL has been reported to possess osmoregulatory activity,
and the large amounts of PRL detectable in amniotic fluid act
as a regulator of amniotic fluid volume. This was demon¬
strated by a link between defective PRL-R expression in
amniotic epithelium and the incidence of polyhydramnios
(19). The presence of PRL-R in the glandular epithelium
during decidualization implicates a similar role for PRL, i.e.
in the down-regulation of glandular activity.
Additional immunoreactivity was observed in a subset of
stromal cells. The identity of these stromal cells is unknown,
although the majority display morphological characteristics
of decidualized stromal cells. This further supports the like¬
lihood of the existence of an autocrine and/or paracrine
interaction between PRL and its receptor. Further colocal-
ization studies are required to determine whether the PRL-
producing cells concurrently express the receptor. Positive
immunostaining for the receptor was detected in the vascu¬
lature of some decidualized endometrial samples examined.
The perivascular cells frequently exhibited immunostaining
as expected, as this is the site of initiation of deciduaiization
in the endometrium. Occasional staining was also observed
that appeared to be endothelial in nature. A 16-kDa N-ter-
minal fragment of human PRL has been noted to be a potent
inhibitor of angiogenesis (34), and a high affinity binding site
has been previously identified on endothelial cells (35).
PRL has important immunoregulatory functions in the
peripheral immune system, including leukocyte prolifera¬
tion, differentiation, and function. An important feature of
the premenstrual endometrium and first trimester decidua is
the accumulation of leukocytes within the decidualized
stroma. These are believed to be essential for successful im¬
plantation and placentation (16), but the mechanism respon¬
sible for the increase in the secretory phase is not fullv un¬
derstood. Of particular interest are the uterus-specific large
granular lymphocytes. It has been speculated that PRL may
have a role in their proliferation and/or differentiation, es¬
pecially after the discovery that these cells, although clearlv
under the influence of progesterone (36), do not express sex
steroid receptors (37). The effect of PRL treatment on these
decidual lymphocytes has been examined (36, 37), but both
studies failed to observe a resultant proliferation or differ¬
entiation. It is not unlikely, however, that PRL may have an
effect on decidual leukocytes, acting indirectly through au¬
tocrine/paracrine factors produced by neighboring cells.
It is probable that the migration of specific leukocytes from
the peripheral circulation also contributes to the increase in
leukocyte numbers. This is supported by the elevated levels
of the chemokines interleukin-8 and monocyte chemoattrac-
tant protein-1 in the endometrium during leukocyte accu¬
mulation (38). PRL may be involved in enhancing this re¬
cruitment, as recent data reveal that the production of
monocyte chemoattractant protein-1 is stimulated by PRL in
ovarian tissue (39). A number of roles for PRL in the immu-
nomodulation of the uterine leukocytes can thus be visual¬
ized, with a potential for augmenting lymphocyte migration,
differentiation, and proliferation. It remains to be deter¬
mined whether the endometrial leukocytes express the
PRL-R.
In third trimester amniochorion, PRL has been implicated
in the enhancement of matrix metalloproteinase activity (21,
40). During menses and placentation in early pregnancy, a
dramatic reorganization of extracellular matrix must occur to
allow endometrial shedding and trophoblast invasion, re¬
spectively. These processes invariably involve the action of
matrix metalloproteinases, and it is possible that PRL may
participate as one of the factors capable of altering the ac¬
tivities of these enzymes in the endometrium.
In summary, this study clearly demonstrates the expres¬
sion of PRL-R in decidualized nonpregnant and pregnant
endometria, with a temporal pattern similar to that of PRL.
Immunohistochemical studies have isolated the glands and
a subset of stromal cells as sites of action foi PRL. PRL has
multiple functions throughout the body, including roles in
growth, differentiation, and immune response, and it is
therefore difficult to isolate a single function for PRL in the
uterus. It is, however, likely that PRL plays an important role
in immunoregulation and additionally in the decidualization
of both stromal and glandular cells of the endometrium.
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Irregular bleeding remains a common reason for the
discontinuation of progestin-only contraception. The levon¬
orgestrel releasing intrauterine system (LNG-IUS) has
profound morphological effects upon the endometrium.
Specific features are gland atrophy and extensive decidual
transformation of the stroma. Morphological changes in
the endometrium may be associated with perturbation of
mechanisms regulating normal endometrial function. This
study describes endometrial stromal and glandular features
prior to and up to 12 months following insertion of
the LNG-IUS. Comparison is made with first trimester
decidua. In order to elucidate further mechanisms govern¬
ing endometrial function with local intrauterine delivery
of LNG, we here report histological features consistent
with decidualization; a significant increase in granulocyte-
macrophage colony stimulating factor (GM-CSF) immuno-
reactivity in decidualized stromal cells; glandular and
stromal prolactin receptor expression and an infiltrate of
CD56+ large granular lymphocytes and CD68+ macro¬
phages. We are unaware of previous reports which have
documented longitudinally both morphological and func¬
tional observations in endometrium exposed to local intra¬
uterine levonorgestrel delivery. These studies demonstrate
that long-term administration of intrauterine levon¬
orgestrel results in features of altered morphology and
function. No correlation was apparent between the end
points in the study and the bleeding patterns described by
the subjects. Further evaluation of these features in the
context of menstrual bleeding experience may contribute
to a better understanding of this troublesome side-effect
which often leads to dissatisfaction and discontinuation of
the intrauterine system.
Key words: decidualization/GM-CSF/intrauterine levonorges-
trel/prolactin receptor/leukocytes
Introduction
Irregular bleeding remains the single most common indication
for discontinuation of progesterone-only methods of contracep-
© European Society for Human Reproduction and Embrvolosy
tion (Findlay, 1996) and the aetiology of this frequent complaint
is not understood. Few data exist concerning endometrial
stromal changes in users of progestin only contraception.
Indeed attention has been drawn to the fact that the 'short
phase of decidualization' observed following commencement
of progesterone only contraception may be transient and thus
the cells are not 'true decidual cells' with the consequence
that factors not normally associated with decidual cells may
be produced (Findlay, 1996).
Steroid releasing intrauterine devices have profound rnorpho-
logical effects on the endometrium. Specific features are
suppression of proliferative activity and atrophy with extensive
decidual transformation of the stroma (Silverberg era/., 1986;
Sheppard, 1987). Intrauterine devices elicit characteristic local
changes in leukocyte populations within the endometrium,
including infiltration of macrophages, lymphocytes and neutro¬
phils which appear in the stroma and epithelium (Sheppard,
1987). Mechanisms concerned with leukocyte distribution in
the endometrium of IUD users are not known. During the
normal menstrual cycle there is a late secretory phase increase
in stromal leukocytes (Bulmer era/., 1988) with a pre-menstrual
increase in stromal macrophages (Kamat and Isaacson, 1987).
Both the late secretory phase endometrium and early decidua
contain a significant population of leukocytes, the majority of
which are CD56+ large granular lymphocytes (LGL) (King
and Loke, 1991).
The temporal expression of prolactin in the uterus implicates
a role for this hormone in decidualization and hence implanta¬
tion (Wu et al, 1995). Prolactin is an immunoregulating agent
and may play a role in leukocyte function. Our group (Jones
et al., 1998) has recently reported the localization of the
prolactin receptor protein in glandular epithelium and some
stromal cells from the mid to late secretory phase of the
menstrual cycle and in first trimester decidua, coinciding with
the onset of decidualization.
Few data are available concerning endometrial cytokines
and their role in mechanisms concerned with endometrial
bleeding. Granulocyte-macrophage colony stimulating factor
(GM-CSF) is an activating growth factor for granulocytic and
monocytic cells. Human GM-CSF is considered to be steroid-
regulated (Sharpe-Timms era/., 1994). GM-CSF is synthesized
by epithelial cells in the murine pregnant and non-pregnant
uterus (Robertson et al., 1992) and is likely to be regulated in
the mouse primarily by oestrogen. In the human, epithelial
cells are the major contributor to production (Giacomini
et al., 1995) and variations are reported in the level of
immunohistochemical expression of GM-CSF in endometrial
epithelial cells (Sharpe-Timms et al., 1994). Furthermore,
GM-CSF production by resident leukocytes (macrophage and
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large gTanular lymphocytes) has been demonstrated (Jokhi
et al., 1994). A potential role for endometrial GM-CSF in
macrophage recruitment into the stroma has been reported in
rodents (Robertson and Seamark, 1992).
This study describes endometrial stromal and glandular
features prior to and up to 12 months following insertion of a
levonorgestrel-releasing intrauterine system (LNG-IUS;
Mirena, Leiras Oy, Finland). The LNG-IUS has an inert frame
on which a silastic capsule has been attached to the vertical
arm, releasing 20 jig levonorgestrel every 24 h to the uterine
cavity from a total load of 52 mg LNG (Luukkainen et al.,
1990). A comparison has been made with the morphological
features of first trimester decidua.
Materials and methods
Ethical approval for the study was obtained from Lothian Research
Ethics Committee (reference: 1702/94/6/44). Informed consent was
obtained from 14 women aged between 32 and 48 years (median age
is 37 years). All subjects were fertile, described regular menstrual
cycles (cycle length 25-35 days) and were not using hormonal or
intrauterine contraception in the 6 months prior to inclusion in the
study. The indication for insertion of the LNG-IUS was either for
contraception (n = 10) or heavy menstruation (n = 4). The study
was longitudinal with each subject acting as her own control. All
subjects underwent a pre-insertion endometrial biopsy either in the
proliferative (n = 7) or secretory (n = 7) phase of the cycle. The
stage of the cycle prior to LNG-IUS insertion was denned according
to the criteria of Noyes et al. (1950). Biopsies were performed in an
outpatient setting with a pipelle suction curette (Laboratoire CCD,
Paris, France). Further endometrial samples were collected 1, 3, 6
and 12 months following insertion of the LNG-IUS. Once the LNG-
IUS was in situ, the histological appearance of endometrium samples
was indistinguishable whether collected in the follicular or luteal
phase, hence data at time period of 1, 3, 6 and 12 months were pooled.
In addition decidual tissue was collected from ten women (8-10
weeks amenorrhoea) undergoing surgical termination of pregnancy.
Decidual biopsies were stained with a monoclonal antibody against
cytokeratin to confirm absence of trophoblast tissue (decidua
parietalis). All endometrial and decidual tissue samples were fixed
overnight in 10% neutral buffered formalin at 4°C, rinsed and stored
in 70% ethanol and thereafter routinely wax embedded. Five micron
sections were cut for routine histopathology (haematoxylin and
eosin staining) and immunohistochemical localization of granulocyte
macrophage colony stimulating factor (GM-CSF); prolactin receptor,
CD56+ large granular lymphocyte (LGL), macrophage (CD68) and
neutrophil elastase immunoreactivity. Our laboratory has recently
described the localization of progesterone receptors (subtypes A +
B) and oestrogen receptors in normal endometrium and decidua
(Wang et al., 1998) and in endometrium exposed to intrauterine LNG
(Critchley et al., 1998).
Immunohistochemistry procedures
Prolactin receptor immunolocalization
Paraffin sections were dewaxed and rehydrated through descending
grades of ethanol to distilled water. The sections were then washed
twice in 0.1 M phosphate buffered saline (PBS) for 5 min. Endogenous
peroxidase activity was quenched by immersion in 3% hydrogen
peroxide (H2O2, BDH Laboratory Supplies, Poole, UK) in distilled
water for 5 min and then sections were again washed. Non-specific
binding was reduced by a 20 min incubation with non-immune goat
serum (Vector Stain Elite®; Vector Laboratories, Peterborough, UK)
in a humidified chamber at room temperature, following which the
excess was carefully removed and the primary antibody (Nevalainen
et al.. 1996) (rabbit polyclonal raised against a rat peptide sequence
common to the short and long form of the receptor, kindly supplied
by Dr P. Ingleton, University of Sheffield) was applied at a dilution
of 1:50. Slides were incubated overnight (17 r 1 h) at 4°C. Antibodv
binding was detected by the sequential application of biotinylated
goat anti-rabbit IgG and an avidin biotin peroxidase complex (ABC
Vector Stain®; Vector Laboratories).
The substrate 3,3' diaminobenzidine (DAB, Vector Laboratories)
was then utilized to visualize positive immunoreactivity. Finally,
sections were counter-stained with Harris' haematoxylin (Pioneer
Research Chemicals Ltd, Colchester, UK), dehydrated and cleared in
xylene before mounting in Pertex® (Cellpath, Hemel Hempstead, UK).
Positive controls included for the prolactin receptor immunohisto-
chemistry were sheep pituitary sections (Tortonese et al., 1996) and
human term fetal membranes (Maaskant et al., 1996). Negative
controls had an equivalent concentration of non-immune rabbit
immunoglobulin substituted for the primary antibody to exclude the
possibility of non-specific binding.
Granulocyte macrophage colony stimulating factor (GM-CSF)
Immunolocalization
A similar protocol as above was used for the localization of GM-
CSF. The primary antibody was raised in the mouse against human
GM-CSF (GM-CSF (ZM-213), Genzyme Diagnostics, Kent, UK].
Incubation with the primary monoclonal antibody at a dilution of
1:75 took place for 90 min at 37°C. Thereafter the protocol was
similar to that employed for prolactin receptor. Tris buffered saline
(TBS) was used throughout instead of PBS. The second antibody
was a horse anti-mouse antibody (Vector Laboratories) and the
avidin biotin peroxidase complex ABC Elite® (Vector Laboratories).
Negative controls were performed by replacing the primary antibody
with mouse immunoglobulin at the same dilution (1:75).
The positive controls were a GM-CSF expressing cell line (MG-
63 cells, derived from a male osteosarcoma cell line and gift of Dr
Fouad Habib, Western General Hospital, Edinburgh). MG-63 cells
were grown up on Chamber slides (Nunc Inc. Naperville, IL, USA).
After fixation, the MG-63 slides were stored in 70% ethanol until
use. Cells were first washed separately in TBS for 5 min and then
included as a positive control.
Leukocyte immunolocalization
Sections (5 pm) from formalin-fixed, paraffin embedded biopsies
were cut for immunohistochemical localization of (i) macrophages
(CD68, DAKO, Code M876); (ii) CD56+ lymphocytes (Zymed, San
Francisco, CA, USA); (iii) neutrophil elastase (DAKO Neutrophil
Elastase, Code M752). Tissue sections were dewaxed and rehydrated.
Non-specific endogenous peroxidase activity was blocked by treatment
with 3% hydrogen peroxide in distilled water for 5 min at room
temperature. Pre-treatment of the sections was necessary for localiz¬
ation of macrophages and CD56+ lymphocytes as described below.
For macrophage (CD 68) immunostaining, tissue sections were
exposed to an enzyme digestion with 0.1% trypsin in 0.1% calcium
chloride at pH 7.8. The digestion was conducted at 37°C for 25 min
and subsequent enzyme activity removed by washing in tap water.
For CD56+ lymphocyte immunostaining, tissue sections were
microwaved at high power in 0.01 M sodium citrate buffer (pH 6.0)
for 20 min then allowed to stand for a further 20 min. Sections were
washed in buffer prior to a non-immune block.
Thereafter all sections were exposed to a non-immune block with
normal horse serum for 20 min at room temperature. Tissue sections
were subsequently incubated with the appropriate primary antibody:
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Figure 1. Photomicrograph of endometrium exposed to intrauterine
levonorgestrel for 3 months. The glands are narrow and inactive
and the stroma is typically decidualized. There is a scanty
granulated lymphocyte infiltrate. Original magnification X185.
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Figure 2. An exampie of the spindle-celled pattern of pseudo-
decidualization of the stroma. The central gland is very narrow and
inactive. Levonorgestrel intrauterine system in situ for 12 months.
Original magnification X185.
(i) macrophage antibody (CD68) dilution 1:50 for 60 min at 37°C;
(ii) CD56 antibody dilution 1:250 for 60 min at 37°C;
(iii) neutrophil elastase antibody dilution 1:50 for 60 min at 37°C.
Sections were labelled with an avidin-biotin-peroxidase detection
system (Vector Stain®; Vector Laboratories). Colour development
employed diaminobenzidine (DAB) solution for 2-10 min. Sub¬
sequently tissue sections were counterstained with haematoxylin,
dehydrated and cleared in xylene and mounted in Pertex. Negative
controls were conduced by replacing the primary antibody with non-
immunized mouse immunoglobulin at the same concentration as the
primary antibody.
Immunostaining intensity and distribution of epitopes in all tissue
sections were assessed semi-quantitatively, on a four point scale: 0 =
no staining, 1 = faint staining, 2 = moderate staining, 3 = intense
staining. Scoring was performed blind by two observers. The mean
and standard error of mean (rSEM) was calculated. The data were
analysed by one-way analysis of variance (ANOVA), using Fisher's
PLSD coefficient to assign significance.
Results
Histology
The LNG-IUS produced widespread morphological changes
in the endometrium (Figures 1 and 2). The histological changes
were not limited to the contact site although typical contact
site changes were observed in the majority of cases. The
superficial part of the endometrium formed cushions of rather
oedematous, spindle-celled, pseudo-decidualized stroma
(Figure 2) and occasionally, microscopic, oedematous, surface
micropapillae were seen. In biopsies where the progestational
effect was long-standing, the endometrial decidualization
remote from the device was spindle-celled and diminished in
intensity whilst the decidualization nearest to the device
remained more typical with 'rounded' cells rather than spindle
cells. Glands in the superficial part of the endometrium were
extremely narrow, whilst those in the deeper layers were
slightly wider and lined by an epithelium which was cubo-
columnar in contrast to the ceils lining the superficial glands
which were flattened cuboidal. In a small number of biopsies




Positive immunostaining (brown) for GM-CSF was observed
in the cytoplasm of glandular and surface epithelial cells in
normal endometrium. In early decidua (Figures 3A and 4)
positive immunoreactivity in epithelial and decidualized
stromal cells, especially in a perivascular location, was noted.
Immurioreactivity tended to be heterogeneous. Regions where
decidualization was marked demonstrated strongest immuno¬
reactivity. Strong cytoplasmic glandular and stromal immuno¬
reactivity, particularly in a perivascular location, was also
evident following insertion of the LNG-IUS (Figures 3B and
4). There was a significant increase (P < 0.05) in GM-CSF
immunoreactivity in the stromal compartment of LNG-exposed
endometrium at 1, 3, 6 and 12 months post insertion compared
with 'pre-insertion' endometrium biopsied in both the prolifer¬
ative (P < 0.01) and secretory phase [P < 0.05) of the cycle
(Figure 4). Immunoreactivity in normal decidual stromal cells
was similar to secretory phase endometrium (see Figure 4B,
lower panel).
Prolactin-receptor immunostaining
Minimal positive immunostaining was observed in pre-inser¬
tion endometrial biopsies collected in the proliferative phase.
However, in pre-insertion endometrial biopsies from the secre¬
tory phase, positive immunoreactivity was evident in the
cytoplasm of glandular epithelium and in some stromal cells.
Biopsies of first trimester decidua displayed strong immuno¬
reactivity in glands and decidualized stromal cells (Figure
3C). Consistent with these features of prolactin receptor
immunoreactivity in early decidual tissue, biopsies collected
post insertion of the LNG-IUS displayed positive immuno¬
staining both in the glandular epithelium and in pseudo-
decidualized stromal cells (Figure 3D). A significant increase
(P < 0.05) in stromal prolactin receptor immunostaining
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Figure 3. Photomicrographs of granulocyte-macrophage colony stimulating factor (GM-CSF) immunostaining in: A. First trimester decidua.
Positive immunoreactivity (brown staining) is noted panicuiariy in the cytoplasm of large decidualized cells often in a perivascular location.
B. Endometrial biopsy from patient 1 month after insertion of levonorgestrei releasing intrauterine system (LNG-1US). Strong cytoplasmic
immunoreactivity is evident in the stroma. Photomicrographs of prolactin receptor immunostaining in: C. First trimester dec.dua. Positive
immunoreactivity (brown) is clearly visible in decasualized stromal cells. D. Endometrial biopsy collected 3 months post LNG-iUS insertion
displaying positive immunostaining in both glandular epithelium and decidualized stroma. Scale bar = 25 lira.
was evident following insertion of the LNG-iUS (Figure 5.
lower panel).
Leukocyte immunostaininq
Intense positive immunostaining of CD56+ LGL was evident
in all endometrial biopsies collected following insertion of the
intrauterine system. There was significantly greater (P < 0.05)
CD56m immunoreactivity in the stroma of secretory compared
to proliferative endometrium, prior to insertion of the LNG-
IUS (Figure 6B). The significant increase (P < 0.05) was still
evident at 1 and 3 months post insertion of the LNG-IUS
when compared to proliferative endometrium prior to LN'G-
IUS insertion (Figure 6B). Strong CD56— immunostaining
was observed however in normal decidua, especially in areas
of full decidualization. Positive immunoreactivity for CD6S-F
macrophages was also obtained in ail endometrial biopsies
following insertion of the LNG-IUS (Figure 6A). .There was
a significant increase in macrophage immunostaining between
proliferative endometrium pre-insertion and the 1st month post
insertion (P < 0.05). A significant decrease (P < 0.05) in
CD68 — macrophage immunoreactivity was noted from 1-12
months post insertion. There was negligible immunostaining
tor neutrophil eiasta.se (polymorphonuclear leukocyte marker)
in all post insertion endometrial biopsies (data not shown).
Discussion
In order to elucidate further local mechanisms governing
endometrial function with local intrauterine delivery ot
levonorgestrei, the present study has reported histological
features consistent with decidualization. We have observed a
significant increase in GM-CSF immunoreactivity, particularly
in the decidualized stromal cells obsen/ed in LNG exposed
endometrium, plus glandular and stromal prolactin receptor
expression and an infiltrate of CD56— large granular lympho¬
cytes and CD68— macrophages. We are unaware of any
previous reports which have documented longitudinally both
morphological and functional observations in endometrium
exposed to local intrauterine LNG delivery.
The endometrial morphological features following intra¬
uterine levonorgestrei delivery are typical of those seen in
long-term users of a progestogen (Silverberg et al.. 19S6;
Buckley and Fox. 1989). The features of pseudo-decidualiz-
ation closely resembled the morphology of early pregnancy
decidua.
The progestational effects observed in this study occurred
throughout the endometrium and are consistent with an earlier
report (Nilsson et ul.. 1978). and were not limited to the
immediate vicinity of the device. The endometrial biopsies
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Figure 4. Granulocyte-macrophage colony stimulating factor
(GM-CSF) immunostaining scores (mean — SEM) in endometrial
glands (upper panel) and stroma (lower panel) prior to and
following insertion of levonorgestrel releasing intrauterine system
(LNG-iUS). Prolif = proliferative phase. Secret = secretory phase,
M = months.
examined in the present study did not display the micropolyps
described by Silverberg et al. (1986) where the median duration
of use was 48 months and women using a device releasing
20 ug daily were all examined after at least 12 months of use.
The lack of observation of micropoiyps in our study may be
due to the fact that the levonorgestrel intrauterine system had
only been in situ for up to 12 months.
In a few biopsies haemorrhagic infarction, necrobiosis ana
coagulative necrosis were present. These features are indicative
of spontaneous tissue breakdown but differ from that seen in
normal menstruation, in that the features were usually focal
or multifocal. All subjects in this study had recorded details
of daily bleeding (if present) for the full 12 months study
period. On review, the biopsies with evidence of spontaneous
tissue breakdown were not from subjects who had described
break-through bleeding (unpublished data).
Any agent which modifies endometrial morphology is likely
also to modify the normal intrauterine processes regulating
function. The stromal GM-CSF immunoreactivity in the local
ievonorgestrel treated endometrium closely resembled GM-
CSF immunostaining in the epithelial and stromal cells of first
trimester decidua. Particularly of note was the localization
of immunostaining to large perivascular decidualized cells.
Appreciable amounts of GM-CSF are known to be produced




Time of LiNG-IUS insertion
Figure 5. Prolactin receptor immunostaining scores (mean ± SEM)
in endometrial glands (upper panel) and stroma (lower panel) prior
to and post insertion of a levonorgestrei releasing intrauterine
system (LNG-IUS).
role in leukocyte recruitment has been proposed (Robertson
and Seamark, 1992).
Prolactin receptor protein has been immunolocalized to the
glandular epithelium and stromal cells of pseudo-decidualized
endometrium following intrauterine levonorgestrel delivery.
Our observation is consistent with data from our group (Jones
et al.. 1998) concerning expression of the prolactin receptor
in both normal endometrium and first trimester decidua. Locally
derived growth factors and cytokines are likely to regulate
prolactin receptor expression (Gu et al., 1994), and the detection
of strong immunoreactivity for the receptor in both epithelium
and stroma in pseudo-decidualized endometrium suggests a
paracrine role for prolactin.
The pseudo-decidualized endometrium associated with local
levonorgestrel delivery displayed a significant increase in
CD56A LGL when compared with proliferative phase endo¬
metrium and has a persistent population of macrophages.
Normal decidua has a similar leukocyte population (Loke and
King, 1995). The mode of recruitment of these ceils types
remains under investigation, although, under the influence of
progesterone, neither cell type to date has been reported
to express sex steroid receptors (King et al.. 1996). Local
intrauterine levonorgestrel delivery results in a down-regulation
of stromal progesterone receptors (Critchley et al.. 199S) at a
time where, in the current study, we have observed strong
prolactin receptor immunoreactivity that increased significantly
1 month post insertion of the LNG-IUS.
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Figure 6. Mean (± SEM) immunostaining scores for
(A) macrophages (CD68 + ) and (B) large granular lymphocytes
(CD56+) in endometrial stroma before and after exposure to
intrauterine ievonorgestrel.
compartment of the endometrium does indeed undergo changes
consistent with decidualization for at least up to 12 months
post insertion of LNG-IUS. Previous examination of the state
of the endometrial stroma in progestin-only contraceptive users
was limited (Findlay, 1996). Furthermore, it has been suggested
(Findlay, 1996) that there may be a short phase of decidualiz¬
ation following commencement of the method. In this study
evidence is presented that GM-CSF and prolactin receptor
proteins immunolocalize to the pseudo-decidualized ceils in a
similar manner to the true decidual cells of first trimester
pregnancy. It is notable that GM-CSF protein localized particu¬
larly to large decidualized perivascular cells. Findlay (1996)
has noted that in progestin exposed endometrium the decidual¬
ized cells may produce factors not normally associated with
true decidualized cells which may have the potential to be
detrimental to blood vessels.
It is worth noting that in normal decidua immunoreactivity
was heterogeneous, and was most marked for GM-CSF,
prolactin receptor and CD56 where decidualization was
apparent. In these early pregnancy biopsies some regions still
displayed a marked glandular morphology. It is recognised
that during the first trimester, two histologically distinguishable
zones may be observed (Bell, 1991).
The presence of a marked and persistent population of
CD56+ LGL is also consistent with the observation that
uterine LGL are the predominant lymphocyte reported in first
106
trimester decidua (Loke and King, 1997). Furthermore, in this
study macrophages were evident throughout the 12 months
following insertion of a LNG-IUS. In this context Clark et al.
(1996) reported a reduced frequency of CD68+ cells in
the atrophic endometrium of Norplant® users (sub-dermal
levonorgestrel). The number of CD68-P ceils was significantly
increased in those women using Norplant with abnormal
bleeding. In the context of the present study there was a
significant increase in macrophage immunoreactivity at 1
month post LNG-IUS insertion and proliferative phase endo¬
metrium. Interestingly, thereafter a significant decrease in
macrophage immunostaining was observed between 1 and 12
month following insertion of LNG-IUS. No formal quantifica¬
tion of immunostaining was undertaken due to the small size
of many of the later biopsies, and hence the description was
subjective.
Bleeding disorders remain a major problem and a primary
reason for discontinuation of progestin-only methods of contra¬
ception (Findlay, 1996). A previous irregular menstrua] history
has been raised as a potential contributing factor to bleeding
disorders. In the present study all women recruited described
a regular bleeding history. Many of them went on to experience
irregular bleeding with the LNG-IUS in situ. A minority (n =
4) also described heavy loss. Nine out of 14 women (64%)
experienced light menstrual blood loss each month and only one
subject achieved amenorrhoea with the LNG-IUS (unpublished
data). Despite detailed study of the several end points in this
study, no correlation was established with the menstrual
bleeding patterns described by the subjects.
A detailed understanding of the local endometrial mechan¬
isms which are disturbed by the presence of high dose
intrauterine progestagen are also important with respect to the
contraceptive action of the LNG-IUS. Recently Mandelin et al.
(1997) described inappropriate glycodelin A mRNA and protein
expression before and at mid cycle in women using a LNG-
IUS. This untimely production of glycodelin A has been
implicated in the contraceptive action of the LNG-IUS. In this
context glycodelin A is usually absent from the endometrium
in the proliferative and immediate postovulatory phases, i.e.
at a time when glandular progesterone receptor expression is
maximal. It is interesting to note that the inappropriate produc¬
tion of glycodelin A coincides with the down regulation of
progesterone receptor reported (Critchley et al., 1998) with
intrauterine levonorgestrel administration.
In summary, the present study has described features consist¬
ent with endometrial decidualization in the presence of an
intrauterine levonorgestrel-releasing system. It is not possible
to determine whether these decidualized cells are 'true decidual
cells' (Findlay, 1996) although several of the features described
herein are almost indistinguishable from normal decidua.
Further study of the decidualized nature of the stromal cells
in the levonorgestrel exposed endometrium should contribute
to a greater understanding of the mechanisms responsible for
break-through bleeding, a major reason for discontent with
progestin-only contraception.
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